BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990;27 Suppl:S21-4. [PMID: 2194422 DOI: 10.1002/ana.410270707] [Cited by in Crossref: 1226] [Cited by in F6Publishing: 1298] [Article Influence: 37.2] [Reference Citation Analysis]
Number Citing Articles
1 Pimentel V, Luchsinger VW, Carvalho GL, Alcará AM, Esper NB, Marinowic D, Zanirati G, da Costa JC. Guillain-Barré syndrome associated with COVID-19: A systematic review. Brain Behav Immun Health 2023;28:100578. [PMID: 36686624 DOI: 10.1016/j.bbih.2022.100578] [Reference Citation Analysis]
2 Bazán-Rodríguez L, Ruiz-Avalos JA, de Saráchaga AJ, Martinez-Jimenez E, López-Hernández JC, Vargas-Cañas S. Dysautonomia and related outcomes in Guillain-Barre syndrome. Auton Neurosci 2023;245:103070. [PMID: 36634383 DOI: 10.1016/j.autneu.2022.103070] [Reference Citation Analysis]
3 Günay Ç, Sarıkaya Uzan G, Hız Kurul S, Yiş U. Sural Sparing Pattern and Sensory Ratio as Electrodiagnostic and Prognostic Markers in Pediatric Guillain-Barré Syndrome. Neuropediatrics 2023;54:20-30. [PMID: 36096153 DOI: 10.1055/a-1941-4513] [Reference Citation Analysis]
4 Yevgi R, Laloğlu E, Bilge N. High plasma calcitonin gene-related peptide and serum pituitary adenylate cyclase-activating polypeptide levels in patients with neuropathic pain. Revue Neurologique 2023. [DOI: 10.1016/j.neurol.2022.10.005] [Reference Citation Analysis]
5 Wang Y, Yang J, Wen Y. The Peculiarity of Infection and Immunity Correlated with Guillain-Barré Syndrome in the HIV-Infected Population. JCM 2023;12:907. [DOI: 10.3390/jcm12030907] [Reference Citation Analysis]
6 Harsini S, Rezaei N. Autoimmune diseases. Clinical Immunology 2023. [DOI: 10.1016/b978-0-12-818006-8.00001-3] [Reference Citation Analysis]
7 Fujii K, Shiohama T, Uchida T, Ikehara H, Fukuhara T, Sawada D, Aoyama H, Uchikawa H, Yoshii S, Arahata Y, Shimojo N, Misawa S, Kuwabara S. Nationwide survey of childhood Guillain-Barré syndrome, Fisher syndrome, and Bickerstaff brainstem encephalitis in Japan. Brain and Development 2023;45:16-25. [DOI: 10.1016/j.braindev.2022.09.007] [Reference Citation Analysis]
8 Ogbebor O, Tariq S, Jaber T, Super J, Bhanot N, Rana S, Malik K. Neurological Emergencies in the Intensive Care Unit. Critical Care Nursing Quarterly 2023;46:17-34. [DOI: 10.1097/cnq.0000000000000435] [Reference Citation Analysis]
9 Pourbakhtyaran E, Heidari M, Akbari MG, Mohammadi M, Badv RS, Zamani G, Tavasoli AR, Rezaei Z, Mamishi S, Haji Esmaeil Memar E, Hosseiny SMM, Ghabeli H, Haghighi R, Ashrafi MR. Childhood Guillain-Barre syndrome in the SARS-CoV-2 era: Is there any causative relation? Clin Case Rep 2022;10:e6772. [PMID: 36545550 DOI: 10.1002/ccr3.6772] [Reference Citation Analysis]
10 Omura S, Shimizu K, Kuwahara M, Morikawa-Urase M, Kusunoki S, Tsunoda I. Exploratory factor analysis determines latent factors in Guillain-Barré syndrome. Sci Rep 2022;12:21837. [PMID: 36528634 DOI: 10.1038/s41598-022-26422-5] [Reference Citation Analysis]
11 Lupu VV, Miron I, Cianga AL, Gavrilovici C, Grigore I, David AG, Pertea LI, Grigore E, David DE, Lupu A. Diagnostic Pitfalls in Guillain-Barré Syndrome: Case Report and Literature Review. Children (Basel) 2022;9. [PMID: 36553412 DOI: 10.3390/children9121969] [Reference Citation Analysis]
12 Görgülü Ü, Geçer B, Bilen Ş, Kolcu G. Early Disability Predictors of Guillain–Barre Syndrome. SDÜ Tıp Fakültesi Dergisi 2022. [DOI: 10.17343/sdutfd.1188650] [Reference Citation Analysis]
13 McCombe PA, Hardy TA, Nona RJ, Greer JM. Sex differences in Guillain Barré syndrome, chronic inflammatory demyelinating polyradiculoneuropathy and experimental autoimmune neuritis. Front Immunol 2022;13:1038411. [PMID: 36569912 DOI: 10.3389/fimmu.2022.1038411] [Reference Citation Analysis]
14 Ha J, Park S, Kang H, Kyung T, Kim N, Kim DK, Kim H, Bae K, Song MC, Lee KJ, Lee E, Hwang BS, Youn J, Seok JM, Park K. Real-World Data on the Incidence and Risk of Guillain-Barre Syndrome Following SARS-CoV-2 Vaccination: A Prospective Surveillance Study.. [DOI: 10.21203/rs.3.rs-2161509/v1] [Reference Citation Analysis]
15 Luijten LWG, Doets AY, Arends S, Dimachkie MM, Gorson KC, Islam B, Kolb NA, Kusunoki S, Papri N, Waheed W, Walgaard C, Yamagishi Y, Lingsma H, Jacobs BC; IGOS Consortium. Modified Erasmus GBS Respiratory Insufficiency Score: a simplified clinical tool to predict the risk of mechanical ventilation in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 2022:jnnp-2022-329937. [PMID: 36428088 DOI: 10.1136/jnnp-2022-329937] [Reference Citation Analysis]
16 Koga M, Maeda T, Shimizu F, Kanda T. Autoantibodies against contactin‐associated protein 1 and complexes of paranode‐specific proteins in chronic inflammatory demyelinating polyradiculoneuropathy. Clinical & Exp Neuroim 2022. [DOI: 10.1111/cen3.12735] [Reference Citation Analysis]
17 Devi AK, Randhawa MS, Bansal A, Angurana SK, Malhi P, Nallasamy K, Jayashree M. Long-Term Neurological, Behavioral, Functional, Quality of Life, and School Performance Outcomes in Children With Guillain-Barré Syndrome Admitted to PICU. Pediatr Neurol 2022;140:18-24. [PMID: 36587490 DOI: 10.1016/j.pediatrneurol.2022.11.002] [Reference Citation Analysis]
18 Sidow NO, Hassan MS. Intravenous immunoglobulin treatment with prognosis for the first six months of Guillain–Barré Syndrome in Somalia: Case series. Annals of Medicine and Surgery 2022. [DOI: 10.1016/j.amsu.2022.104816] [Reference Citation Analysis]
19 Chohan S, Chohan A. Recurrence of a Rare Subtype of Guillain-Barré Syndrome Following a Second Dose of the Shingles Vaccine. Cureus 2022. [DOI: 10.7759/cureus.30717] [Reference Citation Analysis]
20 Rodríguez de la Rosa RP, Cano-Torres JO, Rosales S, Kleinert AP, Gómez A, George F, George J, Piedad García M, Nájera-Cancino G, Guerra-de-Blas PDC, Belaunzarán-Zamudio PF, Beigel J, Ruiz-Palacios GM; Mexican Emerging Infectious Diseases Clinical Research Network. Guillain-Barré syndrome outbreak in Tapachula temporally associated with the Zika virus introduction in Southern Mexico. Epidemiol Infect 2022;150:e181. [PMID: 36384981 DOI: 10.1017/S0950268822001625] [Reference Citation Analysis]
21 Peng Y, Luo M, Zhang Q. Elevated monocyte to high-density lipoprotein cholesterol ratio correlates with clinical severity in acute inflammatory demyelinating polyradiculoneuropathy patients. Front Neurol 2022;13:955933. [DOI: 10.3389/fneur.2022.955933] [Reference Citation Analysis]
22 Noon A, Malhi JK, Wong CK. Atypical Guillain-Barré Syndrome Presenting After COVID-19 Infection. Cureus 2022. [DOI: 10.7759/cureus.29521] [Reference Citation Analysis]
23 Wang J, Zhang Y, Wang M, Ren Y, Tang M, Liu L, Zhou D. Intravenous immunoglobulin therapy for HIV-associated Guillain-Barré syndrome. Int Immunopharmacol 2022;112:109192. [PMID: 36155283 DOI: 10.1016/j.intimp.2022.109192] [Reference Citation Analysis]
24 Pasutharnchat N, Ratanasirisawad V, Santananukarn M, Taychargumpoo C, Amornvit J, Chunharas C. Sural-sparing pattern: A study against electrodiagnostic subtypes of Guillain–Barre syndrome. Clinical Neurophysiology Practice 2022. [DOI: 10.1016/j.cnp.2022.09.001] [Reference Citation Analysis]
25 Sugumar K, Chidambaram AC, Gunasekaran D. Assessment of neurological sequelae and new‐onset symptoms in the long‐term follow‐up of paediatric Guillain–Barre syndrome: A longitudinal study from India. J Paediatrics Child Health. [DOI: 10.1111/jpc.16185] [Reference Citation Analysis]
26 Papri N, Doets AY, Mohammad QD, Endtz HP, Lingsma HF, Jacobs BC, Islam Z. Validation and adjustment of modified Erasmus GBS outcome score in Bangladesh. Ann Clin Transl Neurol 2022. [PMID: 35908170 DOI: 10.1002/acn3.51627] [Reference Citation Analysis]
27 Kim S, Han HJ, Shin HY, Kim SW. Old age and multiple comorbidity are associated with delayed diagnosis of Guillain-Barre syndrome. Sci Rep 2022;12:9913. [PMID: 35705625 DOI: 10.1038/s41598-022-14184-z] [Reference Citation Analysis]
28 Arends S, Drenthen J, Van den Bergh PYK, Hadden RDM, Shahrizaila N, Dimachkie MM, Gutiérrez Gutiérrez G, Katzberg H, Kiers L, Lehmann HC, Péréon Y, Reisin RC, Uncini A, Verhamme C, Waheed W, Cornblath DR, Jacobs BC; IGOS Electrophysiology Expertise Group. Electrodiagnostic subtyping in Guillain-Barré syndrome: Use of criteria in practice based on a survey study in IGOS. J Peripher Nerv Syst 2022. [PMID: 35700346 DOI: 10.1111/jns.12504] [Reference Citation Analysis]
29 Hayat S, Asad A, Hasan I, Jahan I, Papri N, Howlader ZH, Islam Z. Nucleotide oligomerization domain polymorphism confers no risk to Guillain-Barré syndrome. Acta Neurol Scand 2022. [PMID: 35652365 DOI: 10.1111/ane.13649] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Malaga M, Rodriguez-calienes A, Velasquez-rimachi V, Alva-diaz C. Diagnosis of Guillain-Barré syndrome and use of Brighton criteria in Peruvian hospitals. Arq Neuro-Psiquiatr 2022;80:601-606. [DOI: 10.1590/0004-282x-anp-2021-0225] [Reference Citation Analysis]
31 Naranjo Arango YA, García Henao JP, Farfán Cortés AYAA, Álvarez Correa D. Síndrome de Guillain-Barré como manifestación neurológica autoinmune asociado a COVID-19: Una revisión de la literatura. Revista Colombiana de Reumatología 2022;29:S48-S55. [DOI: 10.1016/j.rcreu.2021.01.004] [Reference Citation Analysis]
32 Germano F, Bellucci M, Grisanti S, Beronio A, Grazzini M, Coco E, Tassinari T, Fabio DC, Chiara DM, Baldi O, Sivori G, Murialdo A, Cabona C, Durando P, Uccelli A, Schenone A, Franciotta D, Benedetti L. COVID-19 vaccine-related Guillain-Barré syndrome in the Liguria region of Italy: A multicenter case series. Journal of the Neurological Sciences 2022. [DOI: 10.1016/j.jns.2022.120330] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 López-hernández JC, Galnares-olalde JA, Jorge de Saráchaga A, Briseño-godínez ME, Pérez-valdez E, May-mas RN, Arista-ramírez JL, Bazán-rodríguez L, León-manriquez E, Burgos-centeno J, Vargas-cañas ES. Very low peroneal nerve compound muscle action potential amplitude predicts poor outcome in patients with Guillain-Barré syndrome: a prospective cohort. Neurol Sci 2022;43:3923-3928. [DOI: 10.1007/s10072-021-05834-7] [Reference Citation Analysis]
34 Rajabally YA. Immunoglobulin and Monoclonal Antibody Therapies in Guillain-Barré Syndrome. Neurotherapeutics 2022. [PMID: 35648286 DOI: 10.1007/s13311-022-01253-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
35 Chua SKK, Soh QY, Saffari SE, Tan E. Prognosis of Guillain–Barré Syndrome Linked to COVID-19 Vaccination. Brain Sciences 2022;12:711. [DOI: 10.3390/brainsci12060711] [Reference Citation Analysis]
36 López-Hernández JC, Jorge de Saráchaga A, Briseño-Godínez ME, May-Mas RN, Bazán-Rodríguez L, León-Manriquez E, Cruz-Pérez J, Becerra-Hernández I, Vargas-Cañas ES. Deltoid Muscle Strength and Autonomic Dysfunction as Independent Risk Factors for Invasive Mechanical Ventilation in Patients with Guillain-Barré Syndrome. Int J Neurosci 2022;:1-13. [PMID: 35633066 DOI: 10.1080/00207454.2022.2082963] [Reference Citation Analysis]
37 Štětkářová I, Ehler E, Židó M, Lauer D, Polák J, Keller J, Peisker T. Influence of Hyperglycaemia and CRP on the Need for Mechanical Ventilation in Guillain-Barré Syndrome. Front Neurol 2022;13:875714. [DOI: 10.3389/fneur.2022.875714] [Reference Citation Analysis]
38 Covino M, Romozzi M, Simeoni B, Di Paolantonio A, Sabatelli M, Franceschi F, Luigetti M. Guillain-Barré syndrome from an emergency department view: how to better predict the outcome? Neurol Res 2022;:1-5. [PMID: 35580194 DOI: 10.1080/01616412.2022.2075661] [Reference Citation Analysis]
39 Solana-rojas A, Miguel García-melo L, Daniela Reyes-varela M, Francisco Díaz-sotelo J, Carlos Pérez-moreno J, Eduardo Basulto-lópez F, Salinas-oviedo C. Recurrence of Guillain Barré Syndrome in Patient Pediatric with Presentation of Two Different Clinical Variants. Demyelination Disorders 2022. [DOI: 10.5772/intechopen.96358] [Reference Citation Analysis]
40 Matos LM, Borges AT, Palmeira AB, Lima VM, Maciel EP, Fernandez RNM, Mendes JPL, Romero GAS. Frequency of exposure to arboviruses and characterization of Guillain Barré syndrome in a clinical cohort of patients treated at a tertiary referral center in Brasília, Federal District. Rev Soc Bras Med Trop 2022;55:e03062021. [PMID: 35416870 DOI: 10.1590/0037-8682-0306-2021] [Reference Citation Analysis]
41 Jahan I, Hayat S, Khalid MM, Ahammad RU, Asad A, Islam B, Mohammad QD, Jacobs BC, Islam Z. Association of mannose-binding lectin 2 gene polymorphisms with Guillain-Barré syndrome. Sci Rep 2022;12:5791. [PMID: 35388043 DOI: 10.1038/s41598-022-09621-y] [Reference Citation Analysis]
42 Arriaga-nieto L, Hernández-bautista PF, Vallejos-parás A, Grajales-muñiz C, Rojas-mendoza T, Cabrera-gaytán DA, Grijalva-otero I, Cacho-díaz B, Jaimes-betancourt L, Padilla-velazquez R, Valle-alvarado G, Perez-andrade Y, Ovalle-luna OD, Rivera-mahey M. Predict the incidence of Guillain Barré Syndrome and arbovirus infection in Mexico, 2014–2019. PLOS Glob Public Health 2022;2:e0000137. [DOI: 10.1371/journal.pgph.0000137] [Reference Citation Analysis]
43 Yevgi R, Bilge N. Comparison of electrodiagnostic findings in patients with post-COVID-19 and non-COVID-19 Guillain-Barre syndrome. Journal of Health Sciences and Medicine 2022;5:539-43. [DOI: 10.32322/jhsm.1054313] [Reference Citation Analysis]
44 Aryal R, Karki S, Rajbhandari S, Gajurel BP, Karn R, Rajbhandari R, Paudel S, Gautam N, Shrestha A, Ojha R. Guillain-Barré syndrome associated with Coronavirus disease 2019: A case from Nepal. Clin Case Rep 2022;10:e05638. [PMID: 35356179 DOI: 10.1002/ccr3.5638] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Hu M, Li X, Wong HY, Feng XG, Wang YZ, Zhang GR. Asymmetric limb weakness in Guillain-Barré syndrome: Three case reports. World J Clin Cases 2022; 10(6): 1896-1902 [DOI: 10.12998/wjcc.v10.i6.1896] [Reference Citation Analysis]
46 Suzuki M, Watanabe G, Watari T. Guillain-Barre Syndrome Caused by Mycoplasma pneumoniae Infection in an Elderly Patient Initially Misdiagnosed As Frailty. Cureus 2022. [DOI: 10.7759/cureus.22386] [Reference Citation Analysis]
47 Hiew FL, Thit WM, Alexander M, Thirugnanam U, Siritho S, Tan K, Mya Aye SM, Ohnmar O, Estiasari R, Yassin N, Pasco PM, Keosodsay SS, Trong Nghia HT, Islam MB, Wong SK, Lee S, Chhabra A, Viswanathan S. Consensus recommendation on the use of therapeutic plasma exchange for adult neurological diseases in Southeast Asia from the Southeast Asia therapeutic plasma exchange consortium. J Cent Nerv Syst Dis 2021;13:11795735211057314. [PMID: 35173510 DOI: 10.1177/11795735211057314] [Reference Citation Analysis]
48 Ma L, Liu S, Xiao Z, Guan J, Liu Y, Yao J, Lu Z. Comparison of the effects of different doses of Glucocorticoids on distinct subtypes of Guillain-Barré syndrome in Southern China. BMC Neurol 2022;22. [DOI: 10.1186/s12883-022-02567-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Islam B, Islam Z, Endtz HP, Jahan I, Jacobs BC, Mohammad QD, Franssen H. Electrophysiology of Guillain-Barré syndrome in Bangladesh: A prospective study of 312 patients. Clin Neurophysiol Pract 2021;6:155-63. [PMID: 35112034 DOI: 10.1016/j.cnp.2021.03.007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
50 Yao J, Liu Y, Liu S, Lu Z. Regional Differences of Guillain-Barré Syndrome in China: From South to North. Front Aging Neurosci 2022;14:831890. [DOI: 10.3389/fnagi.2022.831890] [Reference Citation Analysis]
51 Carpentier VT, Le Guennec L, Fall SAA, Viala K, Demeret S, Weiss N. [Pathophysiological and diagnostic aspects of Guillain-Barré syndrome]. Rev Med Interne 2022:S0248-8663(21)01146-2. [PMID: 34998626 DOI: 10.1016/j.revmed.2021.12.005] [Reference Citation Analysis]
52 Arends S, Drenthen J, van den Bergh P, Franssen H, Hadden RD, Islam B, Kuwabara S, Reisin RC, Shahrizaila N, Amino H, Antonini G, Attarian S, Balducci C, Barroso F, Bertorini T, Binda D, Brannagan TH, Buermann J, Casasnovas C, Cavaletti G, Chao C, Dimachkie MM, Fulgenzi EA, Galassi G, Gutiérrez Gutiérrez G, Harbo T, Hartung H, Hsieh S, Kiers L, Lehmann HC, Manganelli F, Marfia GA, Mataluni G, Pardo J, Péréon Y, Rajabally YA, Santoro L, Sekiguchi Y, Stein B, Stettner M, Uncini A, Verboon C, Verhamme C, Vytopil M, Waheed W, Wang M, Zivkovic S, Jacobs BC, Cornblath DR. Electrodiagnosis of Guillain-Barre syndrome in the International GBS Outcome Study: Differences in methods and reference values. Clinical Neurophysiology 2022. [DOI: 10.1016/j.clinph.2021.12.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
53 Joshua AM, Misri Z. Peripheral Nerve Disorders. Physiotherapy for Adult Neurological Conditions 2022. [DOI: 10.1007/978-981-19-0209-3_11] [Reference Citation Analysis]
54 Rabinstein AA. Emergencies in Peripheral Neuropathies. Emergencies in Neuromuscular Disorders 2022. [DOI: 10.1007/978-3-030-91932-0_7] [Reference Citation Analysis]
55 López-hernández J, Lisette B, Adib JDS, Eunice M, Elizabeth L, Erika G, Steven V. Guillain-Barré syndrome following SARS-CoV-2 vaccination: Is there a real association? Neuroimmunology Reports 2022;2:100050. [DOI: 10.1016/j.nerep.2021.100050] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
56 Gupta A, Ranga A, Prakash NB, Khanna M. Rehabilitation outcomes in patients with post-COVID-19 vaccine-associated Guillain-Barre syndrome. J Neurosci Rural Pract 2022;13:684-90. [PMID: 36743741 DOI: 10.25259/JNRP-2022-6-26] [Reference Citation Analysis]
57 Seok JI. A Case of Guillain-Barre Syndrome after COVID-19 Vaccination. Korean J Neuromuscul Disord 2021;13:67-69. [DOI: 10.46518/kjnmd.2021.13.2.67] [Reference Citation Analysis]
58 Chakraborty U, Hati A, Chandra A. Letter and response to letter: Covid-19 associated Guillain-Barré syndrome: A series of a relatively uncommon neurological complication. Diabetes Metab Syndr 2021;16:102370. [PMID: 34972040 DOI: 10.1016/j.dsx.2021.102370] [Reference Citation Analysis]
59 Shasha D, Heymann AD, Zacay G. Real-world safety data for the Pfizer BNT162b2 SARS-CoV-2 vaccine, historical cohort study - Author's reply. Clin Microbiol Infect 2021:S1198-743X(21)00708-4. [PMID: 34923127 DOI: 10.1016/j.cmi.2021.12.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
60 López-Hernández JC, Briseño-Godinez ME, Pérez-Valdez EY, May-Mas RN, Galnares-Olalde JA, Martínez-Angeles V, Ramírez-Bermudez J, León-Manriquez E, Chavira-Hernández G, Vargas-Cañas ES. Inpatient Delirium in Guillain-Barré Syndrome: Frequency and Clinical Characteristics in a Mexican Hospital. Cureus 2021;13:e19260. [PMID: 34900457 DOI: 10.7759/cureus.19260] [Reference Citation Analysis]
61 Zhu J, Zhang Y, Li R, Lin Y, Fu Y, Yan Y, Zhu W, Wang N, Zhang Z, Xu G. Anti-ganglioside Antibodies in Guillain-Barre Syndrome: A Novel Immunoblotting-Panel Assay. Front Neurol 2021;12:760889. [PMID: 34899578 DOI: 10.3389/fneur.2021.760889] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
62 Ren K, Yang A, Lu J, Zhao D, Bai M, Ding J, Wei T, Li H, Guo J. Association between serum low-density neutrophils and acute-onset and recurrent Guillain-Barré syndrome. Brain Behav 2021;:e2456. [PMID: 34894104 DOI: 10.1002/brb3.2456] [Reference Citation Analysis]
63 Cheng K, Wang Y, Zhou Y, Xia R, Tang L, Liu J. Neurological Adverse Events Induced by Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Current Perspectives and New Development. Clin Med Insights Oncol 2021;15:11795549211056261. [PMID: 34866959 DOI: 10.1177/11795549211056261] [Reference Citation Analysis]
64 Sada K, Hidaka S, Takemaru M, Ueno D, Shibata H. A case of polyneuropathy associated with diabetic ketoacidosis in new-onset type 1 diabetes. J Diabetes Investig 2021. [PMID: 34845866 DOI: 10.1111/jdi.13724] [Reference Citation Analysis]
65 Ždraljević M, Radišić V, Perić S, Kačar A, Jovanović D, Berisavac I. Guillain-Barré syndrome during pregnancy: A case series. J Obstet Gynaecol Res 2021. [PMID: 34850502 DOI: 10.1111/jog.15116] [Reference Citation Analysis]
66 Ducci RD, Tessaro CL, Kay CSK, Fustes OJH, Werneck LC, Lorenzoni PJ, Scola RH. Peripheral polyneuropathy from electrodiagnostic tests: a 10-year etiology and neurophysiology overview. Arq Neuropsiquiatr 2021:S0004-282X2021005023201. [PMID: 34816968 DOI: 10.1590/0004-282X-ANP-2020-0561] [Reference Citation Analysis]
67 Oo WM, Giri P, de Souza A. AstraZeneca COVID-19 vaccine and Guillain- Barré Syndrome in Tasmania: A causal link? J Neuroimmunol 2021;360:577719. [PMID: 34560365 DOI: 10.1016/j.jneuroim.2021.577719] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 10.0] [Reference Citation Analysis]
68 Helfferich J, Roodbol J, de Wit MC, Brouwer OF, Jacobs BC; 2016 Enterovirus D68 Acute Flaccid Myelitis Working Group and the Dutch Pediatric GBS Study Group. Acute flaccid myelitis and Guillain-Barré syndrome in children: A comparative study with evaluation of diagnostic criteria. Eur J Neurol 2021. [PMID: 34747551 DOI: 10.1111/ene.15170] [Reference Citation Analysis]
69 Chakraborty U, Hati A, Chandra A. Covid-19 associated Guillain-Barré syndrome: A series of a relatively uncommon neurological complication. Diabetes Metab Syndr 2021;15:102326. [PMID: 34731822 DOI: 10.1016/j.dsx.2021.102326] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
70 Lleixà C, Martín-Aguilar L, Pascual-Goñi E, Franco T, Caballero M, de Luna N, Gallardo E, Suárez-Calvet X, Martínez-Martínez L, Diaz-Manera J, Rojas-García R, Cortés-Vicente E, Turón J, Casasnovas C, Homedes C, Gutiérrez-Gutiérrez G, Jimeno-Montero MC, Berciano J, Sedano-Tous MJ, García-Sobrino T, Pardo-Fernández J, Márquez-Infante C, Rojas-Marcos I, Jericó-Pascual I, Martínez-Hernández E, Morís de la Tassa G, Domínguez-González C, Juárez C, Illa I, Querol L. Autoantibody screening in Guillain-Barré syndrome. J Neuroinflammation 2021;18:251. [PMID: 34719386 DOI: 10.1186/s12974-021-02301-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
71 Narukawa S, Ishizuka K, Sugimoto K, Nomura K. Utility of phrenic nerve conduction studies for identification of patients with neuromuscular diseases requiring invasive mechanical ventilation. Muscle Nerve 2021. [PMID: 34708432 DOI: 10.1002/mus.27449] [Reference Citation Analysis]
72 Min YG, Ju W, Ha YE, Ban JJ, Lee SA, Sung JJ, Shin JY. Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: Report of two cases and review of literature. J Neuroimmunol 2021;359:577691. [PMID: 34416410 DOI: 10.1016/j.jneuroim.2021.577691] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 11.5] [Reference Citation Analysis]
73 Doherty L, Chaudhry V. Inpatient Diagnosis and Management of Neuromuscular Disorders. Semin Neurol 2021;41:493-510. [PMID: 34619777 DOI: 10.1055/s-0041-1733794] [Reference Citation Analysis]
74 Gu BM, Ko HH, Lee HK, Ra YJ, Lee HS, Kim HS. Guillain-Barré Syndrome after Lung Transplantation in the Immediate Postoperative Period: Case Report. J Chest Surg 2021;54:396-9. [PMID: 33767020 DOI: 10.5090/jcs.20.074] [Reference Citation Analysis]
75 Yevgi R. Guillain-Barré Syndrome During the COVID-19 Pandemic and the Relationship Between Acute Phase Reactants and Disability. Archives of Medical Research 2021. [DOI: 10.1016/j.arcmed.2021.10.002] [Reference Citation Analysis]
76 Demuth S, Felten R, Sordet C, Chatelus E, Chanson J, Arnaud L. Le défi diagnostique des présentations rhumatologiques du syndrome de Guillain-Barré : huit cas. Revue du Rhumatisme 2021;88:382-386. [DOI: 10.1016/j.rhum.2021.05.007] [Reference Citation Analysis]
77 Nedkova V, Gutiérrez-Gutiérrez G, Navacerrada-Barrero FJ, Berciano J, Casasnovas C. Re-evaluating the accuracy of optimized electrodiagnostic criteria in very early Guillain-Barré syndrome: a sequential study. Acta Neurol Belg 2021;121:1141-50. [PMID: 33599939 DOI: 10.1007/s13760-021-01603-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
78 Briseño-Godínez ME, Arauz A, López-Hernández JC, de Saráchaga AJ, Pérez-Valdez EY, May-Más RN, López-Hernández G, Bazán-Rodriguez L, Galnares-Olalde JA, León-Manríquez E, Vargas-Cañas ES. Prognostic Factors in Elderly Patients With Guillain-Barré Syndrome: Does Age Matter? Neurohospitalist 2021;11:303-9. [PMID: 34567390 DOI: 10.1177/19418744211002676] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
79 Velásquez-Rimachi V, López-Saavedra AV, Rodriguez-López E, Elguera-Huaman H, Meza K, Alva-Díaz C, Pacheco-Barrios K. Clinical-epidemiological characteristics associated with discharge outcomes and seasonality among surviving patients with Guillain-Barré syndrome in a national third-level hospital, Lima, Peru. Arq Neuropsiquiatr 2021;79:697-704. [PMID: 34550186 DOI: 10.1590/0004-282X-anp-2020-0154] [Reference Citation Analysis]
80 Luijten LWG, Leonhard SE, van der Eijk AA, Doets AY, Appeltshauser L, Arends S, Attarian S, Benedetti L, Briani C, Casasnovas C, Castellani F, Dardiotis E, Echaniz-Laguna A, Garssen MPJ, Harbo T, Huizinga R, Humm AM, Jellema K, van der Kooi AJ, Kuitwaard K, Kuntzer T, Kusunoki S, Lascano AM, Martinez-Hernandez E, Rinaldi S, Samijn JPA, Scheidegger O, Tsouni P, Vicino A, Visser LH, Walgaard C, Wang Y, Wirtz PW, Ripellino P, Jacobs BC; IGOS consortium. Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study. Brain 2021;144:3392-404. [PMID: 34553216 DOI: 10.1093/brain/awab279] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 11.0] [Reference Citation Analysis]
81 Rossetti A, Gheihman G, O'Hare M, Kosowsky JM. Guillain-Barré Syndrome Presenting as Facial Diplegia after COVID-19 Vaccination: A Case Report. J Emerg Med 2021;61:e141-5. [PMID: 34538679 DOI: 10.1016/j.jemermed.2021.07.062] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
82 Kumar M, Kalita J, Kant Misra U, Dhar N. Prediction models for mechanical ventilation and outcome in Guillain-Barré syndrome. J Clin Neurosci 2021;92:131-5. [PMID: 34509240 DOI: 10.1016/j.jocn.2021.07.060] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
83 Luo HY, Li XJ, Cheng M, Wang J, Xie LL, Yao ZX, Jiang L. Clinical characteristics of children with Guillain-Barré syndrome and factors associated with disease severity. J Clin Neurosci 2021;92:120-5. [PMID: 34509238 DOI: 10.1016/j.jocn.2021.08.001] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
84 Oliveira DRDCAB, Fernandez RNM, Grippe TC, Baião FS, Duarte RL, Fernandez DJ. Epidemiological and clinical aspects of Guillain-Barré syndrome and its variants. Arq Neuropsiquiatr 2021;79:497-503. [PMID: 34320055 DOI: 10.1590/0004-282X-ANP-2020-0314] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
85 Dourado Junior MET, Sousa BF, Costa NMCD, Jeronimo SMB. Cytomegalovirus infection in Guillain-Barré syndrome: a retrospective study in Brazil. Arq Neuropsiquiatr 2021;79:607-11. [PMID: 34468494 DOI: 10.1590/0004-282X-ANP-2020-0464] [Reference Citation Analysis]
86 Dhamne MC, Benny R, Singh R, Pande A, Agarwal P, Wagh S, Oak P, Lakhotia A, Godge Y, Bolegave V, Doshi D, Patidar Y, Venkatachalam A, Pujara B, Borse S, Makhija P, Khadilkar S. Guillian--Barre' Syndrome in Patients with SARS-CoV-2: A Multicentric Study from Maharashtra, India. Ann Indian Acad Neurol 2021;24:339-46. [PMID: 34446994 DOI: 10.4103/aian.AIAN_1303_20] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
87 Azab MA, Azzam AY, Salem AE, Reda A, Hassanein SF, Sabra M, Gadelmoula IS. Neurological problems in the context of COVID-19 infection in Egypt. A multicenter retrospective analysis. Interdiscip Neurosurg 2021;26:101345. [PMID: 34426783 DOI: 10.1016/j.inat.2021.101345] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
88 Gong Q, Liu S, Xiao Z, Fu X, Lu Z. Elevated blood and cerebrospinal fluid glucose levels affect the severity and short-term prognosis of Guillain-Barré syndrome. Neurol Res 2021;:1-7. [PMID: 34382919 DOI: 10.1080/01616412.2021.1965337] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
89 Fritz-Weltin M, Frommherz E, Isenmann N, Niedermeier L, Csernalabics B, Boettler T, Neumann-Haefelin C, Endres D, Panning M, Berger B. Hepatitis E virus as a trigger for Guillain-Barré syndrome. BMC Neurol 2021;21:304. [PMID: 34362318 DOI: 10.1186/s12883-021-02334-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
90 Liu L, Ye Y, Wang L, Song X, Cao J, Qi Y, Xing Y. Nerve ultrasound evaluation of Guillain-Barré syndrome subtypes in northern China. Muscle Nerve 2021. [PMID: 34355400 DOI: 10.1002/mus.27386] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
91 Yaranagula SD, Koduri VKC. Spectrum of Acute Neuropathy Associated With Covid-19: A Clinical and Electrophysiological Study of 13 Patients From a Single Center. Int J Infect Dis 2021;110:314-9. [PMID: 34333121 DOI: 10.1016/j.ijid.2021.07.066] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
92 Ohnari K, Okada K, Mafune K, Kusunoki S, Adachi H. Unclassified subtype of Guillain-Barré syndrome is associated with quick recovery. J Clin Neurosci 2021;91:313-8. [PMID: 34373045 DOI: 10.1016/j.jocn.2021.07.025] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
93 Demichelis C, Grisanti S, Massa F, Serrati C, Beronio A, Mannironi A, Mobilia E, Briani C, Schenone A, Benedetti L. Abnormal sweating and "skin flushing" as possible predictive factor for treatment related fluctuations in Guillain-Barré syndrome: a case series and a review of the literature. J Neurol Sci 2021;428:117589. [PMID: 34325159 DOI: 10.1016/j.jns.2021.117589] [Reference Citation Analysis]
94 Sousa IP Jr, Dos Santos FB, de Paula VS, Vieira TCRG, Dias HG, Barros CA, da Silva EE. Viral and Prion Infections Associated with Central Nervous System Syndromes in Brazil. Viruses 2021;13:1370. [PMID: 34372576 DOI: 10.3390/v13071370] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
95 Halani S, Tombindo PE, O'Reilly R, Miranda RN, Erdman LK, Whitehead C, Bielecki JM, Ramsay L, Ximenes R, Boyle J, Krueger C, Willmott S, Morris SK, Murphy KE, Sander B. Clinical manifestations and health outcomes associated with Zika virus infections in adults: A systematic review. PLoS Negl Trop Dis 2021;15:e0009516. [PMID: 34252102 DOI: 10.1371/journal.pntd.0009516] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
96 Dutta D, Debnath M, Nagappa M, Das SK, Wahatule R, Sinha S, Taly AB, Ravi V. Antecedent infections in Guillain-Barré syndrome patients from south India. J Peripher Nerv Syst 2021. [PMID: 34254392 DOI: 10.1111/jns.12459] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
97 Rasera A, Romito S, Segatti A, Concon E, Alessandrini L, Basaldella F, Badari A, Bonetti B, Squintani G. Very early and early neurophysiological abnormalities in Guillain-Barré syndrome: A 4-year retrospective study. Eur J Neurol 2021. [PMID: 34233056 DOI: 10.1111/ene.15011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
98 Khan F, Sharma P, Pandey S, Sharma D, V V, Kumar N, Shukla S, Dandu H, Jain A, Garg RK, Malhotra HS. COVID-19-associated Guillain-Barre syndrome: Postinfectious alone or neuroinvasive too? J Med Virol 2021;93:6045-9. [PMID: 34170552 DOI: 10.1002/jmv.27159] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
99 Bromberg MB. What Is in the Literature. J Clin Neuromuscul Dis 2020;22:35-41. [PMID: 32833722 DOI: 10.1097/CND.0000000000000298] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
100 Wen P, Wang L, Liu H, Gong L, Ji H, Wu H, Chu W. Risk factors for the severity of Guillain-Barré syndrome and predictors of short-term prognosis of severe Guillain-Barré syndrome. Sci Rep 2021;11:11578. [PMID: 34079013 DOI: 10.1038/s41598-021-91132-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
101 Cha HJ, Kim BS, Lee YJ, Kim HB, Sung KJ, Lee YR, Kim JY, Kim ES, Jeon JH, Kim YI. A Patient with Guillain-Barre Syndrome Treated with Combined Korean Medicine Treatments. J Acupunct Res 2021;38:170-4. [DOI: 10.13045/jar.2020.00318] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
102 Maskin LP, Wilken M, Rodriguez Lucci F, Wisnivesky JP, Barroso F, Wainsztein N. Risk factors for respiratory failure among hospitalized patients with Guillain-Barré syndrome. Neurologia 2021:S0213-4853(21)00082-7. [PMID: 34074564 DOI: 10.1016/j.nrl.2021.04.011] [Reference Citation Analysis]
103 Kasemsap N, Vorasoot N, Kongbunkiat K, Tiamkao S, Chotmongkol V, Sawanyawisuth K, Panitchote A. The epidemiology of Guillain-Barré syndrome in Thailand over 13 years (2005-2017): A nationwide population-based retrospective cohort study. J Peripher Nerv Syst 2021;26:202-8. [PMID: 33969589 DOI: 10.1111/jns.12453] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
104 Krishnakumar A, Kewalramani D, Mahalingam H, Manokaran RK. Guillain-Barré Syndrome with Preserved Reflexes in a Child after COVID-19 Infection. Indian J Pediatr 2021;88:831-2. [PMID: 34036543 DOI: 10.1007/s12098-021-03792-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
105 Song Y, Zhang Y, Yuki N, Wakerley BR, Liu C, Song J, Wang M, Feng X, Hao Y, Wang Y. Guillain-Barré syndrome in Eastern China: A study of 595 patients. Eur J Neurol 2021;28:2727-35. [PMID: 33949041 DOI: 10.1111/ene.14898] [Reference Citation Analysis]
106 Malaga M, Rodriguez-Calienes A, Marquez-Nakamatsu A, Recuay K, Merzthal L, Bustamante-Paytan D, Sifuentes JM, Castillo-Kohatsu G, Alva-Diaz C. Predicting Mechanical Ventilation Using the EGRIS in Guillain-Barré Syndrome in a Latin American Country. Neurocrit Care 2021. [PMID: 34021483 DOI: 10.1007/s12028-021-01218-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
107 Chiesa M, Decima R, Bertinat A, Poggi L, Hackembruch H, Montenegro C, Chiparelli H, Vázquez C. Incidence of Guillain-Barré syndrome in an Uruguayan population. A prospective cohort study. J Peripher Nerv Syst 2021;26:209-15. [PMID: 33945181 DOI: 10.1111/jns.12450] [Reference Citation Analysis]
108 Lleixà C, Martín-aguilar L, Pascual-goñi E, Franco T, Caballero M, Diaz-manera J, Rojas-garcía R, de Luna N, Gallardo E, Cortés-vicente E, Turón J, Suárez-calvet X, Casasnovas C, Homedes C, Gutiérrez-gutiérrez G, Jimeno-montero MC, Berciano J, Sedano Tous MJ, Garcia-sobrino T, Pardo-fernandez J, Márquez-infante C, Rojas-marcos I, Jericó-pascual I, Martínez-hernández E, Morís de la Tassa G, Domínguez-gonzález C, Martínez-martínez L, Juárez C, Illa I, Querol L. Autoantibody screening in Guillain-Barré Syndrome.. [DOI: 10.1101/2021.05.10.21256964] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
109 Orlikowski D. Syndrome de Guillain-Barré. Pratique Neurologique - FMC 2021;12:109-115. [DOI: 10.1016/j.praneu.2021.03.004] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
110 Hongo Y, Kaida K, Komuta Y, Takazaki H, Yamazaki K, Suzuki K. Cholesterol-added antigens can enhance antiglycolipid antibody activity: Application to antibody testing. J Neuroimmunol 2021;356:577580. [PMID: 33933819 DOI: 10.1016/j.jneuroim.2021.577580] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
111 Al Maawali SM, Al Shibani AY, Nadeem AS, Al-Salti AM. Guillain-Barre syndrome: demographics, clinical features, and outcome in a single tertiary care hospital, Oman. Neurosciences (Riyadh) 2020;25:369-74. [PMID: 33459285 DOI: 10.17712/nsj.2020.5.20200057] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
112 Tan CY, Razali SNO, Goh KJ, Shahrizaila N. Determining the Utility of the Guillain-Barré Syndrome Classification Criteria. J Clin Neurol 2021;17:273-82. [PMID: 33835749 DOI: 10.3988/jcn.2021.17.2.273] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
113 Keskin H, Keskin F, Basaslan I, Tan H. Çocuk Yoğun Bakım Ünitesinde Takip Edilen Guillain Barre Sendromu Olguları; 3 Yıllık Deneyim. Sakarya Medical Journal 2021. [DOI: 10.31832/smj.855110] [Reference Citation Analysis]
114 Kwan J, Biliciler S. Guillain-Barré Syndrome and Other Acute Polyneuropathies. Clin Geriatr Med 2021;37:313-26. [PMID: 33858613 DOI: 10.1016/j.cger.2021.01.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
115 Walgaard C, Jacobs BC, Lingsma HF, Steyerberg EW, van den Berg B, Doets AY, Leonhard SE, Verboon C, Huizinga R, Drenthen J, Arends S, Budde IK, Kleyweg RP, Kuitwaard K, van der Meulen MFG, Samijn JPA, Vermeij FH, Kuks JBM, van Dijk GW, Wirtz PW, Eftimov F, van der Kooi AJ, Garssen MPJ, Gijsbers CJ, de Rijk MC, Visser LH, Blom RJ, Linssen WHJP, van der Kooi EL, Verschuuren JJGM, van Koningsveld R, Dieks RJG, Gilhuis HJ, Jellema K, van der Ree TC, Bienfait HME, Faber CG, Lovenich H, van Engelen BGM, Groen RJ, Merkies ISJ, van Oosten BW, van der Pol WL, van der Meulen WDM, Badrising UA, Stevens M, Breukelman AJ, Zwetsloot CP, van der Graaff MM, Wohlgemuth M, Hughes RAC, Cornblath DR, van Doorn PA; Dutch GBS Study Group. Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial. Lancet Neurol 2021;20:275-83. [PMID: 33743237 DOI: 10.1016/S1474-4422(20)30494-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
116 Shahrizaila N, Lehmann HC, Kuwabara S. Guillain-Barré syndrome. Lancet 2021;397:1214-28. [PMID: 33647239 DOI: 10.1016/S0140-6736(21)00517-1] [Cited by in Crossref: 92] [Cited by in F6Publishing: 104] [Article Influence: 46.0] [Reference Citation Analysis]
117 Dhar N, Madhaw G, Kumar M, Kumar N, Tiwari A, Jatale V. Non-COVID Neurological Emergencies: A Silent Killer Going Unnoticed during COVID-19 Pandemic. J Neurosci Rural Pract 2021;12:461-9. [PMID: 34295099 DOI: 10.1055/s-0040-1722810] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
118 Hasan I, Papri N, Hayat S, Jahan I, Ara G, Islam B, Islam Z. Clinical and serological prognostic factors in childhood Guillain-Barré syndrome: A prospective cohort study in Bangladesh. J Peripher Nerv Syst 2021;26:83-9. [PMID: 33555098 DOI: 10.1111/jns.12434] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
119 Leonhard SE, Mandarakas MR, Gondim FA, Bateman K, Ferreira ML, Cornblath DR, Van Doorn PA, Dourado ME, Hughes RA, Islam B, Kusunoki S, Pardo CA, Reisin R, Sejvar JJ, Shahrizaila N, Soares C, Umapathi T, Wang Y, Yiu EM, Willison HJ, Jacobs BC. Diretrizes Baseadas em Evidências Diagnóstico e manejo da Síndrome de Guillain–Barré em dez etapas. Rev Neurocienc 2021;29:1-52. [DOI: 10.34024/rnc.2021.v29.11725] [Reference Citation Analysis]
120 Ning P, Yang B, Yang X, Huang H, Shen Q, Zhao Q, Xie D, Lu H, Xu Y. Lymphocyte-based ratios for predicting respiratory failure in Guillain-Barré syndrome. J Neuroimmunol 2021;353:577504. [PMID: 33548620 DOI: 10.1016/j.jneuroim.2021.577504] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
121 Sen S, Kumar A, Roy B. Clinical Outcome of Guillain-Barré Syndrome in 108 Children. Indian Pediatr 2021;58:833-5. [DOI: 10.1007/s13312-021-2302-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
122 Gong Q, Liu S, Liu Y, Yao J, Fu X, Xiao Z, Lu Z. Guillain-Barré syndrome triggered by surgery in a Chinese population: a multicenter retrospective study. BMC Neurol 2021;21:40. [PMID: 33509120 DOI: 10.1186/s12883-021-02067-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
123 Demuth S, Felten R, Sordet C, Chatelus E, Chanson JB, Arnaud L. Rheumatic presentations of Guillain-Barré syndrome as a diagnostic challenge: A case series. Joint Bone Spine 2021;88:105144. [PMID: 33515790 DOI: 10.1016/j.jbspin.2021.105144] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
124 Ali ZPM, Taheri M, Sangsefidi S, Arsang-Jang S, Mazdeh M, Zamani A, Ghafouri-Fard S, Eftekharian MM. Evaluation of Expression of STAT Genes in Immune-Mediated Polyneuropathies. J Mol Neurosci 2020;70:945-52. [PMID: 32036580 DOI: 10.1007/s12031-020-01494-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
125 Özdemir FMA, Ceylan N, Çelik H, Yildiz D, Aksoy A, Yüksel D. Senkopla Başvuran Bir Guillain-Barre Sendromu: Olgu Sunumu. Turkish Journal of Pediatric Disease 2021. [DOI: 10.12956/tchd.731691] [Reference Citation Analysis]
126 Raahimi MM, Kane A, Moore CE, Alareed AW. Late onset of Guillain-Barré syndrome following SARS-CoV-2 infection: part of 'long COVID-19 syndrome'? BMJ Case Rep 2021;14:e240178. [PMID: 33462068 DOI: 10.1136/bcr-2020-240178] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 16.5] [Reference Citation Analysis]
127 Wilks AW, Bucelli RC. Acute and Chronic Immune Neuropathies and Radiculopathies. Neuroimmunology 2021. [DOI: 10.1007/978-3-030-61883-4_18] [Reference Citation Analysis]
128 Kesici S, Bayrakci B. Severe Guillain-Barré syndrome. Zika Virus Impact, Diagnosis, Control, and Models 2021. [DOI: 10.1016/b978-0-12-820267-8.00011-x] [Reference Citation Analysis]
129 Singh V, Allawadhi P, Khurana A, Banothu AK, Bharani KK. Critical neurological features of COVID-19: Role of imaging methods and biosensors for effective diagnosis. Sensors International 2021;2:100098. [DOI: 10.1016/j.sintl.2021.100098] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
130 Yeldo D, Ravindra T, Arjun B. Guillain-Barré Syndrome Associated with COVID-19: A Neurochallenge!! APIK J Int Med 2021;9:264. [DOI: 10.4103/ajim.ajim_76_21] [Reference Citation Analysis]
131 Satkowiak K, Smith AG. Guillain-Barré Syndrome. Emergency Neurology 2021. [DOI: 10.1007/978-3-030-75778-6_12] [Reference Citation Analysis]
132 Papri N, Islam Z, Leonhard SE, Mohammad QD, Endtz HP, Jacobs BC. Guillain-Barré syndrome in low-income and middle-income countries: challenges and prospects. Nat Rev Neurol 2021;17:285-96. [PMID: 33649531 DOI: 10.1038/s41582-021-00467-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
133 Cao Q, Chu H, Fu X, Yao J, Xiao Z, Lu Z. Case Report: Acute Bulbar Palsy Plus Syndrome: A Guillain-Barré Syndrome Variant More Prone to Be a Subtype Than Overlap of Distinct Subtypes. Front Neurol 2020;11:566480. [PMID: 33329308 DOI: 10.3389/fneur.2020.566480] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
134 Tiwari I, Alam A, Kanta C, Koonwar S, Garg RK, Pandey S, Jain A, Kumar R. Clinical Profile and Predictors of Mechanical Ventilation in Guillain-Barre Syndrome in North Indian Children. J Child Neurol 2021;36:453-60. [PMID: 33331796 DOI: 10.1177/0883073820978020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
135 Soytürk H, Yılmaz M. A comparison of IL-17 and IL-34 concentrations in the cerebrospinal fluid of patients with acute inflammatory demyelinating neuropathy and chronic inflammatory demyelinating polyneuropathy. Rev Assoc Med Bras (1992) 2020;66:1583-8. [PMID: 33295414 DOI: 10.1590/1806-9282.66.11.1583] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
136 Hashim NA, Mohamed WS, Emad EM. Neutrophil–lymphocyte ratio and response to plasmapheresis in Guillain–Barré syndrome: a prospective observational study. Egypt J Neurol Psychiatry Neurosurg 2020;56. [DOI: 10.1186/s41983-020-0154-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
137 Hegen H, Ladstätter F, Bsteh G, Auer M, Berek K, Di Pauli F, Walde J, Wanschitz J, Zinganell A, Deisenhammer F. Cerebrospinal fluid protein in Guillain-Barré syndrome: Need for age-dependent interpretation. Eur J Neurol 2021;28:965-73. [PMID: 33073472 DOI: 10.1111/ene.14600] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
138 Ning P, Yang B, Yang X, Huang H, Shen Q, Zhao Q, Lu H, Yang L, Tian S, Xu Y. Clinical value of C-reactive protein/albumin ratio in Guillain-Barré syndrome. Neurol Sci 2021;42:3275-83. [PMID: 33247320 DOI: 10.1007/s10072-020-04930-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
139 Kajumba MM, Kolls BJ, Koltai DC, Kaddumukasa M, Kaddumukasa M, Laskowitz DT. COVID-19-Associated Guillain-Barre Syndrome: Atypical Para-infectious Profile, Symptom Overlap, and Increased Risk of Severe Neurological Complications. SN Compr Clin Med 2020;:1-13. [PMID: 33251483 DOI: 10.1007/s42399-020-00646-w] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
140 Alborzian Deh Sheikh A, Gomaa S, Li X, Routledge M, Saigoh K, Numoto N, Angata T, Hitomi Y, Takematsu H, Tsuiji M, Ito N, Kusunoki S, Tsubata T. A Guillain-Barré syndrome-associated SIGLEC10 rare variant impairs its recognition of gangliosides. J Autoimmun 2021;116:102571. [PMID: 33223341 DOI: 10.1016/j.jaut.2020.102571] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
141 McDonnell EP, Altomare NJ, Parekh YH, Gowda RC, Parikh PD, Lazar MH, Blaser MJ. COVID-19 as a Trigger of Recurrent Guillain-Barré Syndrome. Pathogens 2020;9:E965. [PMID: 33228253 DOI: 10.3390/pathogens9110965] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
142 Meppiel E, Peiffer-Smadja N, Maury A, Bekri I, Delorme C, Desestret V, Gorza L, Hautecloque-Raysz G, Landre S, Lannuzel A, Moulin S, Perrin P, Petitgas P, SellaI F, Wang A, Tattevin P, de Broucker T; contributors to the NeuroCOVID registry. Neurologic manifestations associated with COVID-19: a multicentre registry. Clin Microbiol Infect 2021;27:458-66. [PMID: 33189873 DOI: 10.1016/j.cmi.2020.11.005] [Cited by in Crossref: 50] [Cited by in F6Publishing: 57] [Article Influence: 16.7] [Reference Citation Analysis]
143 Hasan I, Saif‐ur‐rahman K, Hayat S, Papri N, Jahan I, Azam R, Ara G, Islam Z. Guillain‐Barré syndrome associated with SARS‐CoV ‐2 infection: A systematic review and individual participant data meta‐analysis. J Peripher Nerv Syst 2020;25:335-43. [DOI: 10.1111/jns.12419] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 10.7] [Reference Citation Analysis]
144 Martín-Aguilar L, Camps-Renom P, Lleixà C, Pascual-Goñi E, Díaz-Manera J, Rojas-García R, De Luna N, Gallardo E, Cortés-Vicente E, Muñoz L, Alcolea D, Lleó A, Casasnovas C, Homedes C, Gutiérrez-Gutiérrez G, Jimeno-Montero MC, Berciano J, Sedano-Tous MJ, García-Sobrino T, Pardo-Fernández J, Márquez-Infante C, Rojas-Marcos I, Jericó-Pascual I, Martínez-Hernández E, Morís de la Tassa G, Domínguez-González C, Illa I, Querol L. Serum neurofilament light chain predicts long-term prognosis in Guillain-Barré syndrome patients. J Neurol Neurosurg Psychiatry 2020:jnnp-2020-323899. [PMID: 33154183 DOI: 10.1136/jnnp-2020-323899] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
145 Latif A, Kapoor V, Sood A, Thirumalareddy J, Tauseef A. Acute Sensory-Motor Axonal Neuropathy in a 57-Year-Old Male Presenting With Paresthesia and Distal Muscle Weakness. Cureus 2020. [DOI: 10.7759/cureus.11301] [Reference Citation Analysis]
146 Ning P, Yang B, Yang X, Zhao Q, Huang H, Shen Q, Lu H, Tian S, Xu Y. A nomogram to predict mechanical ventilation in Guillain-Barré syndrome patients. Acta Neurol Scand 2020;142:466-74. [PMID: 32497277 DOI: 10.1111/ane.13294] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
147 Das A, Khurshid S, Hayat S, Ahmed R, Islam Z. Glucocorticoid receptor gene polymorphisms in Guillain-Barré syndrome. Journal of Neuroimmunology 2020;348:577388. [DOI: 10.1016/j.jneuroim.2020.577388] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
148 Hirayama T, Hongo Y, Kaida K, Kano O. Guillain-Barré syndrome after COVID-19 in Japan. BMJ Case Rep 2020;13:e239218. [PMID: 33122241 DOI: 10.1136/bcr-2020-239218] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
149 Korinthenberg R, Eckenweiler M, Fuchs H. Severe Locked-In-Like Guillain-Barré's Syndrome: Dilemmas in Diagnosis and Treatment. Neuropediatrics 2021;52:19-26. [PMID: 33111302 DOI: 10.1055/s-0040-1715480] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
150 Gavriilaki M, Kimiskidis VK, Gavriilaki E. Precision Medicine in Neurology: The Inspirational Paradigm of Complement Therapeutics. Pharmaceuticals (Basel) 2020;13:E341. [PMID: 33114553 DOI: 10.3390/ph13110341] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
151 Yang LY, Lin S, Xie QB, Yin G. Central diabetes insipidus unveiled by glucocorticoid therapy in a patient with an empty sella: A case report and literature review. Medicine (Baltimore) 2020;99:e22939. [PMID: 33120853 DOI: 10.1097/MD.0000000000022939] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
152 Capodivento G, De Michelis C, Carpo M, Fancellu R, Schirinzi E, Severi D, Visigalli D, Franciotta D, Manganelli F, Siciliano G, Beronio A, Capello E, Lanteri P, Nobile-Orazio E, Schenone A, Benedetti L, Nobbio L. CSF sphingomyelin: a new biomarker of demyelination in the diagnosis and management of CIDP and GBS. J Neurol Neurosurg Psychiatry 2021;92:303-10. [PMID: 33093191 DOI: 10.1136/jnnp-2020-324445] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
153 Gupta S, Verma R, Sethi R, Garg RK, Malhotra HS, Sharma PK, Rizvi I, Uniyal R. Cardiovascular complications and its relationship with functional outcomes in Guillain-Barré syndrome. QJM 2020;113:93-9. [PMID: 31504947 DOI: 10.1093/qjmed/hcz225] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
154 Yamagishi Y, Kuwahara M, Suzuki H, Sonoo M, Kuwabara S, Yokota T, Nomura K, Chiba A, Kaji R, Kanda T, Kaida KI, Mutoh T, Yamasaki R, Takashima H, Matsui M, Nishiyama K, Sobue G, Kusunoki S. Serum IgG anti-GD1a antibody and mEGOS predict outcome in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 2020;91:1339-42. [PMID: 33041261 DOI: 10.1136/jnnp-2020-323960] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
155 Wahatule R, Dutta D, Debnath M, Nagappa M, Mahadevan A, Sinha S, Sundaravadivel P, Rao U, Periyavan S, Binu V, Rao S, Taly AB. Ganglioside complex antibodies in an Indian cohort of Guillain‐Barré syndrome. Muscle & Nerve 2020;62:728-34. [DOI: 10.1002/mus.27071] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
156 Korem S, Gandhi H, Dayag DB. Guillain-Barré syndrome associated with COVID-19 disease. BMJ Case Rep 2020;13:e237215. [PMID: 32958554 DOI: 10.1136/bcr-2020-237215] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
157 Zhao Y, Zhu R, Tian D, Liu X. Genetic polymorphisms in Guillain-Barré Syndrome: A field synopsis and systematic meta-analysis. Autoimmun Rev 2020;19:102665. [PMID: 32949724 DOI: 10.1016/j.autrev.2020.102665] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
158 Korinthenberg R, Sejvar JJ. The Brighton Collaboration case definition: Comparison in a retrospective and prospective cohort of children with Guillain-Barré syndrome. J Peripher Nerv Syst 2020;25:344-9. [PMID: 32869396 DOI: 10.1111/jns.12411] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
159 Garnero M, Del Sette M, Assini A, Beronio A, Capello E, Cabona C, Reni L, Serrati C, Bandini F, Granata A, Pesce G, Mancardi GL, Uccelli A, Schenone A, Benedetti L. COVID-19-related and not related Guillain-Barré syndromes share the same management pitfalls during lock down: The experience of Liguria region in Italy. J Neurol Sci 2020;418:117114. [PMID: 32947089 DOI: 10.1016/j.jns.2020.117114] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
160 TunÇ A, TekeŞİn A, GÜzel V, ÜnlÜbaŞ Y, SeferoĞlu M. The prognostic value of demyelinating electrophysiologic findings and cerebrospinal fluid protein levels in acute inflammatory demyelinating polyneuropathy. Arq Neuropsiquiatr 2020;78:481-7. [PMID: 32844898 DOI: 10.1590/0004-282x20200042] [Reference Citation Analysis]
161 Hayat S, Ahmad O, Mahmud I, Howlader MZH, Islam Z. Association of matrix metalloproteinase-9 polymorphism with severity of Guillain-Barré syndrome. Journal of the Neurological Sciences 2020;415:116908. [DOI: 10.1016/j.jns.2020.116908] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
162 López-Hernández JC, Colunga-Lozano LE, Garcia-Trejo S, Gomez-Figueroa E, Delgado-Garcia G, Bazán-Rodríguez L, Cervantes-Uribe R, Burgos-Centeno J, Fernandez-Valverde F, Vargas-Cañas ES. Electrophysiological subtypes and associated prognosis factors of Mexican adults diagnosed with Guillain-Barré syndrome, a single center experience. J Clin Neurosci 2020;80:292-7. [PMID: 32674942 DOI: 10.1016/j.jocn.2020.04.059] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
163 Tomohara S, Harano R, Wada S, Ohashi I, Yoshino F, Mito D, Kadowaki M, Takase K, Kuwashiro T, Takaba H, Yasaka M, Okada Y. Recurrent Guillain-Barré and Fisher Syndromes in Two Patients Who Were Subsequently Diagnosed with Aplastic Anemia. Case Rep Neurol 2020;12:148-52. [PMID: 32595475 DOI: 10.1159/000507778] [Reference Citation Analysis]
164 Berciano J. Axonal degeneration in Guillain-Barré syndrome: a reappraisal. J Neurol 2021;268:3728-43. [PMID: 32607643 DOI: 10.1007/s00415-020-10034-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
165 Tan CY, Razali SNO, Goh KJ, Shahrizaila N. Diagnosis of Guillain-Barré syndrome and validation of the Brighton criteria in Malaysia. J Peripher Nerv Syst 2020;25:256-64. [PMID: 32511817 DOI: 10.1111/jns.12398] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
166 Albawaliz A, Abdallah D, Seehra GK, Elkafrawy A, Al-shyoukh A. Asymmetric Lower Extremity Involvement and Facial Palsy: An Atypical Case of Guillain-Barre Syndrome. Cureus 2020. [DOI: 10.7759/cureus.8912] [Reference Citation Analysis]
167 Versace V, Campostrini S, Rastelli E, Sebastianelli L, Nardone R, Pucks-Faes E, Saltuari L, Kofler M, Uncini A. Understanding hyper-reflexia in acute motor axonal neuropathy (AMAN). Neurophysiol Clin 2020;50:139-44. [PMID: 32595063 DOI: 10.1016/j.neucli.2020.05.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
168 Luo H, Hong S, Li M, Wang L, Jiang L. Risk factors for mechanical ventilation in children with Guillain-Barré syndrome. Muscle Nerve 2020;62:214-8. [PMID: 32367533 DOI: 10.1002/mus.26905] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
169 Hayat S, Babu G, Das A, Howlader ZH, Mahmud I, Islam Z. Fc-gamma IIIa-V158F receptor polymorphism contributes to the severity of Guillain-Barré syndrome. Ann Clin Transl Neurol 2020;7:1040-9. [PMID: 32484314 DOI: 10.1002/acn3.51072] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
170 Levison LS, Thomsen RW, Markvardsen LK, Christensen DH, Sindrup SH, Andersen H. Pediatric Guillain-Barré Syndrome in a 30-Year Nationwide Cohort. Pediatric Neurology 2020;107:57-63. [DOI: 10.1016/j.pediatrneurol.2020.01.017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
171 Hosokawa T, Nakajima H, Sawai T, Nakamura Y, Sano E, Tsukahara A, Unoda K, Ishida S, Sakane S, Kimura F, Arawaka S. Clinical features of Guillain-Barré syndrome patients with elevated serum creatine kinase levels. BMC Neurol 2020;20:214. [PMID: 32460711 DOI: 10.1186/s12883-020-01796-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
172 Kuriyama K, Koyama Y, Tsuto K, Tokuhira N, Nagata H, Muramatsu A, Oshiro M, Hirakawa Y, Iwai T, Uchiyama H. Gastric lymphoma complicated by phlegmonous gastritis and Guillain-Barré syndrome: A case report. Medicine (Baltimore) 2020;99:e20030. [PMID: 32358382 DOI: 10.1097/MD.0000000000020030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
173 Marta-enguita J, Rubio-baines I, Gastón-zubimendi I. Fatal Guillain-Barre syndrome after infection with SARS-CoV-2. Neurología (English Edition) 2020;35:265-267. [DOI: 10.1016/j.nrleng.2020.04.004] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
174 Yamagishi Y, Kusunoki S. [The prognosis and prognostic factor of Guillain-Barré Syndrome]. Rinsho Shinkeigaku 2020;60:247-52. [PMID: 32238748 DOI: 10.5692/clinicalneurol.cn-001398] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
175 Marta-Enguita J, Rubio-Baines I, Gastón-Zubimendi I. Fatal Guillain-Barre syndrome after infection with SARS-CoV-2. Neurologia (Engl Ed) 2020;35:265-7. [PMID: 32364124 DOI: 10.1016/j.nrl.2020.04.004] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 11.3] [Reference Citation Analysis]
176 Bao L, Chen X, Li Q, Zhang R, Shi H, Cui G. Surgery and Guillain-Barré Syndrome: A Single-Center Retrospective Study Focused on Clinical and Electrophysiological Subtypes. Neuropsychiatr Dis Treat 2020;16:969-74. [PMID: 32346291 DOI: 10.2147/NDT.S241128] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
177 Wei CW, Liu CY, Chang CY, Liu WC, Cheng HC, Tung HH, Chiang NC, Chang HH. Guillain-Barré syndrome in a heart transplantation recipient. J Am Assoc Nurse Pract 2020;33:639-45. [PMID: 32282569 DOI: 10.1097/JXX.0000000000000400] [Reference Citation Analysis]
178 Koike H, Fukami Y, Nishi R, Kawagashira Y, Iijima M, Katsuno M, Sobue G. Ultrastructural mechanisms of macrophage-induced demyelination in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 2020;91:650-9. [PMID: 32245766 DOI: 10.1136/jnnp-2019-322479] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 7.7] [Reference Citation Analysis]
179 Stribling JC, Robbins MS, Derosa AP. Mapping the Literature of Guillain–Barre Syndrome to Support Current Awareness among Neurologists. Journal of Hospital Librarianship 2020;20:111-119. [DOI: 10.1080/15323269.2020.1738839] [Reference Citation Analysis]
180 Debnath M, Nagappa M, Dutta D, Talukdar PM, Subbanna M, Shivakumar V, Wahatule R, Sinha S, Bindu PS, Periyavan S, Umamaheswara Rao GS, Kumar MA, Taly AB. Evidence of altered Th17 pathway signatures in the cerebrospinal fluid of patients with Guillain Barré Syndrome. J Clin Neurosci 2020;75:176-80. [PMID: 32217048 DOI: 10.1016/j.jocn.2020.03.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
181 Park JH, Chung SG, Kim K. Electrodiagnostic characteristics of upper lumbar stenosis: Discrepancy between neurological and structural levels. Muscle Nerve 2020;61:580-6. [PMID: 32096875 DOI: 10.1002/mus.26844] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
182 Meena P, Bhargava V, Rana DS, Bhalla AK, Gupta A, Malik M, Gupta A, Tiwari V. Tacrolimus-Associated Guillain-Barre Syndrome. Am J Ther 2020;28:e268-70. [PMID: 32091420 DOI: 10.1097/MJT.0000000000001096] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
183 Kalita J, Kumar M, Misra UK. Serial single breath count is a reliable tool for monitoring respiratory functions in Guillain-Barré Syndrome. Journal of Clinical Neuroscience 2020;72:50-6. [DOI: 10.1016/j.jocn.2020.01.032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
184 Iacopi E, Ferranti S, Riitano N, Abbruzzese L, Pieruzzi L, Goretti C, Zampa V, Piaggesi A. Bioactive Glass in a Rare Case of Osteomyelitis of the Heel in a Guillain-Barré Syndrome: A Case Report. The International Journal of Lower Extremity Wounds 2021;20:60-6. [DOI: 10.1177/1534734619896462] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
185 Fan Z, Liu B, Zhang Y, Li M, Lu T. The effectiveness and safety of acupuncture therapy for Guillain-Barré syndrome: A systematic review and meta-analysis protocol. Medicine (Baltimore) 2020;99:e18619. [PMID: 31914040 DOI: 10.1097/MD.0000000000018619] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
186 Doets AY, Hughes RA, Brassington R, Hadden RD, Pritchard J. Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome. Cochrane Database Syst Rev 2020;1:CD008630. [PMID: 31981368 DOI: 10.1002/14651858.CD008630.pub5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
187 Uncini A, Notturno F, Kuwabara S. Hyper-reflexia in Guillain-Barré syndrome: systematic review. J Neurol Neurosurg Psychiatry 2020;91:278-84. [DOI: 10.1136/jnnp-2019-321890] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
188 Korinthenberg R, Trollmann R, Felderhoff-Müser U, Bernert G, Hackenberg A, Hufnagel M, Pohl M, Hahn G, Mentzel HJ, Sommer C, Lambeck J, Mecher F, Hessenauer M, Winterholler C, Kempf U, Jacobs BC, Rostasy K, Müller-Felber W. Diagnosis and treatment of Guillain-Barré Syndrome in childhood and adolescence: An evidence- and consensus-based guideline. Eur J Paediatr Neurol 2020;25:5-16. [PMID: 31941581 DOI: 10.1016/j.ejpn.2020.01.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 8.7] [Reference Citation Analysis]
189 Nagarajan E, Arjun D, Kataria S, Arora N. Pediatric Neuromuscular Emergencies and Urgencies. Neuromuscular Urgencies and Emergencies 2020. [DOI: 10.1007/978-3-030-53145-4_9] [Reference Citation Analysis]
190 Ahuja S, Khanna AK. Management of Patient with Myasthenia Gravis. Problem Based Learning Discussions in Neuroanesthesia and Neurocritical Care 2020. [DOI: 10.1007/978-981-15-0458-7_24] [Reference Citation Analysis]
191 Dray EV. The Urologic Impact of Guillain–Barré Syndrome. Urological Care for Patients with Progressive Neurological Conditions 2020. [DOI: 10.1007/978-3-030-23277-1_16] [Reference Citation Analysis]
192 Groß M, Dorst J, Pelzer K. Beatmung bei neuromuskulären Erkrankungen. Neurologische Beatmungsmedizin 2020. [DOI: 10.1007/978-3-662-59014-0_13] [Reference Citation Analysis]
193 Lunn MP, Lehmann HC, Sheikh KA. Peripheral Neuropathies. The Autoimmune Diseases 2020. [DOI: 10.1016/b978-0-12-812102-3.00052-x] [Reference Citation Analysis]
194 Ju H, Im K, Roh H. A Case of Polyneuritis Cranialis with the Initial Symptom of Isolated Hypoglossal Nerve Palsy. J Clin Neurol 2020;16:702. [DOI: 10.3988/jcn.2020.16.4.702] [Reference Citation Analysis]
195 van Doorn PA. Guillain-Barré syndrome. Dysimmune Neuropathies 2020. [DOI: 10.1016/b978-0-12-814572-2.00002-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
196 Jackson AC. Human disease. Rabies 2020. [DOI: 10.1016/b978-0-12-818705-0.00008-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
197 Kim SH, Samadov F, Mukhamedov A, Kong J, Ko A, Kim YM, Lee Y, Nam SO. Clinical Characteristics and Prognostic Factors of Children with Guillain-Barré Syndrome. Ann Child Neurol 2019;27:113-9. [DOI: 10.26815/acn.2019.00143] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
198 Ripellino P, Pons M, Izzo MGA, Gobbi C. Bilateral phrenic neuropathy responsive to intravenous immunoglobulin treatment. Clinical and Translational Neuroscience 2019;3:2514183X1989160. [DOI: 10.1177/2514183x19891606] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
199 Al Othman B, Raabe J, Kini A, Lee AG. Update: the Miller Fisher variants of Guillain-Barré syndrome. Curr Opin Ophthalmol 2019;30:462-6. [PMID: 31567467 DOI: 10.1097/ICU.0000000000000611] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 6.3] [Reference Citation Analysis]
200 Hutton H, Wilmshurst J. The assessment and management of pain in children with Guillain-Barré Syndrome in a sub-Saharan setting. JICNA 2019. [DOI: 10.17724/jicna.2019.144] [Reference Citation Analysis]
201 Ripellino P, Pasi E, Melli G, Staedler C, Fraga M, Moradpour D, Sahli R, Aubert V, Martinetti G, Bihl F, Bernasconi E, Terziroli Beretta-Piccoli B, Cerny A, Dalton HR, Zehnder C, Mathis B, Zecca C, Disanto G, Kaelin-Lang A, Gobbi C. Neurologic complications of acute hepatitis E virus infection. Neurol Neuroimmunol Neuroinflamm. 2020;7. [PMID: 31806684 DOI: 10.1212/nxi.0000000000000643] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
202 Leonhard SE, Conde RM, de Assis Aquino Gondim F, Jacobs BC. Diagnosis and treatment of Guillain-Barré syndrome during the Zika virus epidemic in Brazil: A national survey study. J Peripher Nerv Syst 2019;24:340-7. [PMID: 31746070 DOI: 10.1111/jns.12358] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
203 Tunç A. Early predictors of functional disability in Guillain-Barré Syndrome. Acta Neurol Belg 2019;119:555-9. [PMID: 30963477 DOI: 10.1007/s13760-019-01133-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
204 Berciano J, Orizaola P, Gallardo E, Pelayo-Negro AL, Sánchez-Juan P, Infante J, Sedano MJ. Very early Guillain-Barré syndrome: A clinical-electrophysiological and ultrasonographic study. Clin Neurophysiol Pract 2020;5:1-9. [PMID: 31886449 DOI: 10.1016/j.cnp.2019.11.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
205 Martín-Aguilar L, Pascual-Goñi E, Querol L. Autoantibodies in immune-mediated inflammatory neuropathies. Med Clin (Barc) 2019;153:360-7. [PMID: 31443948 DOI: 10.1016/j.medcli.2019.06.007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
206 Hao Y, Wang W, Jacobs BC, Qiao B, Chen M, Liu D, Feng X, Wang Y. Antecedent infections in Guillain-Barré syndrome: a single-center, prospective study. Ann Clin Transl Neurol 2019;6:2510-7. [PMID: 31714025 DOI: 10.1002/acn3.50946] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 6.8] [Reference Citation Analysis]
207 Kim YH, Jang SY, Shin YK, Jo YR, Yoon BA, Nam SH, Choi BO, Shin HY, Kim SW, Kim SH, Kim JK, Park HT. Serum CXCL13 reflects local B-cell mediated inflammatory demyelinating peripheral neuropathy. Sci Rep 2019;9:16535. [PMID: 31712675 DOI: 10.1038/s41598-019-52643-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
208 Martín-aguilar L, Pascual-goñi E, Querol L. Autoantibodies in immune-mediated inflammatory neuropathies. Medicina Clínica (English Edition) 2019;153:360-367. [DOI: 10.1016/j.medcle.2019.06.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
209 Pham HP, Schwartz J. Therapeutic Plasma Exchange in Guillain-Barre Syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. Presse Med 2019;48:338-46. [PMID: 31679897 DOI: 10.1016/j.lpm.2019.03.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
210 Chong PF, Kira R, Mori H, Okumura A, Torisu H, Yasumoto S, Shimizu H, Fujimoto T, Hanaoka N, Kusunoki S, Takahashi T, Oishi K, Tanaka-Taya K; Acute Flaccid Myelitis Collaborative Study Investigators. Clinical Features of Acute Flaccid Myelitis Temporally Associated With an Enterovirus D68 Outbreak: Results of a Nationwide Survey of Acute Flaccid Paralysis in Japan, August-December 2015. Clin Infect Dis 2018;66:653-64. [PMID: 29028962 DOI: 10.1093/cid/cix860] [Cited by in Crossref: 78] [Cited by in F6Publishing: 79] [Article Influence: 19.5] [Reference Citation Analysis]
211 Prada V, Massa F, Salerno A, Fregosi D, Beronio A, Serrati C, Mannironi A, Mancardi G, Schenone A, Benedetti L. Importance of intensive and prolonged rehabilitative treatment on the Guillain-Barrè syndrome long-term outcome: a retrospective study. Neurol Sci 2020;41:321-7. [DOI: 10.1007/s10072-019-04077-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
212 Leonhard SE, Mandarakas MR, Gondim FAA, Bateman K, Ferreira MLB, Cornblath DR, van Doorn PA, Dourado ME, Hughes RAC, Islam B, Kusunoki S, Pardo CA, Reisin R, Sejvar JJ, Shahrizaila N, Soares C, Umapathi T, Wang Y, Yiu EM, Willison HJ, Jacobs BC. Diagnosis and management of Guillain-Barré syndrome in ten steps. Nat Rev Neurol 2019;15:671-83. [PMID: 31541214 DOI: 10.1038/s41582-019-0250-9] [Cited by in Crossref: 250] [Cited by in F6Publishing: 266] [Article Influence: 62.5] [Reference Citation Analysis]
213 Netto AB, Taly AB, Kulkarni GB, Uma Maheshwara Rao GS, Rao S. Complications in mechanically ventilated patients of Guillain-Barre syndrome and their prognostic value. J Neurosci Rural Pract 2017;8:68-73. [PMID: 28149085 DOI: 10.4103/0976-3147.193542] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
214 Hayat S, Jahan I, Das A, Hassan Z, Howlader ZH, Mahmud I, Deen Mohammad Q, Islam Z. Human leukocyte antigen-DQB1 polymorphisms and haplotype patterns in Guillain-Barré syndrome. Ann Clin Transl Neurol 2019;6:1849-57. [PMID: 31469245 DOI: 10.1002/acn3.50884] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
215 Zhang G, Wang Q, Song Y, Cheng P, Xu R, Feng X, Li X. Intravenous immunoglobulin promotes the proliferation of CD4+CD25+ Foxp3+ regulatory T cells and the cytokines secretion in patients with Guillain-Barré syndrome in vitro. J Neuroimmunol 2019;336:577042. [PMID: 31479869 DOI: 10.1016/j.jneuroim.2019.577042] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
216 Xu S, Wang YS, Li S, Liu HY. [Guillain-Barre syndrome complicated on post-operation with renal carcinoma and meningioma: a case report]. Beijing Da Xue Xue Bao Yi Xue Ban 2019;51:775-7. [PMID: 31420639 DOI: 10.19723/j.issn.1671-167X.2019.04.032] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
217 Kuwahara M, Kusunoki S. II. Immune-mediated Neuropathies. J Jpn Soc Intern Med 2019;108:1524-1529. [DOI: 10.2169/naika.108.1524] [Reference Citation Analysis]
218 Whelan AJ, Tolaymat A, Rainey SC. Bumbling, Stumbling, Fumbling: Weakness, Steppage Gait, and Facial Droop in a 3-Year-Old Male. Glob Pediatr Health 2019;6:2333794X19865858. [PMID: 31384634 DOI: 10.1177/2333794X19865858] [Reference Citation Analysis]
219 Jia L, Jia R, Zhang H. Correspondence: Guillain-Barré syndrome and hemorrhagic fever with renal syndrome. BMC Infect Dis 2019;19:687. [PMID: 31382899 DOI: 10.1186/s12879-019-4216-8] [Reference Citation Analysis]
220 Bautista LE. Zika virus infection and risk of Guillain-Barré syndrome: A meta-analysis. Journal of the Neurological Sciences 2019;403:99-105. [DOI: 10.1016/j.jns.2019.06.019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
221 Greene-Chandos D, Torbey M. Critical Care of Neuromuscular Disorders. Continuum (Minneap Minn) 2018;24:1753-75. [PMID: 30516604 DOI: 10.1212/CON.0000000000000682] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
222 Kramer CL, Manno EM, Rabinstein AA. Neuromuscular Disorders in the Neurocritical Care Unit. Neurocritical Care 2019. [DOI: 10.1017/9781107587908.016] [Reference Citation Analysis]
223 Doets AY, Verboon C, van den Berg B, Harbo T, Cornblath DR, Willison HJ, Islam Z, Attarian S, Barroso FA, Bateman K, Benedetti L, van den Bergh P, Casasnovas C, Cavaletti G, Chavada G, Claeys KG, Dardiotis E, Davidson A, van Doorn PA, Feasby TE, Galassi G, Gorson KC, Hartung HP, Hsieh ST, Hughes RAC, Illa I, Islam B, Kusunoki S, Kuwabara S, Lehmann HC, Miller JAL, Mohammad QD, Monges S, Nobile Orazio E, Pardo J, Pereon Y, Rinaldi S, Querol L, Reddel SW, Reisin RC, Shahrizaila N, Sindrup SH, Waqar W, Jacobs BC; IGOS Consortium. Regional variation of Guillain-Barré syndrome. Brain 2018;141:2866-77. [PMID: 30247567 DOI: 10.1093/brain/awy232] [Cited by in Crossref: 122] [Cited by in F6Publishing: 125] [Article Influence: 30.5] [Reference Citation Analysis]
224 Tian J, Cao C, Li T, Zhang K, Li P, Liu Y, Liu X. Electrophysiological Subtypes and Prognostic Factors of Guillain-Barre Syndrome in Northern China. Front Neurol 2019;10:714. [PMID: 31333568 DOI: 10.3389/fneur.2019.00714] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
225 Fadia M, Shroff S, Simpson E. Immune-Mediated Neuropathies. Curr Treat Options Neurol 2019;21. [DOI: 10.1007/s11940-019-0569-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
226 Sedano MJ, Orizaola P, Gallardo E, García A, Pelayo-Negro AL, Sánchez-Juan P, Infante J, Berciano J. A unicenter, prospective study of Guillain-Barré syndrome in Spain. Acta Neurol Scand 2019;139:546-54. [PMID: 30929269 DOI: 10.1111/ane.13092] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
227 Taguchi D, Kamada S, Yoshida T, Fukuda K, Shimazu K, Inoue M, Sugawara M, Nanjyo H, Iijima K, Shibata H. Guillain-Barré syndrome in a cancer patient treated with bevacizumab. Int Cancer Conf J 2018;7:87-92. [PMID: 31149522 DOI: 10.1007/s13691-018-0326-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
228 Regenspurger T. Neurophysiologische und sonographische Diagnostik des Guillain-Barré-Syndroms. Das Neurophysiologie-Labor 2019;41:99-112. [DOI: 10.1016/j.neulab.2019.04.002] [Reference Citation Analysis]
229 Umapathi T, Lim CSJ, Ng BCJ, Goh EJH, Ohnmar O. A Simplified, Graded, Electrodiagnostic Criterion for Guillain-Barré Syndrome That Incorporates Sensory Nerve Conduction Studies. Sci Rep 2019;9:7724. [PMID: 31118437 DOI: 10.1038/s41598-019-44090-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
230 Yamana M, Kuwahara M, Fukumoto Y, Yoshikawa K, Takada K, Kusunoki S. Guillain-Barré syndrome and related diseases after influenza virus infection. Neurol Neuroimmunol Neuroinflamm 2019;6:e575. [PMID: 31355311 DOI: 10.1212/NXI.0000000000000575] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
231 Güngör S, Kılıç B. Is Bilateral Facial Paralysis an Indicator of Respiratory Outcome in Guillain-Barré Syndrome? Medicina (Kaunas) 2019;55:E177. [PMID: 31117219 DOI: 10.3390/medicina55050177] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
232 Bourque PR, Brooks J, McCudden CR, Warman-Chardon J, Breiner A. Age matters: Impact of data-driven CSF protein upper reference limits in Guillain-Barré syndrome. Neurol Neuroimmunol Neuroinflamm 2019;6:e576. [PMID: 31355312 DOI: 10.1212/NXI.0000000000000576] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
233 Saeed ML, Kaleem Baloch B, Mahmud SN, Khan MT, Qureshi MSS, Shad ZS, Hussain SW, Munawar K, Qadeer A, Abdullah A. Role of Anti-ganglioside Antibodies in the Diagnosis of Guillain-Barré Syndrome as an Alternate Investigation. Cureus 2019;11:e4625. [PMID: 31312551 DOI: 10.7759/cureus.4625] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
234 Tan CY, Razali SNO, Goh KJ, Shahrizaila N. The utility of Guillain-Barré syndrome prognostic models in Malaysian patients. J Peripher Nerv Syst 2019;24:168-73. [PMID: 31001904 DOI: 10.1111/jns.12320] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
235 Klimkin AV, Voitenkov VB, Skripchenko NV. Inflammatory demyelinating polyneuropathies in children. jour 2019;19:183-191. [DOI: 10.18821/1560-9561-2016-19-3-183-191] [Reference Citation Analysis]
236 Hess SR, Waligora AC, Jiranek WA, Golladay GJ. Inflammatory demyelinating polyneuropathy after total hip arthroplasty. Arthroplast Today 2019;5:17-20. [PMID: 31020015 DOI: 10.1016/j.artd.2018.08.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
237 Doets AY, Jacobs BC, van Doorn PA. Advances in management of Guillain-Barré syndrome. Curr Opin Neurol 2018;31:541-50. [PMID: 30074496 DOI: 10.1097/WCO.0000000000000602] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
238 Levison LS, Thomsen RW, Christensen DH, Mellemkjær T, Sindrup SH, Andersen H. Guillain-Barré syndrome in Denmark: validation of diagnostic codes and a population-based nationwide study of the incidence in a 30-year period. Clin Epidemiol 2019;11:275-83. [PMID: 31114387 DOI: 10.2147/CLEP.S199839] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
239 Muñoz LS, Parra B, Pardo CA; Neuroviruses Emerging in the Americas Study. Neurological Implications of Zika Virus Infection in Adults. J Infect Dis 2017;216:S897-905. [PMID: 29267923 DOI: 10.1093/infdis/jix511] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 13.5] [Reference Citation Analysis]
240 H Siddiqui S, H Siddiqui T, U Babar M, Khoja A, Khan S. Outcomes of patients with Guillain Barre Syndrome – Experience from a tertiary care hospital of a developing Asian country and review of regional literature. Journal of Clinical Neuroscience 2019;62:195-8. [DOI: 10.1016/j.jocn.2018.11.031] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
241 Bölükbaşi F, Ersen G, Gündüz A, Karaali-Savrun F, Yazici S, Uzun N, Akalin MA, Kiziltan ME. Guillain-Barré Syndrome and Its Variants: Clinical Course and Prognostic Factors. Noro Psikiyatr Ars 2019;56:71-4. [PMID: 30911241 DOI: 10.5152/npa.2017.18091] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
242 Jahan I, Ahammad RU, Khalid MM, Rahman MI, Hayat S, Islam B, Mohammad QD, Islam Z. Toll-like receptor-4 299Gly allele is associated with Guillain-Barré syndrome in Bangladesh. Ann Clin Transl Neurol 2019;6:708-15. [PMID: 31019995 DOI: 10.1002/acn3.744] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
243 Benedetti L, Briani C, Beronio A, Massa F, Giorli E, Sani C, Delia P, Artioli S, Sormani MP, Mannironi A, Tartaglione A, Mancardi GL. Increased incidence of axonal Guillain‐Barré syndrome in La Spezia area of Italy: A 13‐year follow‐up study. J Peripher Nerv Syst 2019;24:80-86. [DOI: 10.1111/jns.12292] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
244 Zhang DQ, Deng Y, Zhang LJ, Li LM, Qi Y, Wang J, Wang R, Zhai H, Zhao P, Yang L. Elevated resistin levels may regulate high mobility group box 1 expression in Guillain-Barré syndrome. J Neuroimmunol 2019;330:59-66. [PMID: 30826699 DOI: 10.1016/j.jneuroim.2019.02.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
245 Yoon B, Bae JS, Kim JK. Recent Concepts of Guillain-Barré Syndrome. J Korean Neurol Assoc 2019;37:8-19. [DOI: 10.17340/jkna.2019.1.2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
246 Park SJ, Kim JK, Kim HH, Yoon BA, Ji DY, Lee CW, Kim HJ, Kim KH, Shin HY, Park SJ, Lee DY. Integrative metabolomics reveals unique metabolic traits in Guillain-Barré Syndrome and its variants. Sci Rep 2019;9:1077. [PMID: 30705347 DOI: 10.1038/s41598-018-37572-w] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
247 Yosha-orpaz N, Aharoni S, Rabie M, Nevo Y. Atypical Clinical Presentations of Pediatric Acute Immune-Mediated Polyneuropathy. J Child Neurol 2019;34:268-76. [DOI: 10.1177/0883073818825213] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
248 Tubaki BR, Tarapure S. Ayurveda management of Guillain-Barre syndrome: A case report. J Ayurveda Integr Med 2020;11:73-7. [PMID: 30661945 DOI: 10.1016/j.jaim.2018.08.004] [Reference Citation Analysis]
249 Pathak P, Perimbeti S, Ames A, Moskowitz AJ. Guillain Barré syndrome heralding the diagnosis of angioimmunoblastic T-cell lymphoma. Leuk Lymphoma 2019;60:1835-8. [PMID: 30648445 DOI: 10.1080/10428194.2018.1553299] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
250 Granieri E, Andreasi NG, De Martin P, Govoni V, Castellazzi M, Cesnik E, Pugliatti M, Casetta I. Incidence study of Guillain-Barré syndrome in the province of Ferrara, Northern Italy, between 2003 and 2017. A 40-year follow-up. Neurol Sci 2019;40:603-9. [DOI: 10.1007/s10072-018-3688-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
251 Islam Z, Papri N, Ara G, Ishaque T, Alam AU, Jahan I, Islam B, Mohammad QD. Risk factors for respiratory failure in Guillain-Barré syndrome in Bangladesh: a prospective study. Ann Clin Transl Neurol 2019;6:324-32. [PMID: 30847364 DOI: 10.1002/acn3.706] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
252 Moss HE. Eyelid and Facial Nerve Disorders. Liu, Volpe, and Galetta's Neuro-Ophthalmology 2019. [DOI: 10.1016/b978-0-323-34044-1.00014-6] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
253 Peric S, Basta I, Bozovic I, Berisavac I, Stojiljkovic-tamas O, Rajic S, Dominovic-kovacevic A, Stojanov A, Djordjevic G, Jovanovic D. Recurrent Guillain-Barré syndrome – Case series. Neurol India 2019;67:1536. [DOI: 10.4103/0028-3886.273649] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
254 Grover KM, Sripathi N. Neuromuscular Emergencies. Emergencies in Neurology 2019. [DOI: 10.1007/978-981-13-7381-7_5] [Reference Citation Analysis]
255 Grapperon A, Berro M, Salort-campana E, Verschueren A, Delmont E, Attarian S. Guillain–Barré syndrome subtypes: A clinical electrophysiological study of 100 patients. Revue Neurologique 2019;175:73-80. [DOI: 10.1016/j.neurol.2018.01.379] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
256 Samantaray A, Thota B, Mukkara M, Mohan A, Vengamma B. A study of clinical presentation and outcome of patients with Guillain–Barré syndrome: A prospective observational study at a tertiary care teaching hospital. J Clin Sci Res 2019;8:182. [DOI: 10.4103/jcsr.jcsr_93_19] [Reference Citation Analysis]
257 Lee J, Sunwoo J, Kwon K, Lee KB, Ahn M, Roh H. Guillain-Barré syndrome supervening on meningitis in primary Epstein-Barr virus infection. Ann Clin Neurophysiol 2019;21:48. [DOI: 10.14253/acn.2019.21.1.48] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
258 McCorquodale D, Smith AG. Clinical electrophysiology of axonal polyneuropathies. Handb Clin Neurol 2019;161:217-40. [PMID: 31307603 DOI: 10.1016/B978-0-444-64142-7.00051-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
259 Bril EV, Popugaev KA, Udalov YD, Parinov OV, Zabelin MV, Samoilov AS. Critical Care Management of Guillain-Barré Syndrome. Textbook of Neuroanesthesia and Neurocritical Care 2019. [DOI: 10.1007/978-981-13-3390-3_4] [Reference Citation Analysis]
260 Hannawi Y, Shah JN, Haji S, Mirski MA. Critical Care Neurology. Atlas of Clinical Neurology 2019. [DOI: 10.1007/978-3-030-03283-8_4] [Reference Citation Analysis]
261 Bowley MP, Chad DA. Clinical neurophysiology of demyelinating polyneuropathy. Handbook of Clinical Neurology 2019. [DOI: 10.1016/b978-0-444-64142-7.00052-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
262 Schröder JB, Marian T, Muhle P, Claus I, Thomas C, Ruck T, Wiendl H, Warnecke T, Suntrup-Krueger S, Meuth S, Dziewas R. Intubation, tracheostomy, and decannulation in patients with Guillain-Barré-syndrome-does dysphagia matter? Muscle Nerve 2019;59:194-200. [PMID: 30390307 DOI: 10.1002/mus.26377] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
263 Wang L, Wen J, Gao F, Hao H, Wang L. Hepatitis E Virus-Associated Neurological Injury in China. J Infect Dis 2017;215:1340-1. [PMID: 28329245 DOI: 10.1093/infdis/jix124] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
264 Benedetti L, Briani C, Beronio A, Massa F, Giorli E, Sani C, Delia P, Artioli S, Sormani MP, Mannironi A, Tartaglione A, Mancardi GL. Increased incidence of axonal Guillain-Barré syndrome in La Spezia area of Italy: A 13-year follow-up study. J Peripher Nerv Syst 2019;24:80-6. [PMID: 30421471 DOI: 10.1111/jns.12292] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
265 Al-hakem H, Sindrup SH, Andersen H, de la Cour CD, Lassen LL, van den Berg B, Jacobs BC, Harbo T. Guillain–Barré syndrome in Denmark: a population-based study on epidemiology, diagnosis and clinical severity. J Neurol 2019;266:440-9. [DOI: 10.1007/s00415-018-9151-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
266 Brem MD, Jacobs BC, van Rijs W, Fokkink WJR, Tio-Gillen AP, Walgaard C, van Doorn PA, IJspeert H, van der Burg M, Huizinga R. IVIg-induced plasmablasts in patients with Guillain-Barré syndrome. Ann Clin Transl Neurol 2019;6:129-43. [PMID: 30656191 DOI: 10.1002/acn3.687] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
267 García A, Sedano MJ, Álvarez-Paradelo S, Berciano J. Reversible conduction failure on the deep tendon reflex response recording in early Guillain-Barré syndrome. Clin Neurophysiol Pract 2018;3:159-63. [PMID: 30560219 DOI: 10.1016/j.cnp.2018.09.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
268 Dourado Júnior MET, Fernandes UT, Ramos ES, Vital ALF, Urbano JCC, Queiroz JW, Jeronimo SMB. Egos has a reduced capacity to predicts GBS prognosis in Northeast Brazil. Acta Neurol Scand 2018;138:459-62. [PMID: 30003535 DOI: 10.1111/ane.12995] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
269 Maheshwari A, Sharma RR, Prinja S, Hans R, Modi M, Sharma N, Marwaha N. Cost-minimization analysis in the Indian subcontinent for treating Guillain Barre Syndrome patients with therapeutic plasma exchange as compared to intravenous immunoglobulin. J Clin Apher 2018;33:631-7. [DOI: 10.1002/jca.21646] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
270 Kieseier BC, Mathey EK, Sommer C, Hartung H. Immune-mediated neuropathies. Nat Rev Dis Primers 2018;4. [DOI: 10.1038/s41572-018-0027-2] [Cited by in Crossref: 52] [Cited by in F6Publishing: 55] [Article Influence: 10.4] [Reference Citation Analysis]
271 Blum S, Ji Y, Pennisi D, Li Z, Leo P, Mccombe P, Brown MA. Genome-wide association study in Guillain-Barré syndrome. Journal of Neuroimmunology 2018;323:109-14. [DOI: 10.1016/j.jneuroim.2018.07.016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
272 Vargas Rodríguez LJ, Agudelo Sanabria MB, Márquez Rosales BA, Rozo Ortiz EJ, Vega Sepúlveda AC. Síndrome de Guillain Barré de variante descendente asociado a infección por chikungunya. Neurología Argentina 2018;10:241-244. [DOI: 10.1016/j.neuarg.2018.03.001] [Reference Citation Analysis]
273 Walgaard C, Jacobs BC, Lingsma HF, Steyerberg EW, Cornblath DR, van Doorn PA; Dutch GBS Study Group. Second IVIg course in Guillain-Barré syndrome patients with poor prognosis (SID-GBS trial): Protocol for a double-blind randomized, placebo-controlled clinical trial. J Peripher Nerv Syst 2018;23:210-5. [PMID: 30151941 DOI: 10.1111/jns.12286] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 5.6] [Reference Citation Analysis]
274 Taams NE, Notermans NC, Fokkink WR, Tio‐gillen AP, Huizinga R, Schreurs MWJ, Jacobs BC. Clinical relevance of serum antibodies to GD1b in immune‐mediated neuropathies. J Peripher Nerv Syst 2018;23:227-34. [DOI: 10.1111/jns.12285] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
275 Yoshikawa K, Kuwahara M, Morikawa M, Fukumoto Y, Yamana M, Yamagishi Y, Kusunoki S. Varied antibody reactivities and clinical relevance in anti-GQ1b antibody-related diseases. Neurol Neuroimmunol Neuroinflamm 2018;5:e501. [PMID: 30246056 DOI: 10.1212/NXI.0000000000000501] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
276 Barbieux S, Boyle EM, Baillet C, Demarquette H, Vermersch P, Morschhauser F, Herbaux C. Acute polyradiculopathy secondary to idelalisib in Relapsed Classical Hodgkin's lymphoma. Curr Res Transl Med 2018;66:87-9. [PMID: 30191811 DOI: 10.1016/j.retram.2018.04.004] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
277 Koga M, Kishi M, Fukusako T, Kanda T. Distal limb weakness phenotype of Guillain-Barré syndrome. Journal of the Neurological Sciences 2018;392:83-8. [DOI: 10.1016/j.jns.2018.07.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
278 Yao S, Chen H, Zhang Q, Shi Z, Liu J, Lian Z, Feng H, Du Q, Xie J, Ge W, Zhou H. Pain during the acute phase of Guillain-Barré syndrome. Medicine (Baltimore) 2018;97:e11595. [PMID: 30142753 DOI: 10.1097/MD.0000000000011595] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
279 Islam B, Islam Z, Rahman S, Endtz HP, Vos MC, van der Jagt M, van Doorn PA, Jacobs BC, Mohammad QD. Small volume plasma exchange for Guillain-Barré syndrome in resource-limited settings: a phase II safety and feasibility study. BMJ Open 2018;8:e022862. [PMID: 30121613 DOI: 10.1136/bmjopen-2018-022862] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
280 Donofrio PD. Guillain-Barré Syndrome. Continuum (Minneap Minn) 2017;23:1295-309. [PMID: 28968363 DOI: 10.1212/CON.0000000000000513] [Cited by in Crossref: 20] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
281 Karalok ZS, Taskin BD, Yanginlar ZB, Gurkas E, Guven A, Degerliyurt A, Unlu E, Kose G. Guillain-Barré syndrome in children: subtypes and outcome. Childs Nerv Syst 2018;34:2291-7. [PMID: 29948140 DOI: 10.1007/s00381-018-3856-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 2.4] [Reference Citation Analysis]
282 Ahdab R, Noureldine MHA, Mohammedi K, Nader M, Zouari HG, Nordine T, Créange A, Lefaucheur JP, Ayache SS. The ulnar ratio as a sensitive and specific marker of acute inflammatory demyelinating polyneuropathy. Clin Neurophysiol 2018;129:1699-703. [PMID: 29940481 DOI: 10.1016/j.clinph.2018.05.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
283 Chafale VA, Pandit A, Lahoti SA, Kundu T, Ganguly G. Guillain–Barré Syndrome: Profile of 120 Patients with respect to Response to Various Modalities of Treatment. Indian Journal of Physical Medicine and Rehabilitation 2018;29:31-36. [DOI: 10.5005/jp-journals-10066-0022] [Reference Citation Analysis]
284 Niu J, Liu M, Sun Q, Li Y, Wu S, Ding Q, Guan Y, Cui L. Motor Nerve Conduction Block Predicting Outcome of Guillain-Barre Syndrome. Front Neurol 2018;9:399. [PMID: 29910770 DOI: 10.3389/fneur.2018.00399] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
285 Ansari B, Basiri K, Derakhshan Y, Kadkhodaei F, Okhovat AA. Epidemiology and Clinical Features of Guillain-Barre Syndrome in Isfahan, Iran. Adv Biomed Res 2018;7:87. [PMID: 29930927 DOI: 10.4103/abr.abr_50_17] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
286 Üçeyler N, Vollert J, Broll B, Riediger N, Langjahr M, Saffer N, Schubert A, Siedler G, Sommer C. Sensory profiles and skin innervation of patients with painful and painless neuropathies. Pain 2018;159:1867-76. [DOI: 10.1097/j.pain.0000000000001287] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 7.4] [Reference Citation Analysis]
287 Hocker S, Nagarajan E, Rubin M, Wijdicks EFM. Clinical factors associated with Guillain-Barré syndrome following surgery. Neurol Clin Pract 2018;8:201-6. [PMID: 30105159 DOI: 10.1212/CPJ.0000000000000451] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
288 Tham SL, Prasad K, Umapathi T. Guillain-Barré syndrome mimics. Brain Behav 2018;8:e00960. [PMID: 29761013 DOI: 10.1002/brb3.960] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
289 Mier-Y-Teran-Romero L, Delorey MJ, Sejvar JJ, Johansson MA. Guillain-Barré syndrome risk among individuals infected with Zika virus: a multi-country assessment. BMC Med 2018;16:67. [PMID: 29759069 DOI: 10.1186/s12916-018-1052-4] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 10.0] [Reference Citation Analysis]
290 Li X, Li W, Luo Y, Qin L, Su Q, Mo W. Can we assess severity of Guillain-Barré syndrome using absolute monocyte count? Int J Lab Hematol 2018;40:488-92. [PMID: 29718547 DOI: 10.1111/ijlh.12845] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
291 Oji S, Narukawa S, Ishizuka K, Sugimoto K, Yoshida N, Takeshita H, Kaida K, Nomura K. Guillain-Barré syndrome initially manifesting as motor weakness, urinary dysfunction and hyperreflexia: Case report and literature review. Clin Exp Neuroimmunol 2018;9:110-114. [DOI: 10.1111/cen3.12425] [Reference Citation Analysis]
292 Altaweel YA, Abdelaziz S, Fathy HA, AbdelBadea S. Correlative study between C-reactive protein, clinical severity, and nerve conduction studies in Guillain-Barrè syndrome. Egypt J Neurol Psychiatr Neurosurg 2018;54:4. [PMID: 29780224 DOI: 10.1186/s41983-018-0006-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
293 Debnath M, Nagappa M, Talukdar PM, Subbanna M, Sundaravadivel P, Shivakumar V, Dutta D, Wahatule R, Sinha S, Bindu PS, Periyavan S, Umamaheswara Rao GS, Taly AB. Comprehensive cytokine profiling provides evidence for a multi-lineage Th responses in Guillain Barré Syndrome. Cytokine 2018;110:58-62. [PMID: 29704819 DOI: 10.1016/j.cyto.2018.04.026] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
294 Misawa S, Kuwabara S, Sato Y, Yamaguchi N, Nagashima K, Katayama K, Sekiguchi Y, Iwai Y, Amino H, Suichi T, Yokota T, Nishida Y, Kanouchi T, Kohara N, Kawamoto M, Ishii J, Kuwahara M, Suzuki H, Hirata K, Kokubun N, Masuda R, Kaneko J, Yabe I, Sasaki H, Kaida KI, Takazaki H, Suzuki N, Suzuki S, Nodera H, Matsui N, Tsuji S, Koike H, Yamasaki R, Kusunoki S; Japanese Eculizumab Trial for GBS (JET-GBS) Study Group. Safety and efficacy of eculizumab in Guillain-Barré syndrome: a multicentre, double-blind, randomised phase 2 trial. Lancet Neurol 2018;17:519-29. [PMID: 29685815 DOI: 10.1016/S1474-4422(18)30114-5] [Cited by in Crossref: 75] [Cited by in F6Publishing: 78] [Article Influence: 15.0] [Reference Citation Analysis]
295 Tan CY, Shahrizaila N, Yeoh KY, Goh KJ, Tan MP. Heart rate variability and baroreflex sensitivity abnormalities in Guillain-Barré syndrome: a pilot study. Clin Auton Res 2019;29:339-48. [PMID: 29654380 DOI: 10.1007/s10286-018-0525-z] [Reference Citation Analysis]
296 van den Berg B, Storm EF, Garssen MJP, Blomkwist-Markens PH, Jacobs BC. Clinical outcome of Guillain-Barré syndrome after prolonged mechanical ventilation. J Neurol Neurosurg Psychiatry 2018;89:949-54. [PMID: 29627773 DOI: 10.1136/jnnp-2018-317968] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
297 GeurtsvanKessel CH, Islam Z, Islam MB, Kamga S, Papri N, van de Vijver DAMC, Reusken C, Mogling R, Heikema AP, Jahan I, Pradel FK, Pavlicek RL, Mohammad QD, Koopmans MPG, Jacobs BC, Endtz HP. Zika virus and Guillain-Barré syndrome in Bangladesh. Ann Clin Transl Neurol 2018;5:606-15. [PMID: 29761123 DOI: 10.1002/acn3.556] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
298 Jacobs BC, van den Berg B, Verboon C, Chavada G, Cornblath DR, Gorson KC, Harbo T, Hartung HP, Hughes RAC, Kusunoki S, van Doorn PA, Willison HJ; IGOS Consortium. International Guillain-Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome. J Peripher Nerv Syst 2017;22:68-76. [PMID: 28406555 DOI: 10.1111/jns.12209] [Cited by in Crossref: 73] [Cited by in F6Publishing: 75] [Article Influence: 14.6] [Reference Citation Analysis]
299 Ishaque T, Islam MB, Ara G, Endtz HP, Mohammad QD, Jacobs BC, Islam Z. High mortality from Guillain-Barré syndrome in Bangladesh. J Peripher Nerv Syst 2017;22:121-6. [PMID: 28447405 DOI: 10.1111/jns.12215] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
300 Sonavane AD, Saigal S, Kathuria A, Choudhary NS, Saraf N. Guillain-Barré syndrome: rare extra-intestinal manifestation of hepatitis B. Clin J Gastroenterol 2018;11:312-4. [PMID: 29542024 DOI: 10.1007/s12328-018-0847-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
301 Matsui N, Nodera H, Kuzume D, Iwasa N, Unai Y, Sakai W, Miyazaki Y, Yamazaki H, Osaki Y, Mori A, Furukawa T, Tsukamoto-miyashiro A, Shimatani Y, Yamasaki M, Izumi Y, Kusunoki S, Arisawa K, Kaji R. Guillain−Barré syndrome in a local area in Japan, 2006-2015: an epidemiological and clinical study of 108 patients. Eur J Neurol 2018;25:718-24. [DOI: 10.1111/ene.13569] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
302 Chandra SR, Karru VR, Mukheem Mudabbir MA, Ramakrishnan S, Mahadevan A. Immune-mediated Neuropathies Our Experience over 3 Years. J Neurosci Rural Pract 2018;9:30-5. [PMID: 29456342 DOI: 10.4103/jnrp.jnrp_376_17] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
303 Davidson AI, Halstead SK, Goodfellow JA, Chavada G, Mallik A, Overell J, Lunn MP, McConnachie A, van Doorn P, Willison HJ. Inhibition of complement in Guillain-Barré syndrome: the ICA-GBS study. J Peripher Nerv Syst 2017;22:4-12. [PMID: 27801990 DOI: 10.1111/jns.12194] [Cited by in Crossref: 53] [Cited by in F6Publishing: 40] [Article Influence: 10.6] [Reference Citation Analysis]
304 Fong CY, Aung HWW, Khairani A, Gan CS, Shahrizaila N, Goh KJ. Bickerstaff's brainstem encephalitis with overlapping Guillain-Barré syndrome: Usefulness of sequential nerve conduction studies. Brain Dev 2018;40:507-11. [PMID: 29459060 DOI: 10.1016/j.braindev.2018.02.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
305 Islam Z, Jahan I, Ahammad RU, Shahnaij M, Nahar S, Mohammad QD. FAS promoter polymorphisms and serum sFas level are associated with increased risk of nerve damage in Bangladeshi patients with Guillain-Barré syndrome. PLoS One 2018;13:e0192703. [PMID: 29432441 DOI: 10.1371/journal.pone.0192703] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
306 Islam B, Islam Z, GeurtsvanKessel CH, Jahan I, Endtz HP, Mohammad QD, Jacobs BC. Guillain-Barré syndrome following varicella-zoster virus infection. Eur J Clin Microbiol Infect Dis 2018;37:511-8. [PMID: 29411189 DOI: 10.1007/s10096-018-3199-5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
307 Hughes RAC, Cornblath DR, Willison HJ. Guillain-Barré syndrome in the 100 years since its description by Guillain, Barré and Strohl. Brain 2016;139:3041-7. [PMID: 29106487 DOI: 10.1093/brain/aww247] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
308 Islam MB, Islam Z, Farzana KS, Sarker SK, Endtz HP, Mohammad QD, Jacobs BC. Guillain-Barré syndrome in Bangladesh: validation of Brighton criteria. J Peripher Nerv Syst 2016;21:345-51. [PMID: 27616152 DOI: 10.1111/jns.12189] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
309 Hüner EA, Dai AI, Demiryürek AT. Association of Neutrophil/Lymphocyte Ratio With Intravenous Immunoglobulin Treatment in Children With Guillain-Barré Syndrome. J Child Neurol 2018;33:164-7. [DOI: 10.1177/0883073817748109] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
310 Liu S, Xiao Z, Lou M, Ji F, Shao B, Dai H, Luo C, Hu B, Zhou R, Zou Z, Li J, Li X, Xu J, Hu F, Qin C, Wang L, Liu T, Bai R, Chen Y, Lv H, Zhang R, Wang X, Wang Y, Ren S, He X, Jiang Z, Wu H, Yu D, Yang W, Luo W, Gong D, Chen B, Liu Y, Yao J, Yang Y, Guan J, Zhu M, Fu X, Gao G, Zhang H, Ding M, Fan S, Cao Q, Lu J, Lu Z. Guillain-Barré syndrome in southern China: retrospective analysis of hospitalised patients from 14 provinces in the area south of the Huaihe River. J Neurol Neurosurg Psychiatry 2018;89:618-26. [PMID: 29326294 DOI: 10.1136/jnnp-2017-316930] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
311 Doctor GT, Alexander SK, Radunovic A. Guillain-Barré syndrome with exaggerated pleocytosis and anti-GM1 ganglioside antibodies. BMJ Case Rep 2018;2018:bcr-2017-222995. [PMID: 29306858 DOI: 10.1136/bcr-2017-222995] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
312 Van den Bergh PYK, Piéret F, Woodard JL, Attarian S, Grapperon AM, Nicolas G, Brisset M, Cassereau J, Rajabally YA, Van Parijs V, Verougstraete D, Jacquerye P, Raymackers JM, Redant C, Michel C, Delmont E; University of Louvain GBS Electrodiagnosis Study Group. Guillain-BarrÉ syndrome subtype diagnosis: A prospective multicentric European study. Muscle Nerve 2018. [PMID: 29315669 DOI: 10.1002/mus.26056] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
313 Yang Y, Lu J, Bao H. Serial electromyographic findings in Guillain-Barré syndrome patients. Eur J Inflamm 2018;16:205873921879353. [DOI: 10.1177/2058739218793536] [Reference Citation Analysis]
314 Meyer Sauteur PM, Huizinga R, Tio-gillen AP, Drenthen J, Unger WW, Jacobs E, van Rossum AM, Jacobs BC. Intrathecal antibody responses to GalC in Guillain-Barré syndrome triggered by Mycoplasma pneumoniae. Journal of Neuroimmunology 2018;314:13-6. [DOI: 10.1016/j.jneuroim.2017.11.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
315 Kim JK, Kim YH, Yoon BA, Cho JY, Oh SY, Shin HY, Kim JS, Park KH, Kim SY, Suh BC, Seok HY, Yoo JH, Bae JS. Clinical Heterogeneity of Anti-GM2-Ganglioside-Antibody Syndrome. J Clin Neurol 2018;14:401-6. [PMID: 29971981 DOI: 10.3988/jcn.2018.14.3.401] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
316 Rahman MI, Jahan I, Khalid MM, Jahan I, Ahammad RU, Nahar S, Islam Z. CD1A and CD1E gene polymorphisms are not associated with susceptibility to Guillain-Barré syndrome in the Bangladeshi population. Journal of Neuroimmunology 2018;314:8-12. [DOI: 10.1016/j.jneuroim.2017.11.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
317 Fary K, Ng L. Guillain-Barré Syndrome. Encyclopedia of Clinical Neuropsychology 2018. [DOI: 10.1007/978-3-319-57111-9_554] [Reference Citation Analysis]
318 Khadilkar SV, Yadav RS, Patel BA. Guillain–Barré Syndrome. Neuromuscular Disorders 2018. [DOI: 10.1007/978-981-10-5361-0_36] [Reference Citation Analysis]
319 Dayal Singh R, Abhinav K. BILATERAL FACIAL PALSY IN GUILLAIN-BARRE SYNDROME- INCIDENCE AND PROGNOSTIC SIGNIFICANCE. jemds 2017;6:7051-7054. [DOI: 10.14260/jemds/2017/1529] [Reference Citation Analysis]
320 Guan Z, Shang L, Zhang W, Guo Y, Xue Y, Li X, Gong Y, Liu X. A rating scale for the severity of Guillain-Barré syndrome. Acta Neurol Scand 2017;136:680-7. [PMID: 28612931 DOI: 10.1111/ane.12786] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
321 Wang Y, Shang P, Xin M, Bai J, Zhou C, Zhang HL. The usefulness of chief complaints to predict severity, ventilator dependence, treatment option, and short-term outcome of patients with Guillain-Barré syndrome: a retrospective study. BMC Neurol 2017;17:200. [PMID: 29157205 DOI: 10.1186/s12883-017-0982-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
322 Berciano J. Spinal nerve involvement in early Guillain-Barré syndrome: The Haymaker and Kernohan's legacy. J Neurol Sci 2017;382:1-9. [PMID: 29110997 DOI: 10.1016/j.jns.2017.09.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
323 Li X, Li W, Shi X, Mo L, Luo Y, Qin L, Yang Z, Mo W. Is serum bilirubin associated with the severity of Guillain-Barré syndrome? Int J Neurosci 2018;128:595-9. [PMID: 29130362 DOI: 10.1080/00207454.2017.1404465] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
324 Sevy A, Grapperon AM, Salort Campana E, Delmont E, Attarian S. Detection of proximal conduction blocks using a triple stimulation technique improves the early diagnosis of Guillain-Barré syndrome. Clin Neurophysiol 2018;129:127-32. [PMID: 29182914 DOI: 10.1016/j.clinph.2017.10.035] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
325 Kalita J, Kumar M, Misra UK. Prospective comparison of acute motor axonal neuropathy and acute inflammatory demyelinating polyradiculoneuropathy in 140 children with Guillain-Barré syndrome in India: AMAN vs. AIDP in Children. Muscle Nerve 2018;57:761-5. [DOI: 10.1002/mus.25992] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
326 Tobon A. The Role of Immunoglobulin in the Treatment of Immune-Mediated Peripheral Neuropathies. Journal of Infusion Nursing 2017;40:375-9. [DOI: 10.1097/nan.0000000000000248] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
327 Surpur SS, Govindarajan R. Role of "Sural Sparing" Pattern (Absent/Abnormal Median and Ulnar with Present Sural SNAP) Compared to Absent/Abnormal Median or Ulnar with Normal Sural SNAP in Acute Inflammatory Demyelinating Polyneuropathy. Front Neurol 2017;8:512. [PMID: 29085327 DOI: 10.3389/fneur.2017.00512] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
328 Kamate M. Guillaine-Barre Syndrome with Retained Deep Tendon Reflexes. Indian Pediatr 2017;54:887. [PMID: 29120341 DOI: 10.1007/s13312-017-1157-4] [Reference Citation Analysis]
329 Hanche-olsen S, Matiasek K, Molín J, Rosati M, Hahn C, Hultin Jäderlund K, Gröndahl G. Acquired equine polyneuropathy of Nordic horses: A conspicuous inclusion body schwannopathy. Neuromuscular Disorders 2017;27:931-41. [DOI: 10.1016/j.nmd.2017.06.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
330 Islam MB, Islam Z, Rahman S, Endtz HP, Vos MC, van der Jagt M, van Doorn PA, Jacobs BC, Mohammad QD. Small volume plasma exchange for Guillain-Barré syndrome in resource poor settings: a safety and feasibility study. Pilot Feasibility Stud 2017;3:40. [PMID: 28975040 DOI: 10.1186/s40814-017-0185-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
331 Yamagishi Y, Suzuki H, Sonoo M, Kuwabara S, Yokota T, Nomura K, Chiba A, Kaji R, Kanda T, Kaida K, Ikeda SI, Mutoh T, Yamasaki R, Takashima H, Matsui M, Nishiyama K, Sobue G, Kusunoki S. Markers for Guillain-Barré syndrome with poor prognosis: a multi-center study. J Peripher Nerv Syst 2017;22:433-9. [PMID: 28833828 DOI: 10.1111/jns.12234] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
332 Nagappa M, Rahul W, Sinha S, Bindu PS, Mathuranath PS, Rao S, Periyavan S, Umamaheshwara Rao GS, Taly AB. Guillain Barre Syndrome in the elderly: Experience from a tertiary-care hospital in India. J Clin Neurosci 2017;46:45-9. [PMID: 28890042 DOI: 10.1016/j.jocn.2017.08.048] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
333 Wang Y, Lang W, Zhang Y, Ma X, Zhou C, Zhang HL. Long-term prognosis of Guillain-Barré syndrome not determined by treatment options? Oncotarget 2017;8:79991-80001. [PMID: 29108381 DOI: 10.18632/oncotarget.20620] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
334 Elkoundi A, Kartite N, Bensghir M, Doghmi N, Lalaoui SJ. Gitelman syndrome: a rare life-threatening case of hypokalemic paralysis mimicking Guillain-Barré syndrome during pregnancy and review of the literature. Clin Case Rep 2017;5:1597-603. [PMID: 29026553 DOI: 10.1002/ccr3.1122] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
335 Tang HY, Chiu DT, Lin JF, Huang CY, Chang KH, Lyu RK, Ro LS, Kuo HC, Cheng ML, Chen CM. Disturbance of Plasma Lipid Metabolic Profile in Guillain-Barre Syndrome. Sci Rep 2017;7:8140. [PMID: 28811529 DOI: 10.1038/s41598-017-08338-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
336 Tolosa N, Tinker SC, Pacheco O, Valencia D, Botero DS, Tong VT, Mercado M, Gilboa SM, Gonzalez M, Nelson CA, Pardo L, Rao CY, Rico A, Moore M, Parra E, Honein MA, Ospina Martínez ML. Zika Virus Disease in Children in Colombia, August 2015 to May 2016. Paediatr Perinat Epidemiol 2017;31:537-45. [PMID: 28806479 DOI: 10.1111/ppe.12391] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
337 Capodivento G, Visigalli D, Garnero M, Fancellu R, Ferrara MD, Basit A, Hamid Z, Pastore VP, Garibaldi S, Armirotti A, Mancardi G, Serrati C, Capello E, Schenone A, Nobbio L. Sphingomyelin as a myelin biomarker in CSF of acquired demyelinating neuropathies. Sci Rep 2017;7:7831. [PMID: 28798317 DOI: 10.1038/s41598-017-08314-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
338 Nomura K, Kusunoki S, the Research Group of IVIG for GBS in Japan. Japanese multicenter clinical trial of intravenous polyethylene glycol-treated immunoglobulin and comparison with previous clinical trial of sulfonated immunoglobulin in Guillain-Barré syndrome. Clin Exp Neuroimmunol 2017;8:258-266. [DOI: 10.1111/cen3.12407] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
339 Chen EY, Stratton C, Mercer B, Hohler A, Tannoury TY, Tannoury C. Guillain-Barré Syndrome After Elective Spinal Surgery. J Am Acad Orthop Surg 2017;25:587-93. [PMID: 28644175 DOI: 10.5435/JAAOS-D-16-00572] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
340 Rosenberg J, Aradi S, Pruitt A. Clinical Reasoning: A man with rapidly ascending paralysis. Neurology 2017;89:e25-e31. [DOI: 10.1212/wnl.0000000000004156] [Reference Citation Analysis]
341 Balavoine S, Pircher M, Hoen B, Herrmann-Storck C, Najioullah F, Madeux B, Signate A, Valentino R, Lannuzel A, Saint Louis M, Cassadou S, Cabié A, Schepers K. Guillain-Barré Syndrome and Chikungunya: Description of All Cases Diagnosed during the 2014 Outbreak in the French West Indies. Am J Trop Med Hyg 2017;97:356-60. [PMID: 28722564 DOI: 10.4269/ajtmh.15-0753] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
342 Nayak R. Practical approach to the patient with acute neuromuscular weakness. World J Clin Cases 2017; 5(7): 270-279 [PMID: 28798922 DOI: 10.12998/wjcc.v5.i7.270] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
343 Semproni M, Gibson G, Kuyper L, Tam P. Unusual sensory variant of Guillain-Barré syndrome. BMJ Case Rep 2017;2017:bcr-2016-218935. [PMID: 28710191 DOI: 10.1136/bcr-2016-218935] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
344 Kramer CL, Boon AJ, Harper CM, Goodman BP. Compound muscle action potential duration in critical illness neuromyopathy. Muscle Nerve 2018;57:395-400. [PMID: 28646510 DOI: 10.1002/mus.25732] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
345 Olubajo F, Yermakova T, Highley JR, Arzoglou V. Concomitant idiopathic hypertrophic spinal pachymeningitis and Guillain-Barré syndrome in a patient: coincidence or a triggering mechanism? J Neurosurg Spine 2017;27:335-40. [PMID: 28644069 DOI: 10.3171/2017.3.SPINE161112] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
346 Sahin S, Cinar N, Karsidag S. Are Cerebrospinal Fluid Protein Levels and Plasma Neutrophil/Lymphocyte Ratio Associated with Prognosis of Guillain Barré Syndrome? Neurol Int 2017;9:7032. [PMID: 28713530 DOI: 10.4081/ni.2017.7032] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
347 Jahan I, Ahammad RU, Farzana KS, Khalid MM, Islam MB, Rahman MI, Nahar S, Kabir Y, Mohmmad QD, Islam Z. Tumor necrosis factor-alpha -863C/A polymorphism is associated with Guillain-Barré syndrome in Bangladesh. J Neuroimmunol 2017;310:46-50. [PMID: 28778444 DOI: 10.1016/j.jneuroim.2017.06.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
348 Tabib A, Karbian N, Mevorach D. Demyelination, strokes, and eculizumab: Lessons from the congenital CD59 gene mutations. Mol Immunol 2017;89:69-72. [PMID: 28622911 DOI: 10.1016/j.molimm.2017.05.024] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
349 Drenthen J, Roodbol J, Maathuis EM, Catsman-berrevoets CE, Blok JH, de Wit MY, Jacobs BC. Motor nerve excitability after childhood Guillain-Barré syndrome: Drenthen et al. J Peripher Nerv Syst 2017;22:100-5. [DOI: 10.1111/jns.12213] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
350 Peric S, Bozovic I, Bjelica B, Berisavac I, Stojiljkovic O, Basta I, Beslac-bumbasirevic L, Rakocevic-stojanovic V, Lavrnic D, Stevic Z. Diabetes mellitus may affect short-term outcome of Guillain-Barré syndrome: Peric et al. J Peripher Nerv Syst 2017;22:127-30. [DOI: 10.1111/jns.12206] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
351 Barzegar M, Toopchizadeh V, Maher MHK, Sadeghi P, Jahanjoo F, Pishgahi A. Predictive factors for achieving independent walking in children with Guillain-Barre syndrome. Pediatr Res 2017;82:333-9. [PMID: 28422939 DOI: 10.1038/pr.2017.67] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
352 Hiew FL, Ramlan R, Viswanathan S, Puvanarajah S. Guillain-Barré Syndrome, variants & forms fruste: Reclassification with new criteria. Clin Neurol Neurosurg 2017;158:114-8. [PMID: 28514704 DOI: 10.1016/j.clineuro.2017.05.006] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
353 Tang HY, Ho HY, Chiu DT, Huang CY, Cheng ML, Chen CM. Alterations of plasma concentrations of lipophilic antioxidants are associated with Guillain-Barre syndrome. Clin Chim Acta 2017;470:75-80. [PMID: 28476374 DOI: 10.1016/j.cca.2017.05.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
354 Zhang L, Guo H, Zhang D, Wang R, Li T, Li L, Suo D, Yang L. Analysis of serum interleukin-27 and interleukin-35 concentrations in patients with Guillain-Barré syndrome. Clinica Chimica Acta 2017;468:5-9. [DOI: 10.1016/j.cca.2017.02.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
355 Grimaldi-bensouda L, Rossignol M, Koné-paut I, Krivitzky A, Lebrun-frenay C, Clet J, Brassat D, Papeix C, Nicolino M, Benhamou P, Fain O, Costedoat-chalumeau N, Courcoux M, Viallard J, Godeau B, Papo T, Vermersch P, Bourgault-villada I, Breart G, Abenhaim L, Abbas F, Abdelmoumni A, Hilliquin P, Requeda E, Adoue D, Brassat D, Agard C, Masseau A, Aladjidi N, Clet J, Fernandes H, Lemasson G, Perel Y, Raymond I, Richer O, Vital A, Allain-launay E, Bru M, Nicolino M, Thomas C, Altman J, Amsallem D, Aras N, Boukari L, Dubrel M, Fain O, Letellier E, Lucidarme N, Mekinian A, Morin A, Stirnemann J, Atlan C, Audry D, Augustin J, Bakir R, Bartolucci P, Chevalier X, Godeau B, Guillaud C, Khellaf M, Limal N, Lousteau V, Mahevas M, Méliksetyan G, Michel M, Roumier M, Bayart S, Bonnet F, Decaux O, Bekherraz A, Brihaye B, Dachez R, Daugas E, Hayem G, Meyer O, Papo T, Pasqualoni E, Sacre K, Travert F, Bellon H, Beltrand J, Lefrere F, Simon A, Benhamou P, Benveniste O, Bolgert F, Costedoat-chalumeau N, De Paz R, Demeret S, Fautrel B, Jacqueminet S, Louapre C, Maillart E, Morel N, Papeix C, Rigabert J, Bensaid P, Berger C, Berquin P, Le Moing A, Berroir S, Besson G, Boutte C, Casez O, Bonnotte B, Audia S, Bossu-estour C, Bourgarit A, Dupuy A, Keshmandt H, Bourre B, Brac A, Perrin A, Pondarré C, Villar-fimbel S, Bruckert I, Cosson A, Magy-bertrand N, Tisserand G, Camu W, Carlander B, Morales RJ, Cances C, Pasquet M, Castilla Lievre MA, Chabroux S, Charif M, Chatelus E, Sibilia J, Chevrant-breton J, Clavel S, Bille-turc F, Cohen J, Courcoux MF, Leverger G, Machet L, Cuisset J, Cony-makhoul P, Darsy P, Favre S, Giraud P, Leitenschenck L, Monteiro I, Morati C, Deseze J, Dinulescu M, Dhaoui T, Dommange-romero F, Drevard E, Dupuis C, Dumuis M, Durand J, Farad S, Lecomte P, Pierre P, Fouyssac F, Gaudin P, Gautier A, Gellen-dautremer J, Jarrin I, Richette P, Georget E, Gras P, Moreau T, Giraud E, Hacini M, Mayer A, Guillaumat C, Guillaume S, Guitton C, Kone-paut I, Marsaud C, Rossi L, Guyot M, Hassler P, Heimfert C, Heinzlef O, Hillion B, Hocquelet C, Husson H, Ichai P, Jeziorski E, Deslandre CJ, Le Guern V, Kamenov K, Kerlan V, Lemoine P, Misery L, Pan-petesch B, Krivitzky A, Labauge P, Rodier M, Lacade C, Razafimahefa B, Lachgar K, Larmarau M, Leblanc T, Lebrun-frenay C, Lefèbvre P, Lejoyeux P, Leske C, Ly K, Magy L, Mansuy S, Marechaud R, Martin Negrier M, Sole G, Maupetit J, Mazingue F, Mochon S, Moktar B, Morcamp D, Morlet-barla N, Nicolas G, Pautot V, Pellier I, Verret J, Outteryck O, Vermersch P, Pallot-prades B, Paquet JM, Puechal X, Sortais A, Pelletier J, Rico A, Pez D, Stankoff B, Quittet P, Rémy C, Roba E, Rosario H, Roudaut N, Sonnet E, Ruel M, Sebban S, Schaepelynck P, Simonin M, Vial C, Viallard J, Ladedan I, Zenone T. Risk of autoimmune diseases and human papilloma virus (HPV) vaccines: Six years of case-referent surveillance. Journal of Autoimmunity 2017;79:84-90. [DOI: 10.1016/j.jaut.2017.01.005] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 9.3] [Reference Citation Analysis]
356 Kahlmann V, Roodbol J, van Leeuwen N, Ramakers CRB, van Pelt D, Neuteboom RF, Catsman-Berrevoets CE, de Wit MCY, Jacobs BC. Validated age-specific reference values for CSF total protein levels in children. Eur J Paediatr Neurol 2017;21:654-60. [PMID: 28461111 DOI: 10.1016/j.ejpn.2017.03.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
357 Üçeyler N, Braunsdorf S, Kunze E, Riediger N, Scheytt S, Divisova Š, Bekircan‐kurt CE, Toyka KV, Sommer C. Cellular infiltrates in skin and sural nerve of patients with polyneuropathies. Muscle Nerve 2017;55:884-93. [DOI: 10.1002/mus.25240] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
358 Roodbol J, de Wit MY, van den Berg B, Kahlmann V, Drenthen J, Catsman-Berrevoets CE, Jacobs BC. Diagnosis of Guillain-Barré syndrome in children and validation of the Brighton criteria. J Neurol 2017;264:856-61. [PMID: 28251358 DOI: 10.1007/s00415-017-8429-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
359 Chevret S, Hughes RA, Annane D. Plasma exchange for Guillain-Barré syndrome. Cochrane Database Syst Rev 2017;2:CD001798. [PMID: 28241090 DOI: 10.1002/14651858.CD001798.pub3] [Cited by in Crossref: 37] [Cited by in F6Publishing: 55] [Article Influence: 6.2] [Reference Citation Analysis]
360 Zhang B, Wu X, Shen D, Li T, Li C, Mao M, Zhang HL, Liu K. The clinical characteristics and short-term prognosis in elderly patients with Guillain-Barré syndrome. Medicine (Baltimore) 2017;96:e5848. [PMID: 28072747 DOI: 10.1097/MD.0000000000005848] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
361 Pinto-Díaz CA, Rodríguez Y, Monsalve DM, Acosta-Ampudia Y, Molano-González N, Anaya JM, Ramírez-Santana C. Autoimmunity in Guillain-Barré syndrome associated with Zika virus infection and beyond. Autoimmun Rev 2017;16:327-34. [PMID: 28216074 DOI: 10.1016/j.autrev.2017.02.002] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
362 Yang J, Lee YB, Lee KW, Park HM. Atypical Acute Motor Axonal Neuropathy with Cerebrospinal Pleocytosis Mimicking Myelitis. J Clin Neurol 2017;13:205-6. [PMID: 28176505 DOI: 10.3988/jcn.2017.13.2.205] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
363 Sogawa K, Nodera H, Takamatsu N, Mori A, Yamazaki H, Shimatani Y, Izumi Y, Kaji R. Neurogenic and Myogenic Diseases: Quantitative Texture Analysis of Muscle US Data for Differentiation. Radiology 2017;283:492-8. [PMID: 28156201 DOI: 10.1148/radiol.2016160826] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 5.3] [Reference Citation Analysis]
364 Kaushik P, Cohen AJ, Zuckerman SJ, Vatsavai SR, Pepper JS, Banda VR, Eason JD, Loss GE, Kaushik R. Miller Fisher Variant of Guillain—Barré Syndrome Requiring a Cardiac Pacemaker in a Patient on Tacrolimus after Liver Transplantation. Ann Pharmacother 2005;39:1124-7. [DOI: 10.1345/aph.1e676] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
365 Anaya JM, Rodríguez Y, Monsalve DM, Vega D, Ojeda E, González-Bravo D, Rodríguez-Jiménez M, Pinto-Díaz CA, Chaparro P, Gunturiz ML, Ansari AA, Gershwin ME, Molano-González N, Ramírez-Santana C, Acosta-Ampudia Y. A comprehensive analysis and immunobiology of autoimmune neurological syndromes during the Zika virus outbreak in Cúcuta, Colombia. J Autoimmun 2017;77:123-38. [PMID: 28062188 DOI: 10.1016/j.jaut.2016.12.007] [Cited by in Crossref: 53] [Cited by in F6Publishing: 45] [Article Influence: 8.8] [Reference Citation Analysis]
366 Jann S, Facchetti D, Costi I. Guillain-Barré Syndrome. Emergency Management in Neurology 2017. [DOI: 10.1007/978-3-319-56654-2_3] [Reference Citation Analysis]
367 Fary K, Ng L. Guillain-Barré Syndrome. Encyclopedia of Clinical Neuropsychology 2017. [DOI: 10.1007/978-3-319-56782-2_554-3] [Reference Citation Analysis]
368 Rana AQ, Ghouse AT, Govindarajan R. Peripheral Neuropathy. Neurophysiology in Clinical Practice 2017. [DOI: 10.1007/978-3-319-39342-1_10] [Reference Citation Analysis]
369 Ramakrishnan S, Mustare V, Philip M, Thennarasu K, Periyavan S. Treatment-related Fluctuations in Guillain Barre Syndrome and the Conundrum of Additional Cycles of Plasmapheresis. Ann Indian Acad Neurol 2017;20:372-7. [PMID: 29184340 DOI: 10.4103/aian.AIAN_242_17] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
370 Kuwahara M, Samukawa M, Ikeda T, Morikawa M, Ueno R, Hamada Y, Kusunoki S. Characterization of the neurological diseases associated with Mycoplasma pneumoniae infection and anti-glycolipid antibodies. J Neurol 2017;264:467-75. [DOI: 10.1007/s00415-016-8371-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
371 Toamad U, Kongkamol C, Setthawatcharawanich S, Limapichat K, Phabphal K, Sathirapanya P. Clinical presentations as predictors of prolonged mechanical ventilation in Guillain-Barré syndrome in an institution with limited medical resources. Singapore Med J 2015;56:558-61. [PMID: 26512148 DOI: 10.11622/smedj.2015152] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
372 Goodfellow JA, Willison HJ. Guillain-Barré syndrome: a century of progress. Nat Rev Neurol 2016;12:723-31. [PMID: 27857121 DOI: 10.1038/nrneurol.2016.172] [Cited by in Crossref: 110] [Cited by in F6Publishing: 112] [Article Influence: 15.7] [Reference Citation Analysis]
373 Pritchard J, Hughes RA, Hadden RD, Brassington R. Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome. Cochrane Database Syst Rev 2016;11:CD008630. [PMID: 27846348 DOI: 10.1002/14651858.CD008630.pub4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
374 Kadoya M, Kaida K, Koike H, Takazaki H, Ogata H, Moriguchi K, Shimizu J, Nagata E, Takizawa S, Chiba A, Yamasaki R, Kira JI, Sobue G, Ikewaki K. IgG4 anti-neurofascin155 antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: Clinical significance and diagnostic utility of a conventional assay. J Neuroimmunol 2016;301:16-22. [PMID: 27852440 DOI: 10.1016/j.jneuroim.2016.10.013] [Cited by in Crossref: 59] [Cited by in F6Publishing: 61] [Article Influence: 8.4] [Reference Citation Analysis]
375 Yamaguchi N, Misawa S, Sato Y, Nagashima K, Katayama K, Sekiguchi Y, Iwai Y, Amino H, Suichi T, Yokota T, Nishida Y, Kohara N, Hirata K, Nishiyama K, Yabe I, Kaida KI, Suzuki N, Nodera H, Tsuji S, Koike H, Kira JI, Hanaoka H, Kusunoki S, Kuwabara S; JET-GBS Group. A Prospective, Multicenter, Randomized Phase II Study to Evaluate the Efficacy and Safety of Eculizumab in Patients with Guillain-Barré Syndrome (GBS): Protocol of Japanese Eculizumab Trial for GBS (JET-GBS). JMIR Res Protoc 2016;5:e210. [PMID: 27821382 DOI: 10.2196/resprot.6610] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
376 Morikawa M, Kuwahara M, Ueno R, Samukawa M, Hamada Y, Kusunoki S. Serological study using glycoarray for detecting antibodies to glycolipids and glycolipid complexes in immune-mediated neuropathies. J Neuroimmunol 2016;301:35-40. [PMID: 27836184 DOI: 10.1016/j.jneuroim.2016.10.010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
377 Kusunoki S. History of Guillain-Barré syndrome. Clin Exp Neuroimmunol 2016;7:305-311. [DOI: 10.1111/cen3.12339] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
378 Goldman AS, Schmalstieg EJ, Dreyer CF, Schmalstieg FC Jr, Goldman DA. Franklin Delano Roosevelt's (FDR's) (1882-1945) 1921 neurological disease revisited; the most likely diagnosis remains Guillain-Barré syndrome. J Med Biogr 2016;24:452-9. [PMID: 26508622 DOI: 10.1177/0967772015605738] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
379 Hughes RA, Brassington R, Gunn AA, van Doorn PA. Corticosteroids for Guillain-Barré syndrome. Cochrane Database Syst Rev 2016;10:CD001446. [PMID: 27775812 DOI: 10.1002/14651858.CD001446.pub5] [Cited by in Crossref: 42] [Cited by in F6Publishing: 60] [Article Influence: 6.0] [Reference Citation Analysis]
380 Papathanasiou A, Markakis I. Clinical Heterogeneity of Guillain-Barré Syndrome in the Emergency Department: Impact on Clinical Outcome. Case Rep Emerg Med 2016;2016:4981274. [PMID: 27761272 DOI: 10.1155/2016/4981274] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
381 Gupta SK, Jha KK, Chalati MD, Alashi LT. Miller Fisher syndrome. BMJ Case Rep 2016;2016:bcr2016217085. [PMID: 27737870 DOI: 10.1136/bcr-2016-217085] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
382 Jackson AC. Human Rabies: a 2016 Update. Curr Infect Dis Rep 2016;18:38. [PMID: 27730539 DOI: 10.1007/s11908-016-0540-y] [Cited by in Crossref: 52] [Cited by in F6Publishing: 37] [Article Influence: 7.4] [Reference Citation Analysis]
383 Liu H, Xing Y, Guo Y, Liu P, Zhang H, Xue B, Shou J, Qian J, Peng J, Wang R, Gao Y, Fang S. Polymorphisms in exon 2 of CD1 genes are associated with susceptibility to Guillain–Barré syndrome. Journal of the Neurological Sciences 2016;369:39-42. [DOI: 10.1016/j.jns.2016.07.029] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
384 Liou L, Chung C, Wu Y, Tsao C, Wu Y, Chien W, Chang C. Epidemiology and prognostic factors of inpatient mortality of Guillain-Barré syndrome: A nationwide population study over 14 years in Asian country. Journal of the Neurological Sciences 2016;369:159-64. [DOI: 10.1016/j.jns.2016.08.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
385 Halstead SK, Kalna G, Islam MB, Jahan I, Mohammad QD, Jacobs BC, Endtz HP, Islam Z, Willison HJ. Microarray screening of Guillain-Barré syndrome sera for antibodies to glycolipid complexes. Neurol Neuroimmunol Neuroinflamm 2016;3:e284. [PMID: 27790627 DOI: 10.1212/NXI.0000000000000284] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
386 Mevorach D, Reiner I, Grau A, Ilan U, Berkun Y, Ta-shma A, Elpeleg O, Shorer Z, Edvardson S, Tabib A. Therapy with eculizumab for patients with CD59 p.Cys89Tyr mutation: Eculizumab for Non-Functional CD59. Ann Neurol 2016;80:708-17. [DOI: 10.1002/ana.24770] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 4.6] [Reference Citation Analysis]
387 Kharwar N, Prasad K, Singh K, Paliwal V, Modi D. Polymorphisms of IL-17 and ICAM-1 and their expression in Guillain–Barré syndrome. International Journal of Neuroscience 2016;127:680-7. [DOI: 10.1080/00207454.2016.1231186] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
388 Ditunno JF, Becker BE, Herbison GJ. Franklin Delano Roosevelt: The Diagnosis of Poliomyelitis Revisited. PM&R 2016;8:883-93. [DOI: 10.1016/j.pmrj.2016.05.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
389 Dourado ME, Ferreira LC, Freire-neto FP, Jeronimo SM. No association between FCGR2A and FCGR3A polymorphisms in Guillain-Barré Syndrome in a Brazilian population. Journal of Neuroimmunology 2016;298:160-4. [DOI: 10.1016/j.jneuroim.2016.07.020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
390 López-marina V, Alcolea García R, Ramírez Rueda I, Rama Martínez T, Pizarro Romero G. Encefalitis de Bickerstaff: a propósito de un caso. SEMERGEN - Medicina de Familia 2016;42:e83-e86. [DOI: 10.1016/j.semerg.2015.10.005] [Reference Citation Analysis]
391 Meyer Sauteur PM, Huizinga R, Tio-Gillen AP, Roodbol J, Hoogenboezem T, Jacobs E, van Rijn M, van der Eijk AA, Vink C, de Wit MC, van Rossum AM, Jacobs BC. Mycoplasma pneumoniae triggering the Guillain-Barré syndrome: A case-control study. Ann Neurol 2016;80:566-80. [PMID: 27490360 DOI: 10.1002/ana.24755] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 5.9] [Reference Citation Analysis]
392 Wakerley BR, Kokubun N, Funakoshi K, Nagashima T, Hirata K, Yuki N. Clinical classification of 103 Japanese patients with Guillain-Barré syndrome. J Neurol Sci 2016;369:43-7. [PMID: 27653863 DOI: 10.1016/j.jns.2016.08.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
393 Kim JK, Hong SK, Bae JS, Yoon BA, Park HT, Huh SY, Kim SJ, Kim JE, Kim DS. Ophthalmoplegic Guillain-Barré syndrome: An independent entity or a transitional spectrum? J Clin Neurosci 2016;32:19-23. [PMID: 27436763 DOI: 10.1016/j.jocn.2015.11.034] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
394 Parker V, Warman Chardon J, Mills J, Goldsmith C, Bourque PR. Supramaximal Stimulus Intensity as a Diagnostic Tool in Chronic Demyelinating Neuropathy. Neurosci J 2016;2016:6796270. [PMID: 27413732 DOI: 10.1155/2016/6796270] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
395 Singhi SC, Jayshree M, Singhi P, Banerjee S, Prabhakar S. Intravenous immunoglobulin in very severe childhood Guillain-Barré syndrome. Annals of Tropical Paediatrics 2016;19:167-74. [DOI: 10.1080/02724939992491] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
396 Ammache Z, Afifi AK, Brown CK, Kimura J. Childhood Guillain-Barré Syndrome: Clinical and Electrophysiologic Features Predictive of Outcome. J Child Neurol 2001;16:477-83. [DOI: 10.1177/088307380101600703] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
397 Molinero MR, Varon D, Holden KR, Sladky JT, Molina IB, Cleaves F. Epidemiology of Childhood Guillain-Barré Syndrome as a Cause of Acute Flaccid Paralysis in Honduras: 1989—1999. J Child Neurol 2003;18:741-7. [DOI: 10.1177/08830738030180110801] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
398 Forsberg A, Press R, Einarsson U, de Pedro-cuesta J, Holmqvist LW. Disability and health-related quality of life in Guillain-Barré syndrome during the first two years after onset: a prospective study. Clin Rehabil 2005;19:900-9. [DOI: 10.1191/0269215505cr918oa] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 5.7] [Reference Citation Analysis]
399 Nadri Q, Althaf MM. Guillian-Barre syndrome as the initial presentation of systemic lupus erythematosus--case report and review of literature. Ann Saudi Med 2015;35:263-5. [PMID: 26409804 DOI: 10.5144/0256-4947.2015.263] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
400 Kirac Unal Z, Karaca Umay E, Tombak Y, Gundogdu I, Erdem Sultanoglu T, Aytul Cakci F. Guillain Barre Syndrome Following Traumatic Brain Injury: A Rare Case. Middle East J Rehabil Health 2016;3. [DOI: 10.17795/mejrh-38121] [Reference Citation Analysis]
401 Sung EJ, Kim DY, Chang MC, Ko EJ. Prediction of Functional Outcome in Axonal Guillain-Barre Syndrome. Ann Rehabil Med 2016;40:481-8. [PMID: 27446785 DOI: 10.5535/arm.2016.40.3.481] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
402 Goldman AS, Schmalstieg EJ, Freeman DH, Goldman DA, Schmalstieg FC. What was the Cause of Franklin Delano Roosevelt's Paralytic Illness? J Med Biogr 2003;11:232-40. [DOI: 10.1177/096777200301100412] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
403 Berciano J, Sedano MJ, Pelayo-Negro AL, García A, Orizaola P, Gallardo E, Lafarga M, Berciano MT, Jacobs BC. Proximal nerve lesions in early Guillain-Barré syndrome: implications for pathogenesis and disease classification. J Neurol 2017;264:221-36. [PMID: 27314967 DOI: 10.1007/s00415-016-8204-2] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 6.0] [Reference Citation Analysis]
404 Hosokawa T, Nakajima H, Unoda K, Yamane K, Doi Y, Ishida S, Kimura F, Hanafusa T. Serial electrophysiological findings in Guillain-Barré syndrome not fulfilling AIDP or AMAN criteria. J Neurol 2016;263:1709-18. [PMID: 27278064 DOI: 10.1007/s00415-016-8192-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
405 Léger J, Haghi B, Guimarães-costa R. Syndrome de Guillain-Barré : prise en charge thérapeutique. Bulletin de l'Académie Nationale de Médecine 2016;200:1101-1113. [DOI: 10.1016/s0001-4079(19)30653-3] [Reference Citation Analysis]
406 Peric S, Berisavac I, Stojiljkovic Tamas O, Rajic S, Babic M, Cvijanovic M, Dominovic-kovacevic A, Basta I, Beslac-bumbasirevic L, Lavrnic D. Guillain-Barré syndrome in the elderly: Peric et al. J Peripher Nerv Syst 2016;21:105-10. [DOI: 10.1111/jns.12163] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
407 Meyer Sauteur PM, Roodbol J, Hackenberg A, de Wit MC, Vink C, Berger C, Jacobs E, van Rossum AM, Jacobs BC. Severe childhood Guillain-Barré syndrome associated with Mycoplasma pneumoniae infection: a case series. J Peripher Nerv Syst 2015;20:72-8. [PMID: 26115201 DOI: 10.1111/jns.12121] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
408 Draak TH, Gorson KC, Vanhoutte EK, van Nes SI, van Doorn PA, Cornblath DR, van den Berg LH, Faber CG, Merkies IS; PeriNomS Study Group. Correlation of the patient's reported outcome Inflammatory-RODS with an objective metric in immune-mediated neuropathies. Eur J Neurol 2016;23:1248-53. [PMID: 27129110 DOI: 10.1111/ene.13025] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
409 Sandbrink F. Acquired neuropathies. International Neurology 2016. [DOI: 10.1002/9781118777329.ch102] [Reference Citation Analysis]
410 Nakane S, Higuchi O, Hamada Y, Maeda Y, Mukaino A, Sakai W, Kusunoki S, Matsuo H. Ganglionic acetylcholine receptor autoantibodies in patients with Guillain-Barré syndrome. J Neuroimmunol 2016;295-296:54-9. [PMID: 27235349 DOI: 10.1016/j.jneuroim.2016.04.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
411 Alhefzi M, Aycart M, Bueno E, Kueckelhaus M, Fischer S, Snook R, Sharfuddin A, Hadad I, Malla P, Amato A, Pomahac B, Marty F. Guillain-Barré syndrome associated with resistant cytomegalovirus infection after face transplantation. Transpl Infect Dis 2016;18:288-92. [DOI: 10.1111/tid.12516] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
412 Suryapranata FS, Ang CW, Chong LL, Murk JL, Falconi J, Huits RM. Epidemiology of Guillain-Barré Syndrome in Aruba. Am J Trop Med Hyg 2016;94:1380-4. [PMID: 27022152 DOI: 10.4269/ajtmh.15-0070] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
413 Mori A, Nodera H, Takamatsu N, Maruyama-Saladini K, Osaki Y, Shimatani Y, Kaji R. Sonographic evaluation of peripheral nerves in subtypes of Guillain-Barré syndrome. J Neurol Sci 2016;364:154-9. [PMID: 27084237 DOI: 10.1016/j.jns.2016.03.042] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
414 Godoy DA, Rabinstein A. Is a second cycle of immunoglobulin justified in axonal forms of Guillain-Barré syndrome? Arq Neuropsiquiatr 2015;73:848-51. [PMID: 26465402 DOI: 10.1590/0004-282X20150136] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
415 Wu X, Shen D, Li T, Zhang B, Li C, Mao M, Zhao J, Liu K, Zhang HL. Distinct Clinical Characteristics of Pediatric Guillain-Barré Syndrome: A Comparative Study between Children and Adults in Northeast China. PLoS One 2016;11:e0151611. [PMID: 26974666 DOI: 10.1371/journal.pone.0151611] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
416 Farzi MA. A Case of Miller Fisher Syndrome with Unusual Features: Normal Muscle Stretch Reflexes and Facial Palsy and Dramatic Response to IVIG. JNSK 2016;4. [DOI: 10.15406/jnsk.2016.04.00131] [Reference Citation Analysis]
417 Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barré syndrome. Lancet. 2016;388:717-727. [PMID: 26948435 DOI: 10.1016/s0140-6736(16)00339-1] [Cited by in Crossref: 716] [Cited by in F6Publishing: 754] [Article Influence: 102.3] [Reference Citation Analysis]
418 Zhang DQ, Wang R, Li T, Zhou JP, Chang GQ, Zhao N, Yang LN, Zhai H, Yang L. Reduced soluble RAGE is associated with disease severity of axonal Guillain-Barré syndrome. Sci Rep 2016;6:21890. [PMID: 26902096 DOI: 10.1038/srep21890] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
419 Kharwar NK, Prasad KN, Paliwal VK, Modi DR. Association of NOD1 and NOD2 polymorphisms with Guillain-Barré syndrome in Northern Indian population. J Neurol Sci 2016;363:57-62. [PMID: 27000222 DOI: 10.1016/j.jns.2016.02.028] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
420 Wu X, Zhang B, Li C, Shen D, Liu K, Zhu J, Zhang HL. Short-Term Prognosis of Mechanically Ventilated Patients With Guillain-Barré Syndrome Is Worsened by Corticosteroids as an Add-On Therapy. Medicine (Baltimore) 2015;94:e1898. [PMID: 26512609 DOI: 10.1097/MD.0000000000001898] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
421 Saad K, Mohamad IL, Abd El-Hamed MA, Tawfeek MS, Ahmed AE, Abdel Baseer KA, El-Shemy AS, El-Houfey AA, Tamer DM. A comparison between plasmapheresis and intravenous immunoglobulin in children with Guillain-Barré syndrome in Upper Egypt. Ther Adv Neurol Disord 2016;9:3-8. [PMID: 26788127 DOI: 10.1177/1756285615610471] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
422 Santhanam I, Yoganathan S. Acute Neurological Emergencies in Children. Clinical Pathways in Emergency Medicine 2016. [DOI: 10.1007/978-81-322-2713-7_6] [Reference Citation Analysis]
423 Kiribayashi M, Kurashiki T, Funaki K, Inagaki Y. A case of Guillain-Barré syndrome complicated with takotsubo cardiomyopathy. Nihon Shuchu Chiryo Igakukai zasshi 2016;23:59-60. [DOI: 10.3918/jsicm.23.59] [Reference Citation Analysis]
424 Paramanathan S, Tankisi H, Andersen H, Fuglsang-frederiksen A. Axonal loss in patients with inflammatory demyelinating polyneuropathy as determined by motor unit number estimation and MUNIX. Clinical Neurophysiology 2016;127:898-904. [DOI: 10.1016/j.clinph.2015.05.004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
425 Shahrizaila N, Yuki N. Guillain–Barré Syndrome and Campylobacter jejuni Enteritis. Neuro-Immuno-Gastroenterology 2016. [DOI: 10.1007/978-3-319-28609-9_9] [Reference Citation Analysis]
426 Kusunoki S. Guillain-Barré Syndrome: Epidemiology, Diagnosis, and Treatment. Neuroimmunological Diseases 2016. [DOI: 10.1007/978-4-431-55594-0_9] [Reference Citation Analysis]
427 Koo YS, Shin HY, Kim JK, Nam TS, Shin KJ, Bae JS, Suh BC, Oh J, Yoon BA, Kim BJ. Early Electrodiagnostic Features of Upper Extremity Sensory Nerves Can Differentiate Axonal Guillain-Barré Syndrome from Acute Inflammatory Demyelinating Polyneuropathy. J Clin Neurol 2016;12:495-501. [PMID: 27819421 DOI: 10.3988/jcn.2016.12.4.495] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
428 Miyaji K, Paul F, Shahrizaila N, Umapathi T, Yuki N. Autoantibodies to tetraspanins (CD9, CD81 and CD82) in demyelinating diseases. J Neuroimmunol 2016;291:78-81. [PMID: 26857499 DOI: 10.1016/j.jneuroim.2015.12.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
429 Varol S, Ozdemir HH, Akil E, Arslan D, Aluclu MU, Demir CF, Yucel Y. Facial diplegia: etiology, clinical manifestations, and diagnostic evaluation. Arq Neuropsiquiatr 2015;73:998-1001. [PMID: 26677119 DOI: 10.1590/0004-282X20150174] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
430 Farbu E, Rudolph T, Stefansdottir S. Guillain Barré syndrome--Incidence and clinical course in Southern Rogaland, Norway. Clin Neurol Neurosurg 2016;141:33-7. [PMID: 26724429 DOI: 10.1016/j.clineuro.2015.12.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
431 Grimm A, Décard BF, Axer H. Ultrasonography of the peripheral nervous system in the early stage of Guillain-Barré syndrome. J Peripher Nerv Syst 2014;19:234-41. [PMID: 25418824 DOI: 10.1111/jns.12091] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 6.1] [Reference Citation Analysis]
432 Pyun SY, Jeong JH, Bae JS. Recurrent Guillain-Barré syndrome presenting stereotypic manifestations, positive antiganglioside antibodies, and rapid recovery. Clin Neurol Neurosurg 2015;139:230-3. [PMID: 26519894 DOI: 10.1016/j.clineuro.2015.10.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
433 Kalita J, Ranjan A, Misra UK. Outcome of Guillain-Barre syndrome patients with respiratory paralysis. QJM 2016;109:319-23. [PMID: 26475599 DOI: 10.1093/qjmed/hcv190] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
434 Ubogu EE. Inflammatory neuropathies: pathology, molecular markers and targets for specific therapeutic intervention. Acta Neuropathol 2015;130:445-68. [PMID: 26264608 DOI: 10.1007/s00401-015-1466-4] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 5.9] [Reference Citation Analysis]
435 Wakerley BR, Yuki N. Polyneuritis cranialis—subtype of Guillain–Barré syndrome? Nat Rev Neurol 2015;11:664-664. [DOI: 10.1038/nrneurol.2015.115] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
436 Wakerley BR, Yuki N. Isolated facial diplegia in Guillain-Barré syndrome: Bifacial weakness with paresthesias. Muscle Nerve 2015;52:927-32. [PMID: 26315943 DOI: 10.1002/mus.24887] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
437 Ogata H, Yamasaki R, Hiwatashi A, Oka N, Kawamura N, Matsuse D, Kuwahara M, Suzuki H, Kusunoki S, Fujimoto Y, Ikezoe K, Kishida H, Tanaka F, Matsushita T, Murai H, Kira J. Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy. Ann Clin Transl Neurol 2015;2:960-71. [PMID: 26478896 DOI: 10.1002/acn3.248] [Cited by in Crossref: 123] [Cited by in F6Publishing: 124] [Article Influence: 15.4] [Reference Citation Analysis]
438 Wu X, Li C, Zhang B, Shen D, Li T, Liu K, Zhang HL. Predictors for mechanical ventilation and short-term prognosis in patients with Guillain-Barré syndrome. Crit Care 2015;19:310. [PMID: 26330143 DOI: 10.1186/s13054-015-1037-z] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 4.6] [Reference Citation Analysis]
439 White CM, Hadden RD, Robert-Lewis SF, McCrone PR, Petty JL. Observer blind randomised controlled trial of a tailored home exercise programme versus usual care in people with stable inflammatory immune mediated neuropathy. BMC Neurol 2015;15:147. [PMID: 26293925 DOI: 10.1186/s12883-015-0398-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
440 Blum S, Csurhes P, McCombe P. The frequencies of Killer immunoglobulin-like receptors and their HLA ligands in chronic inflammatory demyelinating polyradiculoneuropathy are similar to those in Guillian Barre syndrome but differ from those of controls, suggesting a role for NK cells in pathogenesis. J Neuroimmunol 2015;285:53-6. [PMID: 26198918 DOI: 10.1016/j.jneuroim.2015.05.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
441 Yang CW, Gao F, Xia ZZ. Guillain-Barré Syndrome in a Boy With Lung Fluke Infection: Case Report and Literature Review. J Child Neurol 2015;30:1208-10. [PMID: 25252759 DOI: 10.1177/0883073814546689] [Reference Citation Analysis]
442 Scheytt S, Riediger N, Braunsdorf S, Sommer C, Üçeyler N. Increased gene expression of growth associated protein-43 in skin of patients with early-stage peripheral neuropathies. Journal of the Neurological Sciences 2015;355:131-7. [DOI: 10.1016/j.jns.2015.05.044] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
443 Kim MH, Hwang MS, Park YK, Park Y, Ahn YC, Oh HS, Ahn HJ. Paraneoplastic Guillain-Barré Syndrome in Small Cell Lung Cancer. Case Rep Oncol 2015;8:295-300. [PMID: 26351437 DOI: 10.1159/000437295] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
444 Décard BF, Fladt J, Axer H, Fischer D, Grimm A. Nerve ultrasound in Miller Fisher variant of Guillain-Barré syndrome. Muscle Nerve 2015;52:1106-10. [PMID: 26123539 DOI: 10.1002/mus.24753] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
445 Grimm A, Décard BF, Schramm A, Pröbstel AK, Rasenack M, Axer H, Fuhr P. Ultrasound and electrophysiologic findings in patients with Guillain-Barré syndrome at disease onset and over a period of six months. Clin Neurophysiol 2016;127:1657-63. [PMID: 26220732 DOI: 10.1016/j.clinph.2015.06.032] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 5.5] [Reference Citation Analysis]
446 Razali SNO, Arumugam T, Yuki N, Rozalli FI, Goh KJ, Shahrizaila N. Serial peripheral nerve ultrasound in Guillain-Barré syndrome. Clin Neurophysiol 2016;127:1652-6. [PMID: 26228791 DOI: 10.1016/j.clinph.2015.06.030] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
447 Huizinga R, van den Berg B, van Rijs W, Tio-gillen AP, Fokkink WJR, Bakker-jonges LE, Geleijns K, Samsom JN, van Doorn PA, Laman JD, Jacobs BC. Innate Immunity to Campylobacter jejuni in Guillain-Barré Syndrome: Innate Immunity in GBS. Ann Neurol 2015;78:343-54. [DOI: 10.1002/ana.24442] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
448 Farmakidis C, Inan S, Milstein M, Herskovitz S. Headache and Pain in Guillain-Barré Syndrome. Curr Pain Headache Rep 2015;19. [DOI: 10.1007/s11916-015-0508-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
449 Wong AHY, Umapathi T, Nishimoto Y, Wang YZ, Chan YC, Yuki N. Cytoalbuminologic dissociation in Asian patients with Guillain-Barré and Miller Fisher syndromes. J Peripher Nerv Syst 2015;20:47-51. [DOI: 10.1111/jns.12104] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
450 Koga M, Takahashi M, Yokoyama K, Kanda T. Ambiguous value of anti-ganglioside IgM autoantibodies in Guillain-Barré syndrome and its variants. J Neurol 2015;262:1954-60. [PMID: 26050638 DOI: 10.1007/s00415-015-7806-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
451 Deng Y, Ma XJ, Peng W, Sanvito L; Cochrane Neuromuscular Group. Acupuncture for Guillain-Barré syndrome. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd007797.pub2] [Reference Citation Analysis]
452 Sharma SR, Sharma N, Masaraf H, Singh SA. Guillain-Barré syndrome complicating pregnancy and correlation with maternal and fetal outcome in North Eastern India: A retrospective study. Ann Indian Acad Neurol 2015;18:215-8. [PMID: 26019422 DOI: 10.4103/0972-2327.150608] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
453 Yin PQ, Sun YY, Chen HP, Li GZ, Zhong D. Genome-wide gene expression analysis of peripheral leukocytes in relation to the male predominance of Guillain-Barre syndrome: differential gene expression between male and female patients. Int J Neurosci 2016;126:531-41. [PMID: 26000914 DOI: 10.3109/00207454.2015.1044088] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
454 Kerasnoudis A, Pitarokoili K, Behrendt V, Gold R, Yoon MS. Bochum ultrasound score versus clinical and electrophysiological parameters in distinguishing acute-onset chronic from acute inflammatory demyelinating polyneuropathy. Muscle Nerve. 2015;51:846-852. [PMID: 25297575 DOI: 10.1002/mus.24484] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 4.9] [Reference Citation Analysis]
455 Deshmukh IS, Bang AB, Jain MA, Vilhekar KY. Concurrent acute disseminated encephalomyelitis and Guillain-Barré syndrome in a child. J Pediatr Neurosci 2015;10:61-3. [PMID: 25878749 DOI: 10.4103/1817-1745.154357] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
456 Matsumoto H, Hanajima R, Terao Y, Hashida H, Ugawa Y. Cauda equina conduction time in Guillain-Barré syndrome. J Neurol Sci 2015;351:187-90. [PMID: 25770878 DOI: 10.1016/j.jns.2015.02.049] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
457 Liu J, Wang LN, McNicol ED. Pharmacological treatment for pain in Guillain-Barré syndrome. Cochrane Database Syst Rev 2015;2015:CD009950. [PMID: 25855461 DOI: 10.1002/14651858.CD009950.pub3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
458 Ansar V, Valadi N. Guillain-Barré syndrome. Prim Care 2015;42:189-93. [PMID: 25979580 DOI: 10.1016/j.pop.2015.01.001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
459 Hendawi T, Zavatsky JM. Guillain-Barré syndrome after pelvic fracture fixation: a rare cause of postoperative paralysis. Spine (Phila Pa 1976) 2015;40:E372-4. [PMID: 25774469 DOI: 10.1097/BRS.0000000000000779] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
460 Mathey EK, Park SB, Hughes RA, Pollard JD, Armati PJ, Barnett MH, Taylor BV, Dyck PJ, Kiernan MC, Lin CS. Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype. J Neurol Neurosurg Psychiatry 2015;86:973-85. [PMID: 25677463 DOI: 10.1136/jnnp-2014-309697] [Cited by in Crossref: 243] [Cited by in F6Publishing: 258] [Article Influence: 30.4] [Reference Citation Analysis]
461 Grimm A, Décard BF, Axer H, Fuhr P. The Ultrasound pattern sum score - UPSS. A new method to differentiate acute and subacute neuropathies using ultrasound of the peripheral nerves. Clin Neurophysiol 2015;126:2216-25. [PMID: 25691156 DOI: 10.1016/j.clinph.2015.01.011] [Cited by in Crossref: 63] [Cited by in F6Publishing: 64] [Article Influence: 7.9] [Reference Citation Analysis]
462 Chung SJ, Lee H, Shin HY, Kim SM. Hypothyroidism Mimicking Guillain-Barré Syndrome. J Korean Neurol Assoc 2015;33:51-53. [DOI: 10.17340/jkna.2015.1.13] [Reference Citation Analysis]
463 Albiol-Pérez S, Forcano-García M, Muñoz-Tomás MT, Manzano-Fernández P, Solsona-Hernández S, Mashat MA, Gil-Gómez JA. A novel virtual motor rehabilitation system for Guillain-Barré syndrome. Two single case studies. Methods Inf Med 2015;54:127-34. [PMID: 25609504 DOI: 10.3414/ME14-02-0002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
464 Le Guennec L, Brisset M, Viala K, Essardy F, Maisonobe T, Rohaut B, Demeret S, Bolgert F, Weiss N. Post-traumatic stress symptoms in Guillain-Barré syndrome patients after prolonged mechanical ventilation in ICU: a preliminary report: Guennec. J Peripher Nerv Syst 2014;19:218-23. [DOI: 10.1111/jns.12087] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
465 Tatsumoto M, Misawa S, Kokubun N, Sekiguchi Y, Hirata K, Kuwabara S, Yuki N. Delayed facial weakness in Guillain-Barré and Miller Fisher syndromes. Muscle Nerve 2015;51:811-4. [PMID: 25287079 DOI: 10.1002/mus.24475] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
466 Jones HR, Grattan-smith PJ, Ryan MM. Acute Polyneuropathies. Neuromuscular Disorders of Infancy, Childhood, and Adolescence 2015. [DOI: 10.1016/b978-0-12-417044-5.00020-2] [Reference Citation Analysis]
467 Kumar M, Aroor S, Mundkur S, Kumar S. Guillain-barré syndrome: a clinical study of twenty children. J Clin Diagn Res 2015;9:SC09-12. [PMID: 25738052 DOI: 10.7860/JCDR/2015/8344.5491] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
468 Fabrizi GM, Zanette G. Disorders of Peripheral Nerves. Prognosis of Neurological Diseases 2015. [DOI: 10.1007/978-88-470-5755-5_35] [Reference Citation Analysis]
469 Korinthenberg (FEDERFÜHREND) R, Gold R, Felderhoff-müser U. Guillain-Barré-Syndrom im Kindes- und Jugendalter 1 1Bei der hier abgedruckten Fassung handelt es sich um eine Kurzfassung. Die Langfassung ist auf der Leitlinien-Webseite der AWMF publiziert (http://www.awmf.org). (S2e). Leitlinien Kinder- und Jugendmedizin 2015. [DOI: 10.1016/b978-3-437-22061-6.50572-3] [Reference Citation Analysis]
470 Nithyashree N, Dhanaraj M, Kumar S, Saraswathi MB. Factors predicting poor outcome in patients with fulminant Guillaine-Barré syndrome. Ann Indian Acad Neurol 2014;17:463-5. [PMID: 25506175 DOI: 10.4103/0972-2327.144040] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
471 Ye Y, Li S, Li Y. Comparison on therapeutic effect of plasma exchange and intravenous immunoglobulin for Guillian-Barre syndrome: Comparison of PE and IVIg for GBS. Transfusion Med 2015;25:79-84. [DOI: 10.1111/tme.12169] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
472 Lyu R, Liao M, Kuo H, Chu C, Chang K. Effect of Coexistent Carpal Tunnel Abnormality on Sensory Conduction Findings in Polyneuropathy. Journal of Clinical Neuromuscular Disease 2014;16:51-58. [DOI: 10.1097/cnd.0000000000000053] [Reference Citation Analysis]
473 Blum S, Reddel S, Spies J, McCombe P. Clinical features of patients with Guillain-Barré syndrome at seven hospitals on the East Coast of Australia. J Peripher Nerv Syst 2013;18:316-20. [PMID: 24172315 DOI: 10.1111/jns5.12045] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
474 Maddur MS, Rabin M, Hegde P, Bolgert F, Guy M, Vallat J, Magy L, Bayry J, Kaveri SV. Intravenous immunoglobulin exerts reciprocal regulation of Th1/Th17 cells and regulatory T cells in Guillain–Barré syndrome patients. Immunol Res 2014;60:320-9. [DOI: 10.1007/s12026-014-8580-6] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 4.9] [Reference Citation Analysis]
475 Tripp A. Acute Transverse Myelitis and Guillain–Barre Overlap Syndrome Following Influenza Infection. CNS spectr 2008;13:744-7. [DOI: 10.1017/s1092852900013845] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
476 Zhang J, Liu N, Zhang ZC, Zheng RZ, Li Q. Sensory Guillain-Barré syndrome: A case report. Exp Ther Med 2014;8:1713-6. [PMID: 25371720 DOI: 10.3892/etm.2014.1995] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
477 Üçeyler N, Riediger N, Kafke W, Sommer C. Differential gene expression of cytokines and neurotrophic factors in nerve and skin of patients with peripheral neuropathies. J Neurol 2015;262:203-12. [PMID: 25371017 DOI: 10.1007/s00415-014-7556-8] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
478 Ritzenthaler T, Sharshar T, Orlikowski D. Síndrome de Guillain-Barré. EMC - Anestesia-Reanimación 2014;40:1-8. [DOI: 10.1016/s1280-4703(14)68953-2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
479 Miyaji K, Shahrizaila N, Umapathi T, Chan Y, Hirata K, Yuki N. Are ERM (ezrin/radixin/moesin) proteins targets for autoantibodies in demyelinating neuropathies? Human Immunology 2014;75:1089-91. [DOI: 10.1016/j.humimm.2014.09.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
480 Kerasnoudis A, Gold R, Yoon M. Differenzierung der CIDP vom GBS mit neuem Ultraschall-Score. NeuroTransmitter 2014;25:35-42. [DOI: 10.1007/s15016-014-0843-0] [Reference Citation Analysis]
481 Ritzenthaler T, Sharshar T, Orlikowski D. Sindrome di Guillain-Barré. EMC - Anestesia-Rianimazione 2014;19:1-7. [DOI: 10.1016/s1283-0771(14)68864-2] [Reference Citation Analysis]
482 Kalita J, Misra UK, Goyal G, Das M. Guillain-Barré syndrome: subtypes and predictors of outcome from India. J Peripher Nerv Syst 2014;19:36-43. [PMID: 24456386 DOI: 10.1111/jns5.12050] [Cited by in Crossref: 40] [Cited by in F6Publishing: 48] [Article Influence: 4.4] [Reference Citation Analysis]
483 Carr KR, Shah M, Garvin R, Shakir A, Jackson C. Post-Traumatic brain injury (TBI) presenting with Guillain-Barré syndrome and elevated anti-ganglioside antibodies: a case report and review of the literature. Int J Neurosci 2015;125:486-92. [PMID: 25158009 DOI: 10.3109/00207454.2014.957760] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
484 Hou HQ, Miao J, Feng XD, Han M, Song XJ, Guo L. Changes in lymphocyte subsets in patients with Guillain-Barré syndrome treated with immunoglobulin. BMC Neurol 2014;14:202. [PMID: 25315010 DOI: 10.1186/s12883-014-0202-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
485 Xiang J, Zhang Y, Tan Z, Huang J, Zhao Y. Guillain–Barré Syndrome Associated with Japanese Encephalitis Virus Infection in China. Viral Immunology 2014;27:418-20. [DOI: 10.1089/vim.2014.0049] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
486 Tassart G, Balbeur S, Deltombe T, Tintillier M, Cuvelier Ch. Guillain-Barré syndrome associated with Puumula Hantavirus infection. Acta Clin Belg 2014;69:371-4. [PMID: 25092197 DOI: 10.1179/0001551214Z.00000000085] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
487 Roodbol J, de Wit MY, Aarsen FK, Catsman-berrevoets CE, Jacobs BC. Long-term outcome of Guillain-Barré syndrome in children: Roodbol et al. J Peripher Nerv Syst 2014;19:121-6. [DOI: 10.1111/jns5.12068] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 3.4] [Reference Citation Analysis]
488 Blum S, Mccombe PA. Genetics of Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): current knowledge and future directions: Blum and McCombe. J Peripher Nerv Syst 2014;19:88-103. [DOI: 10.1111/jns5.12074] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 5.0] [Reference Citation Analysis]
489 Hughes RA, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain-Barré syndrome. Cochrane Database Syst Rev 2014;:CD002063. [PMID: 25238327 DOI: 10.1002/14651858.CD002063.pub6] [Cited by in Crossref: 90] [Cited by in F6Publishing: 138] [Article Influence: 10.0] [Reference Citation Analysis]
490 Ranjani P, Khanna M, Gupta A, Nagappa M, Taly AB, Haldar P. Prevalence of fatigue in Guillain-Barre syndrome in neurological rehabilitation setting. Ann Indian Acad Neurol 2014;17:331-5. [PMID: 25221406 DOI: 10.4103/0972-2327.138521] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
491 Forsberg A, Widén-holmqvist L, Ahlström G. Balancing everyday life two years after falling ill with Guillain-Barré syndrome: a qualitative study. Clin Rehabil 2015;29:601-10. [DOI: 10.1177/0269215514549564] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
492 Ye Y, Wang K, Sun L, Wang Z. Clinical and electrophysiologic features of childhood Guillain-Barré syndrome in Northeast China. Journal of the Formosan Medical Association 2014;113:634-9. [DOI: 10.1016/j.jfma.2012.08.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
493 Cats EA, van der Pol W, Tio-gillen AP, Diekstra FP, van den Berg LH, Jacobs BC. Clonality of anti-GM1 IgM antibodies in multifocal motor neuropathy and the Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 2015;86:502-4. [DOI: 10.1136/jnnp-2014-308118] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
494 Gallardo E, Sedano MJ, Orizaola P, Sánchez-Juan P, González-Suárez A, García A, Terán-Villagrá N, Ruiz-Soto M, Álvaro RL, Berciano MT, Lafarga M, Berciano J. Spinal nerve involvement in early Guillain-Barré syndrome: a clinico-electrophysiological, ultrasonographic and pathological study. Clin Neurophysiol 2015;126:810-9. [PMID: 25213352 DOI: 10.1016/j.clinph.2014.06.051] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 5.4] [Reference Citation Analysis]
495 Vucic S. Nerve ultrasound in detecting spinal nerve pathology in GBS: a novel diagnostic approach? Clin Neurophysiol 2015;126:649-50. [PMID: 25176598 DOI: 10.1016/j.clinph.2014.07.023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
496 Hosokawa T, Nakajima H, Unoda K, Yamane K, Doi Y, Ishida S, Kimura F, Hanafusa T. An electrophysiological classification associated with Guillain–Barré syndrome outcomes. J Neurol 2014;261:1986-93. [DOI: 10.1007/s00415-014-7452-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
497 Wu X, Wu W, Wang Z, Shen D, Pan W, Wang Y, Wu L, Wu X, Feng J, Liu K, Zhu J, Zhang HL. More severe manifestations and poorer short-term prognosis of ganglioside-associated Guillain-Barré syndrome in Northeast China. PLoS One 2014;9:e104074. [PMID: 25084153 DOI: 10.1371/journal.pone.0104074] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
498 Wakerley BR, Uncini A, Yuki N; GBS Classification Group., GBS Classification Group. Guillain-Barré and Miller Fisher syndromes--new diagnostic classification. Nat Rev Neurol 2014;10:537-44. [PMID: 25072194 DOI: 10.1038/nrneurol.2014.138] [Cited by in Crossref: 330] [Cited by in F6Publishing: 342] [Article Influence: 36.7] [Reference Citation Analysis]
499 Naik KR, Saroja AO, Mahajan M. Intact thumb reflex in areflexic Guillain Barré syndrome: A novel phenomenon. Ann Indian Acad Neurol 2014;17:199-201. [PMID: 25024572 DOI: 10.4103/0972-2327.132628] [Reference Citation Analysis]
500 van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA. Guillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol 2014;10:469-82. [DOI: 10.1038/nrneurol.2014.121] [Cited by in Crossref: 525] [Cited by in F6Publishing: 556] [Article Influence: 58.3] [Reference Citation Analysis]
501 Mathew T, Srinivas M, Nadig R, Arumugam R, Sarma GR. Seasonal and monthly trends in the occurrence of Guillain-Barre syndrome over a 5-year period: A tertiary care hospital-based study from South India. Ann Indian Acad Neurol 2014;17:239-41. [PMID: 25024587 DOI: 10.4103/0972-2327.132662] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
502 Islam Z, van Belkum A, Wagenaar JA, Cody AJ, de Boer AG, Sarker SK, Jacobs BC, Talukder KA, Endtz HP. Comparative population structure analysis of Campylobacter jejuni from human and poultry origin in Bangladesh. Eur J Clin Microbiol Infect Dis 2014;33:2173-81. [PMID: 24962195 DOI: 10.1007/s10096-014-2184-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
503 Sung JY, Tani J, Park SB, Kiernan MC, Lin CS. Early identification of 'acute-onset' chronic inflammatory demyelinating polyneuropathy. Brain 2014;137:2155-63. [PMID: 24983276 DOI: 10.1093/brain/awu158] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
504 Wong AH, Umapathi T, Shahrizaila N, Chan YC, Kokubun N, Fong MK, Chu YP, Lau PK, Yuki N. The value of comparing mortality of Guillain-Barré syndrome across different regions. J Neurol Sci 2014;344:60-2. [PMID: 24993467 DOI: 10.1016/j.jns.2014.06.021] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
505 김동휘. Electrodiagnosis of Guillain-Barre Syndrome. jouranlofkoreanassociationofemgelectrodiagnosticmedicine 2014;16:14-19. [DOI: 10.18214/jkaem.2014.16.1.14] [Reference Citation Analysis]
506 Gwathmey K, Balogun RA, Burns T. Neurologic indications for therapeutic plasma exchange: 2013 update: Neurologic Indications for Therapeutic Plasma Exchange. J Clin Apheresis 2014;29:211-9. [DOI: 10.1002/jca.21331] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
507 Yuki N, Fukami Y, Yanaka C, Koike S, Hirata K. GD1b-specific antibodies may bind to complex of GQ1b and GM1, causing ataxia. J Neurol 2014;261:1565-9. [DOI: 10.1007/s00415-014-7388-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
508 Li S, Jin T, Zhang HL, Yu H, Meng F, Concha Quezada H, Zhu J. Circulating Th17, Th22, and Th1 cells are elevated in the Guillain-Barré syndrome and downregulated by IVIg treatments. Mediators Inflamm 2014;2014:740947. [PMID: 24899787 DOI: 10.1155/2014/740947] [Cited by in Crossref: 35] [Cited by in F6Publishing: 46] [Article Influence: 3.9] [Reference Citation Analysis]
509 Rajabally YA, Durand M, Mitchell J, Orlikowski D, Nicolas G. Electrophysiological diagnosis of Guillain–Barré syndrome subtype: could a single study suffice? J Neurol Neurosurg Psychiatry 2014;86:115-9. [DOI: 10.1136/jnnp-2014-307815] [Cited by in Crossref: 107] [Cited by in F6Publishing: 109] [Article Influence: 11.9] [Reference Citation Analysis]
510 Mishra A, Dave N, Mehta M. Fulminant guillain-barré syndrome with myocarditis. J Family Med Prim Care 2014;3:84-5. [PMID: 24791246 DOI: 10.4103/2249-4863.130335] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
511 Yadegari S, Kazemi N, Nafissi S. Clinical and electrophysiological features of Guillain-Barré syndrome in Iran. J Clin Neurosci 2014;21:1554-7. [PMID: 24786718 DOI: 10.1016/j.jocn.2013.11.041] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
512 Kerasnoudis A, Pitarokoili K, Behrendt V, Gold R, Yoon M. Increased cerebrospinal fluid protein and motor conduction studies as prognostic markers of outcome and nerve ultrasound changes in Guillain–Barré syndrome. Journal of the Neurological Sciences 2014;340:37-43. [DOI: 10.1016/j.jns.2014.02.019] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
513 Fanshawe A, Bain C, Williams A. An unusual case of Guillain–Barre syndrome following toxic shock syndrome in a burned child. Burns 2014;40:e18-20. [DOI: 10.1016/j.burns.2013.09.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
514 Jacobs BC, van Belkum A, Endtz HP. Guillain-Barré Syndrome and Campylobacter Infection. In: Nachamkin I, Szymanski CM, Blaser MJ, editors. Campylobacter. Washington: ASM Press; 2008. pp. 245-61. [DOI: 10.1128/9781555815554.ch13] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
515 Kim JK, Bae JS, Kim DS, Kusunoki S, Kim JE, Kim JS, Park YE, Park KJ, Song HS, Kim SY, Lim JG, Kim NH, Suh BC, Nam TS, Park MS, Choi YC, Sohn EH, Na SJ, Huh SY, Kwon O, Lee SY, Lee SH, Oh SY, Jeong SH, Lee TK, Kim DU. Prevalence of anti-ganglioside antibodies and their clinical correlates with guillain-barré syndrome in Korea: a nationwide multicenter study. J Clin Neurol 2014;10:94-100. [PMID: 24829594 DOI: 10.3988/jcn.2014.10.2.94] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 6.2] [Reference Citation Analysis]
516 Kerasnoudis A, Pitarokoili K, Behrendt V, Gold R, Yoon MS. Correlation of nerve ultrasound, electrophysiological, and clinical findings in post Guillain-Barré syndrome. J Peripher Nerv Syst 2013;18:232-40. [PMID: 24028191 DOI: 10.1111/jns5.12037] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
517 Hersalis Eldar A, Chapman J. Guillain Barré syndrome and other immune mediated neuropathies: Diagnosis and classification. Autoimmunity Reviews 2014;13:525-30. [DOI: 10.1016/j.autrev.2014.01.033] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 3.8] [Reference Citation Analysis]
518 Lu L, Luo G, Xiao F. A retrospective survey of the quality of reports and their correlates among randomized controlled trials of immunotherapy for Guillain-Barré syndrome. Immunotherapy 2013;5:829-36. [PMID: 23902552 DOI: 10.2217/imt.13.75] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
519 Quek AM, Soon D, Chan YC, Thamboo TP, Yuki N. Acute-onset chronic inflammatory demyelinating polyneuropathy with focal segmental glomerulosclerosis. J Neurol Sci 2014;341:139-43. [PMID: 24726719 DOI: 10.1016/j.jns.2014.03.040] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
520 Korinthenberg R. Acute polyradiculoneuritis: Guillain-Barré syndrome. Handb Clin Neurol 2013;112:1157-62. [PMID: 23622324 DOI: 10.1016/B978-0-444-52910-7.00036-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
521 Kishore CK, Vijayabhaskar J, Vishnu Vardhan R, Sainaresh VV, Sriramnaveen P, Sridhar AV, Varalaxmi B, Sandeep P, Ram R, Vengamma B, Siva Kumar V. Management of Guillain-Barré syndrome with plasmapheresis or immunoglobulin: our experience from a tertiary care institute in South India. Ren Fail 2014;36:732-6. [PMID: 24593239 DOI: 10.3109/0886022X.2014.890859] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
522 Zhang C, Xie B, Li X, Yao Y. Contact heat-evoked potentials as a useful means in patients with Guillain–Barré syndrome. Neurol Sci 2014;35:1209-14. [DOI: 10.1007/s10072-014-1682-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
523 Sankhyan N, Sharma S, Konanki R, Gulati S. Childhood Guillain–Barré syndrome subtypes in northern India. Journal of Clinical Neuroscience 2014;21:427-30. [DOI: 10.1016/j.jocn.2013.04.030] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
524 Kinboshi M, Inoue M, Kojima Y, Ono M, Nakagawa T, Kanda M, Shibasaki H. Pain in the acute phase of Guillain-Barré syndrome. Neurol Clin Neurosci 2014;2:50-53. [DOI: 10.1111/ncn3.84] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
525 Fokkink WJ, Selman MH, Dortland JR, Durmuş B, Kuitwaard K, Huizinga R, van Rijs W, Tio-Gillen AP, van Doorn PA, Deelder AM, Wuhrer M, Jacobs BC. IgG Fc N-glycosylation in Guillain-Barré syndrome treated with immunoglobulins. J Proteome Res 2014;13:1722-30. [PMID: 24533874 DOI: 10.1021/pr401213z] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 4.1] [Reference Citation Analysis]
526 Blum S, Csurhes P, Reddel S, Spies J, Mccombe P. Killer immunoglobulin-like receptor and their HLA ligands in Guillain–Barré Syndrome. Journal of Neuroimmunology 2014;267:92-6. [DOI: 10.1016/j.jneuroim.2013.12.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
527 Shahrizaila N, Goh KJ, Kokubun N, Tan AH, Tan CY, Yuki N. Sensory nerves are frequently involved in the spectrum of fisher syndrome: Sensory Nerve Involvement in FS. Muscle Nerve 2014;49:558-63. [DOI: 10.1002/mus.23973] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
528 Rinaldi S. Update on Guillain-Barré syndrome. J Peripher Nerv Syst 2013;18:99-112. [PMID: 23781958 DOI: 10.1111/jns5.12020] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
529 Tsang RS, Valdivieso-garcia A. Pathogenesis of Guillain–Barré syndrome. Expert Review of Anti-infective Therapy 2014;1:597-608. [DOI: 10.1586/14787210.1.4.597] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
530 Uncini A, Yuki N. Electrophysiologic and immunopathologic correlates in Guillain–Barré syndrome subtypes. Expert Review of Neurotherapeutics 2014;9:869-84. [DOI: 10.1586/ern.09.43] [Cited by in Crossref: 35] [Cited by in F6Publishing: 40] [Article Influence: 3.9] [Reference Citation Analysis]
531 Ye Y, Zhu D, Liu L, Wang K, Huang K, Hou C. Electrophysiological measurement at Erb's point during the early stage of Guillain-Barré syndrome. J Clin Neurosci 2014;21:786-9. [PMID: 24412297 DOI: 10.1016/j.jocn.2013.07.022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
532 Yang M, Rainone A, Shi XQ, Fournier S, Zhang J. A new animal model of spontaneous autoimmune peripheral polyneuropathy: implications for Guillain-Barré syndrome. Acta Neuropathol Commun 2014;2:5. [PMID: 24401681 DOI: 10.1186/2051-5960-2-5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
533 Vaishnavi C, Behura C, Prabhakar S. Automatic Evaluation of Test Strips for Anti-Ganglioside Antibodies in Patients with Guillain-Barré Syndrome Using EUROLineScan Software. AiM 2014;04:890-898. [DOI: 10.4236/aim.2014.413099] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
534 Piccione EA, Salame K, Katirji B. Guillain-Barré Syndrome and Related Disorders. Neuromuscular Disorders in Clinical Practice 2014. [DOI: 10.1007/978-1-4614-6567-6_28] [Cited by in Crossref: 5] [Article Influence: 0.6] [Reference Citation Analysis]
535 Kortazar Zubizarreta I, Somme JH, Álvarez Vadillo E, González Chinchón G. Parálisis orofaríngea aguda como forma de presentación de la variante faringo-cérvico-braquial del Guillain-Barré. Neurología Argentina 2014;6:44-46. [DOI: 10.1016/j.neuarg.2013.11.003] [Reference Citation Analysis]
536 Lunn MP, Sheikh KA. Peripheral Neuropathies. The Autoimmune Diseases 2014. [DOI: 10.1016/b978-0-12-384929-8.00053-8] [Reference Citation Analysis]
537 Rinaldi S, Brennan KM, Kalna G, Walgaard C, van Doorn P, Jacobs BC, Yu RK, Mansson JE, Goodyear CS, Willison HJ. Antibodies to heteromeric glycolipid complexes in Guillain-Barré syndrome. PLoS One 2013;8:e82337. [PMID: 24358172 DOI: 10.1371/journal.pone.0082337] [Cited by in Crossref: 49] [Cited by in F6Publishing: 54] [Article Influence: 4.9] [Reference Citation Analysis]
538 Verma R, Chaudhari TS, Raut TP, Garg RK. Clinico-electrophysiological profile and predictors of functional outcome in Guillain–Barre syndrome (GBS). Journal of the Neurological Sciences 2013;335:105-11. [DOI: 10.1016/j.jns.2013.09.002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
539 Mitsui Y, Kusunoki S, Arimura K, Kaji R, Kanda T, Kuwabara S, Sonoo M, Takada K; Japanese GBS Study Group. A multicentre prospective study of Guillain-Barré syndrome in Japan: a focus on the incidence of subtypes. J Neurol Neurosurg Psychiatry 2015;86:110-4. [PMID: 24273220 DOI: 10.1136/jnnp-2013-306509] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 3.9] [Reference Citation Analysis]
540 Grimaldi-Bensouda L, Guillemot D, Godeau B, Bénichou J, Lebrun-Frenay C, Papeix C, Labauge P, Berquin P, Penfornis A, Benhamou PY, Nicolino M, Simon A, Viallard JF, Costedoat-Chalumeau N, Courcoux MF, Pondarré C, Hilliquin P, Chatelus E, Foltz V, Guillaume S, Rossignol M, Abenhaim L; PGRx-AID Study Group. Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects. J Intern Med 2014;275:398-408. [PMID: 24206418 DOI: 10.1111/joim.12155] [Cited by in Crossref: 101] [Cited by in F6Publishing: 107] [Article Influence: 10.1] [Reference Citation Analysis]
541 Samukawa M, Hamada Y, Kuwahara M, Takada K, Hirano M, Mitsui Y, Sonoo M, Kusunoki S; Japanese GBS Study Group. Clinical features in Guillain-Barré syndrome with anti-Gal-C antibody. J Neurol Sci 2014;337:55-60. [PMID: 24289889 DOI: 10.1016/j.jns.2013.11.016] [Cited by in Crossref: 29] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
542 Kim HS, Yun DH, Chon J, Lee JE, Park MH, Han YJ. Syringomyelia coexisting with guillain-barre syndrome. Ann Rehabil Med 2013;37:745-9. [PMID: 24236267 DOI: 10.5535/arm.2013.37.5.745] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
543 Han RK, Cheng YF, Zhou SS, Guo H, He RD, Chi LJ, Zhang LM. Increased Circulating Th17 Cell Populations and Elevated CSF Osteopontin and IL-17 Concentrations in Patients with Guillain-Barré Syndrome. J Clin Immunol 2014;34:94-103. [DOI: 10.1007/s10875-013-9965-3] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
544 Kannan Kanikannan MA, Durga P, Venigalla NK, Kandadai RM, Jabeen SA, Borgohain R. Simple bedside predictors of mechanical ventilation in patients with Guillain-Barre syndrome. J Crit Care 2014;29:219-23. [PMID: 24378177 DOI: 10.1016/j.jcrc.2013.10.026] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
545 Fokke C, van den Berg B, Drenthen J, Walgaard C, van Doorn PA, Jacobs BC. Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. Brain 2014;137:33-43. [PMID: 24163275 DOI: 10.1093/brain/awt285] [Cited by in Crossref: 408] [Cited by in F6Publishing: 431] [Article Influence: 40.8] [Reference Citation Analysis]
546 Liu J, Wang LN, McNicol ED. Pharmacological treatment for pain in Guillain-Barré syndrome. Cochrane Database Syst Rev 2013;:CD009950. [PMID: 24142399 DOI: 10.1002/14651858.CD009950.pub2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
547 Samadi M, Kazemi B, Golzari Oskoui S, Barzegar M. Assessment of autonomic dysfunction in childhood guillain-barré syndrome. J Cardiovasc Thorac Res 2013;5:81-5. [PMID: 24252981 DOI: 10.5681/jcvtr.2013.018] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
548 Barzegar M, Malaki M. Guillain-Barre syndrome presenting with severe hydrocephalus in a child. J Pediatr Neurosci 2013;8:175-6. [PMID: 24082947 DOI: 10.4103/1817-1745.117868] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
549 Kerasnoudis A, Pitarokoili K, Behrendt V, Gold R, Yoon MS. Nerve ultrasound score in distinguishing chronic from acute inflammatory demyelinating polyneuropathy. Clin Neurophysiol 2014;125:635-41. [PMID: 24070674 DOI: 10.1016/j.clinph.2013.08.014] [Cited by in Crossref: 61] [Cited by in F6Publishing: 49] [Article Influence: 6.1] [Reference Citation Analysis]
550 Li C, Zhao P, Sun X, Che Y, Jiang Y. Elevated levels of cerebrospinal fluid and plasma interleukin-37 in patients with Guillain-Barré syndrome. Mediators Inflamm 2013;2013:639712. [PMID: 24174711 DOI: 10.1155/2013/639712] [Cited by in Crossref: 36] [Cited by in F6Publishing: 42] [Article Influence: 3.6] [Reference Citation Analysis]
551 Chen Y, Ma F, Zhang J, Chu X, Xu Y. Population incidence of Guillain−Barré syndrome in parts of China: three large populations in Jiangsu province, 2008-2010. Eur J Neurol 2014;21:124-9. [DOI: 10.1111/ene.12265] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
552 Rodríguez-gonzález A, Torres-niño J, Valencia-garcia R, Mayer MA, Alor-hernandez G. Using experts feedback in clinical case resolution and arbitration as accuracy diagnosis methodology. Computers in Biology and Medicine 2013;43:975-86. [DOI: 10.1016/j.compbiomed.2013.05.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
553 Nyati KK, Nyati R. Role of Campylobacter jejuni infection in the pathogenesis of Guillain-Barré syndrome: an update. Biomed Res Int 2013;2013:852195. [PMID: 24000328 DOI: 10.1155/2013/852195] [Cited by in Crossref: 104] [Cited by in F6Publishing: 109] [Article Influence: 10.4] [Reference Citation Analysis]
554 Tomita M, Koike H, Kawagashira Y, Iijima M, Adachi H, Taguchi J, Abe T, Sako K, Tsuji Y, Nakagawa M, Kanda F, Takeda F, Sugawara M, Toyoshima I, Asano N, Sobue G. Clinicopathological features of neuropathy associated with lymphoma. Brain 2013;136:2563-78. [DOI: 10.1093/brain/awt193] [Cited by in Crossref: 121] [Cited by in F6Publishing: 124] [Article Influence: 12.1] [Reference Citation Analysis]
555 González-Suárez I, Sanz-Gallego I, Rodríguez de Rivera FJ, Arpa J. Guillain-Barré syndrome: natural history and prognostic factors: a retrospective review of 106 cases. BMC Neurol 2013;13:95. [PMID: 23876199 DOI: 10.1186/1471-2377-13-95] [Cited by in Crossref: 59] [Cited by in F6Publishing: 61] [Article Influence: 5.9] [Reference Citation Analysis]
556 Armin S, Mahvelati Shamsabadi F, Kiomarci A, Jadali F. Virologic Evidences of Active Herpesviridae Infection in Children With Guillain-Barre Syndrome. Arch Pediatr Infect Dis 2013;2:169-73. [DOI: 10.5812/pedinfect.11251] [Reference Citation Analysis]
557 Lee TW, Duff AJ, Martin T, Barrett JM. Enuresis and more. Arch Dis Child Educ Pract Ed 2013;98:162-70. [PMID: 23839342 DOI: 10.1136/archdischild-2012-303489] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
558 Amatya B, Khan F, Whishaw M, Pallant JF. Guillain-Barré syndrome: prevalence and long-term factors impacting bladder function in an Australian community cohort. J Clin Neurol 2013;9:144-50. [PMID: 23894237 DOI: 10.3988/jcn.2013.9.3.144] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
559 Shahrizaila N, Goh KJ, Abdullah S, Kuppusamy R, Yuki N. Two sets of nerve conduction studies may suffice in reaching a reliable electrodiagnosis in Guillain–Barré syndrome. Clinical Neurophysiology 2013;124:1456-9. [DOI: 10.1016/j.clinph.2012.12.047] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
560 Devos D, Magot A, Perrier-Boeswillwald J, Fayet G, Leclair-Visonneau L, Ollivier Y, Nguyen The Tich S, Pereon Y. Guillain-Barré syndrome during childhood: particular clinical and electrophysiological features. Muscle Nerve 2013;48:247-51. [PMID: 23813561 DOI: 10.1002/mus.23749] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
561 Sharma B, Nagpal K, Handa R, Dubey P. Combination of AIDP and pyramidal signs associated with antecedent hepatitis A infection: a rare (co)occurrence. BMJ Case Rep 2013;2013:bcr2013009530. [PMID: 23761608 DOI: 10.1136/bcr-2013-009530] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
562 Tateyama M, Nakashima I, Suzuki N, Kanaoka-suzuki C, Takano R, Sato H, Kusunoki S, Fujihara K, Itoyama Y, Aoki M. Inflammatory demyelinating polyneuropathy with nephrotic syndrome: Report of a case and review of the literature. Clin Exp Neuroimmunol 2013;4:79-88. [DOI: 10.1111/cen3.12009] [Reference Citation Analysis]
563 Koike H, Sobue G. Wide range of clinicopathological features in immune-mediated autonomic neuropathies. Clin Exp Neuroimmunol 2013;4:46-59. [DOI: 10.1111/cen3.12003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
564 Matsushita M, Kitoh H, Itomi K, Kitakoji T, Iwata K, Mishima K, Ishiguro N, Hattori T. Orthopaedic manifestations and diagnostic clues in children with Guillain-Barré syndrome. J Child Orthop 2013;7:177-82. [PMID: 23755090 DOI: 10.1007/s11832-012-0475-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
565 Gustafsson R, Reitsma R, Strålfors A, Lindholm A, Press R, Fogdell-hahn A. Incidence of human herpesvirus 6 in clinical samples from Swedish patients with demyelinating diseases. Journal of Microbiology, Immunology and Infection 2014;47:418-21. [DOI: 10.1016/j.jmii.2013.03.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
566 Lin JJ, Hsia SH, Wang HS, Lyu RK, Chou ML, Hung PC, Hsieh MY, Lin KL. Clinical variants of Guillain-Barré syndrome in children. Pediatr Neurol 2012;47:91-6. [PMID: 22759683 DOI: 10.1016/j.pediatrneurol.2012.05.011] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 3.9] [Reference Citation Analysis]
567 El-beleidy AS, Khattab AA, El-sherbini SA, El-adely TZ, Sleem HM, El-haware RE. Antiganglioside antibodies determine the clinical severity and predict response to therapy in Egyptian children with Guillain–Barré Syndrome. Pediatria Polska 2013;88:224-229. [DOI: 10.1016/j.pepo.2013.02.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
568 van Doorn PA. Diagnosis, treatment and prognosis of Guillain-Barré syndrome (GBS). Presse Med 2013;42:e193-201. [PMID: 23628447 DOI: 10.1016/j.lpm.2013.02.328] [Cited by in Crossref: 67] [Cited by in F6Publishing: 77] [Article Influence: 6.7] [Reference Citation Analysis]
569 Wakerley BR, Soon D, Chan YC, Yuki N. Atypical Bickerstaff brainstem encephalitis: ataxic hypersomnolence without ophthalmoplegia. J Neurol Neurosurg Psychiatry 2013;84:1206-7. [PMID: 23564757 DOI: 10.1136/jnnp-2013-304993] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
570 Al-Hashel JY, John JK, Vembu P. Unusual presentation of Guillain-Barré syndrome following traumatic bone injuries: report of two cases. Med Princ Pract 2013;22:597-9. [PMID: 23571555 DOI: 10.1159/000348797] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
571 Yuki N. Guillain-Barré syndrome and anti-ganglioside antibodies: a clinician-scientist's journey. Proc Jpn Acad Ser B Phys Biol Sci 2012;88:299-326. [PMID: 22850724 DOI: 10.2183/pjab.88.299] [Cited by in Crossref: 67] [Cited by in F6Publishing: 69] [Article Influence: 6.7] [Reference Citation Analysis]
572 Kokubun N, Shahrizaila N, Koga M, Hirata K, Yuki N. The demyelination neurophysiological criteria can be misleading in Campylobacter jejuni-related Guillain-Barré syndrome. Clin Neurophysiol 2013;124:1671-9. [PMID: 23514735 DOI: 10.1016/j.clinph.2013.02.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
573 Guillain–Barré syndrome. Neuromuscular Disease A Case-Based Approach 2013. [DOI: 10.1017/cbo9780511735905.016] [Reference Citation Analysis]
574 Hughes RA, Pritchard J, Hadden RD. Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome. Cochrane Database Syst Rev 2013;:CD008630. [PMID: 23450584 DOI: 10.1002/14651858.CD008630.pub3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
575 Bloch SA, Akhavan M, Avarello J. Weakness and the inability to ambulate in a 14-month-old female: a case report and concise review of guillain-barre syndrome. Case Rep Emerg Med 2013;2013:953612. [PMID: 23431480 DOI: 10.1155/2013/953612] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
576 Dimachkie MM, Barohn RJ. Guillain-Barré syndrome and variants. Neurol Clin. 2013;31:491-510. [PMID: 23642721 DOI: 10.1016/j.ncl.2013.01.005] [Cited by in Crossref: 191] [Cited by in F6Publishing: 202] [Article Influence: 19.1] [Reference Citation Analysis]
577 Karkare K, Sinha S, Taly AB, Rao S. Prevalence and profile of sleep disturbances in Guillain-Barre Syndrome: a prospective questionnaire-based study during 10 days of hospitalization. Acta Neurol Scand 2013;127:116-23. [PMID: 22642612 DOI: 10.1111/j.1600-0404.2012.01688.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
578 Sedano MJ, Canga A, de Pablos C, Polo JM, Berciano J. Muscle MRI in severe Guillain-Barré syndrome with motor nerve inexcitability. J Neurol 2013;260:1624-30. [PMID: 23370612 DOI: 10.1007/s00415-013-6845-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
579 Miki Y, Tomiyama M, Ueno T, Haga R, Nishijima H, Arai A, Suzuki C, Nunomura J, Baba M. Radicular myoclonus in a patient with Guillain-Barré Syndrome. Intern Med 2012;51:2021-3. [PMID: 22864130 DOI: 10.2169/internalmedicine.51.7042] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
580 Witsch J, Galldiks N, Bender A, Kollmar R, Bösel J, Hobohm C, Günther A, Schirotzek I, Fuchs K, Jüttler E. Long-term outcome in patients with Guillain–Barré syndrome requiring mechanical ventilation. J Neurol 2013;260:1367-74. [DOI: 10.1007/s00415-012-6806-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
581 Fujimura H. The Guillain-Barré syndrome. Handb Clin Neurol 2013;115:383-402. [PMID: 23931791 DOI: 10.1016/B978-0-444-52902-2.00021-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
582 Greenberg SB, Tokarczyk AJ, Zahed C, Coursin DB. Endocrine Issues in Neurocritical Care. Textbook of Neurointensive Care 2013. [DOI: 10.1007/978-1-4471-5226-2_15] [Reference Citation Analysis]
583 Jackson AC. Human Disease. Rabies. Elsevier; 2013. pp. 269-98. [DOI: 10.1016/b978-0-12-396547-9.00007-9] [Cited by in Crossref: 11] [Article Influence: 1.1] [Reference Citation Analysis]
584 Lee DH, Lee CJ, Lee JJW, Lee JK. Guillain-Barré Syndrome Presenting as Bilateral Vocal Cord Paralysis. Korean J Otorhinolaryngol-Head Neck Surg 2013;56:169. [DOI: 10.3342/kjorl-hns.2013.56.3.169] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
585 Campanharo FF, Santana EF, Sarmento SG, Mattar R, Sun SY, Moron AF. Guillain-Barré Syndrome after H1N1 Shot in Pregnancy: Maternal and Fetal Care in the Third Trimester-Case Report. Case Rep Obstet Gynecol 2012;2012:323625. [PMID: 23259096 DOI: 10.1155/2012/323625] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
586 Rodríguez-González A, Alor-Hernández G. An approach for solving multi-level diagnosis in high sensitivity medical diagnosis systems through the application of semantic technologies. Comput Biol Med 2013;43:51-62. [PMID: 23177782 DOI: 10.1016/j.compbiomed.2012.10.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
587 Heikema AP, Jacobs BC, Horst-Kreft D, Huizinga R, Kuijf ML, Endtz HP, Samsom JN, van Wamel WJ. Siglec-7 specifically recognizes Campylobacter jejuni strains associated with oculomotor weakness in Guillain-Barré syndrome and Miller Fisher syndrome. Clin Microbiol Infect 2013;19:E106-12. [PMID: 23173866 DOI: 10.1111/1469-0691.12073] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
588 Verma R, Chaudhari TS. Two unusual variants of Guillain-Barre syndrome. BMJ Case Rep 2012;2012:bcr2012007088. [PMID: 23162026 DOI: 10.1136/bcr-2012-007088] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
589 Etemadifar M, Roomizadeh P, Abtahi SH, Sajjadi S, Abedini A, Golabbakhsh A, Fereidan-Esfahani M, Akbari M. Linkage of multiple sclerosis and guillain-barre syndrome: a population-based survey in isfahan, iran. Autoimmune Dis 2012;2012:232139. [PMID: 23198139 DOI: 10.1155/2012/232139] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
590 Hartung HP, Keller-Stanislawski B, Hughes RA, Lehmann HC. [Guillain-Barré syndrome after exposure to influenza]. Nervenarzt 2012;83:714-30. [PMID: 22528062 DOI: 10.1007/s00115-012-3479-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
591 Biotti D, Vignal C, Sharshar T, Gout O, Mccoy AN, Miller NR. Blindness, Weakness, and Tingling. Survey of Ophthalmology 2012;57:565-72. [DOI: 10.1016/j.survophthal.2011.10.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
592 Omejec G, Podnar S. Retrospective analysis of Slovenian patients with Guillain-Barré syndrome. J Peripher Nerv Syst 2012;17:217-9. [PMID: 22734909 DOI: 10.1111/j.1529-8027.2012.00397.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
593 Morata Alba J, Alpera Lacruz R. [Guillain-Barré syndrome and anti-ganglioside antibodies]. An Pediatr (Barc) 2013;78:277-9. [PMID: 23083942 DOI: 10.1016/j.anpedi.2012.08.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
594 Verma R, Chaudhari TS, Giri P. Unilateral facial palsy in Guillain-Barre syndrome (GBS): a rare occurrence. BMJ Case Rep 2012;2012:bcr2012007077. [PMID: 23087283 DOI: 10.1136/bcr-2012-007077] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
595 Ye Y, Wang K, Deng F, Xing Y. Electrophysiological subtypes and prognosis of Guillain-Barré syndrome in northeastern China. Muscle Nerve 2013;47:68-71. [PMID: 23042578 DOI: 10.1002/mus.23477] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
596 Li S, Yu M, Li H, Zhang H, Jiang Y. IL-17 and IL-22 in cerebrospinal fluid and plasma are elevated in Guillain-Barré syndrome. Mediators Inflamm 2012;2012:260473. [PMID: 23091305 DOI: 10.1155/2012/260473] [Cited by in Crossref: 47] [Cited by in F6Publishing: 58] [Article Influence: 4.3] [Reference Citation Analysis]
597 Sarkar UK, Menon L, Sarbapalli D, Pal R, Zaman FA, Kar S, Singh J, Mondal M, Mukherjee S. Spectrum of Guillain-Barré syndrome in tertiary care hospital at Kolkata. J Nat Sci Biol Med 2011;2:211-5. [PMID: 22346239 DOI: 10.4103/0976-9668.92320] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
598 Netto AB, Taly AB, Kulkarni GB, Rao UG, Rao S. Mortality in mechanically ventilated patients of Guillain Barré Syndrome. Ann Indian Acad Neurol 2011;14:262-6. [PMID: 22346014 DOI: 10.4103/0972-2327.91942] [Cited by in Crossref: 34] [Cited by in F6Publishing: 39] [Article Influence: 3.1] [Reference Citation Analysis]
599 Netto AB, Kulkarni GB, Taly AB, Rao GU, Periyavan S, Rao S. A comparison of immunomodulation therapies in mechanically ventilated patients with Guillain Barré syndrome. J Clin Neurosci 2012;19:1664-7. [PMID: 23036171 DOI: 10.1016/j.jocn.2012.04.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
600 Naik KR, Saroja AO, Patil BP. Familial Guillain-Barré syndrome: First Indian report. Ann Indian Acad Neurol 2012;15:44-7. [PMID: 22412273 DOI: 10.4103/0972-2327.93278] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
601 Ogawa G, Kaida K, Kuwahara M, Kimura F, Kamakura K, Kusunoki S. An antibody to the GM1/GalNAc-GD1a complex correlates with development of pure motor Guillain-Barré syndrome with reversible conduction failure. J Neuroimmunol 2013;254:141-5. [PMID: 23000056 DOI: 10.1016/j.jneuroim.2012.09.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
602 Baig F, Knopp M, Rajabally YA. Diagnosis, epidemiology and treatment of inflammatory neuropathies. Br J Hosp Med (Lond) 2012;73:380-5. [PMID: 22875431 DOI: 10.12968/hmed.2012.73.7.380] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
603 Mossberg N, Nordin M, Movitz C, Nilsson S, Hellstrand K, Bergström T, Andersson B, Andersen O. The recurrent Guillain-Barré syndrome: a long-term population-based study. Acta Neurol Scand 2012;126:154-61. [PMID: 22507178 DOI: 10.1111/j.1600-0404.2012.01667.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
604 Islam Z, Gilbert M, Mohammad QD, Klaij K, Li J, van Rijs W, Tio-Gillen AP, Talukder KA, Willison HJ, van Belkum A, Endtz HP, Jacobs BC. Guillain-Barré syndrome-related Campylobacter jejuni in Bangladesh: ganglioside mimicry and cross-reactive antibodies. PLoS One 2012;7:e43976. [PMID: 22952833 DOI: 10.1371/journal.pone.0043976] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 3.7] [Reference Citation Analysis]
605 Sharshar T, Polito A, Porcher R, Merhbene T, Blanc M, Antona M, Durand MC, Friedman D, Orlikowski D, Annane D, Marcadet MH. Relevance of anxiety in clinical practice of Guillain-Barre syndrome: a cohort study. BMJ Open 2012;2:e000893. [PMID: 22923622 DOI: 10.1136/bmjopen-2012-000893] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
606 Hughes RA, van Doorn PA. Corticosteroids for Guillain-Barré syndrome. Cochrane Database Syst Rev 2012;:CD001446. [PMID: 22895921 DOI: 10.1002/14651858.CD001446.pub4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
607 Raphaël JC, Chevret S, Hughes RA, Annane D. Plasma exchange for Guillain-Barré syndrome. Cochrane Database Syst Rev 2012;:CD001798. [PMID: 22786475 DOI: 10.1002/14651858.CD001798.pub2] [Cited by in Crossref: 57] [Cited by in F6Publishing: 69] [Article Influence: 5.2] [Reference Citation Analysis]
608 Liu J, Wang L, Mcnicol ED, Liu J. Pharmacological treatment for pain in Guillain-Barré syndrome. Cochrane Database of Systematic Reviews. Chichester: John Wiley & Sons, Ltd; 1996. [DOI: 10.1002/14651858.cd009950] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
609 Hughes RA, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain-Barré syndrome. Cochrane Database Syst Rev 2012;:CD002063. [PMID: 22786476 DOI: 10.1002/14651858.CD002063.pub5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 43] [Article Influence: 1.8] [Reference Citation Analysis]
610 Liang SL, Wang WZ, Huang S, Wang XK, Zhang S, Wu Y. Th17 helper cell and T-cell immunoglobulin and mucin domain 3 involvement in Guillain-Barré syndrome. Immunopharmacol Immunotoxicol. 2012;34:1039-1046. [PMID: 22738814 DOI: 10.3109/08923973.2012.697469] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
611 Shaikh AG, Termsarasab P, Nwankwo C, Rao-frisch A, Katirji B. Atypical forms of Guillain-Barré syndrome and H1N1-influenza vaccination. Vaccine 2012;30:3251-4. [DOI: 10.1016/j.vaccine.2012.03.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
612 Gensicke H, Datta AN, Dill P, Schindler C, Fischer D. Increased incidence of Guillain-Barré syndrome after surgery. Eur J Neurol 2012;19:1239-44. [PMID: 22519650 DOI: 10.1111/j.1468-1331.2012.03730.x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 65] [Article Influence: 5.5] [Reference Citation Analysis]
613 Gwathmey K, Balogun RA, Burns T. Neurologic indications for therapeutic plasma exchange: 2011 update. J Clin Apheresis 2012;27:138-45. [DOI: 10.1002/jca.21219] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
614 Naphade PU, Verma R, Garg RK, Singh M, Malhotra HS, Shankwar SN. Prevalence of bladder dysfunction, urodynamic findings, and their correlation with outcome in Guillain-Barre syndrome. Neurourol Urodyn 2012;31:1135-40. [PMID: 22488834 DOI: 10.1002/nau.22236] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
615 Uncini A, Kuwabara S. Electrodiagnostic criteria for Guillain-Barrè syndrome: a critical revision and the need for an update. Clin Neurophysiol 2012;123:1487-95. [PMID: 22480600 DOI: 10.1016/j.clinph.2012.01.025] [Cited by in Crossref: 169] [Cited by in F6Publishing: 125] [Article Influence: 15.4] [Reference Citation Analysis]
616 Comi C, Fleetwood T, Dianzani U. The role of T cell apoptosis in nervous system autoimmunity. Autoimmun Rev 2012;12:150-6. [PMID: 22504460 DOI: 10.1016/j.autrev.2011.08.011] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 3.0] [Reference Citation Analysis]
617 Rosen BA. Guillain-Barre Syndrome. Pediatrics in Review 2012;33:164-71. [DOI: 10.1542/pir.33-4-164] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
618 Pavone P, Praticò A, Ruggieri M, Verrotti A, Castellano-chiodo D, Greco F, Falsaperla R, Pavone L. Acquired Peripheral Neuropathy: A Report on 20 Children. Int J Immunopathol Pharmacol 2012;25:513-7. [DOI: 10.1177/039463201202500222] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
619 Rosen BA. Guillain-Barré Syndrome. Pediatrics In Review 2012;33:164-171. [DOI: 10.1542/pir.33.4.164] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
620 Sang D, Chen Q, Liu X, Qu H, Wei D, Yin L, Zhang L. Fc receptor like 3 in Chinese patients of Han nationality with Guillain-Barré syndrome. J Neuroimmunol 2012;246:65-8. [PMID: 22458979 DOI: 10.1016/j.jneuroim.2012.03.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
621 Vasconcelos A, Abecasis F, Monteiro R, Camilo C, Vieira M, de Carvalho M, Correia M. A 3-month-old baby with H1N1 and Guillain-Barré syndrome. BMJ Case Rep 2012;2012:bcr1220115462. [PMID: 22605827 DOI: 10.1136/bcr.12.2011.5462] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
622 Forsberg A, Press R, Holmqvist LW. Residual disability 10 years after falling ill in Guillain-Barré syndrome: a prospective follow-up study. J Neurol Sci 2012;317:74-9. [PMID: 22425539 DOI: 10.1016/j.jns.2012.02.026] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
623 Lee KL, Lim OK, Lee JK, Park KD. Treatment of Dysphagia with pyridostigmine bromide in a patient with the pharyngeal-cervical-brachial variant of guillain-barré syndrome. Ann Rehabil Med 2012;36:148-53. [PMID: 22506249 DOI: 10.5535/arm.2012.36.1.148] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
624 Pardal-Fernández JM, Vega-González G, Rodríguez-Vázquez M, Iniesta-López I. A new median motor test: comparison with conventional motor studies in carpal tunnel syndrome. J Clin Neurophysiol 2012;29:84-8. [PMID: 22353991 DOI: 10.1097/WNP.0b013e3182466def] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
625 Rezania K, Goldenberg FD, White S. Neuromuscular Disorders and Acute Respiratory Failure: Diagnosis and Management. Neurologic Clinics 2012;30:161-85. [DOI: 10.1016/j.ncl.2011.09.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
626 Pérez-lledó E, Díaz-vico A, Gómez-gosálvez F. Síndrome de Guillain-Barré: presentación clínica y evolución en menores de 6 años de edad. Anales de Pediatría 2012;76:69-76. [DOI: 10.1016/j.anpedi.2011.01.013] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
627 Zhang HL, Zhang XM, Mao XJ, Deng H, Li HF, Press R, Fredrikson S, Zhu J. Altered cerebrospinal fluid index of prealbumin, fibrinogen, and haptoglobin in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. Acta Neurol Scand 2012;125:129-35. [PMID: 21434877 DOI: 10.1111/j.1600-0404.2011.01511.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
628 Bos Eyssen ME, van Doorn PA, Jacobs BC, Steyerberg EW, van der Voort PH, Zandstra DF, Horn J, Spronk PE, Hoedemaekers CW, Bakker J, van der Jagt M. Selective digestive tract decontamination decreases time on ventilator in Guillain-Barré syndrome. Neurocrit Care 2011;15:128-33. [PMID: 21468781 DOI: 10.1007/s12028-011-9536-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
629 Tang J, Dai Y, Li M, Cheng M, Hong S, Jiang L, Cai F, Zhong M. Guillain-Barré syndrome in Chinese children: a retrospective analysis. Pediatr Neurol 2011;45:233-7. [PMID: 21907884 DOI: 10.1016/j.pediatrneurol.2011.06.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
630 Islam Z, Jacobs BC, Islam MB, Mohammad QD, Diorditsa S, Endtz HP. High incidence of Guillain-Barre syndrome in children, Bangladesh. Emerg Infect Dis 2011;17:1317-8. [PMID: 21762603 DOI: 10.3201/eid1707.102031] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
631 Dimario FJ Jr, Edwards C. Autonomic dysfunction in childhood Guillain-Barré syndrome. J Child Neurol 2012;27:581-6. [PMID: 22241710 DOI: 10.1177/0883073811420872] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
632 Islam Z, Jacobs BC, Islam MB, Mohammad QD, Diorditsa S, Endtz HP. High incidence of Guillain-Barre syndrome in children, Bangladesh. Emerg Infect Dis 2011;17:1317-8. [PMID: 21762603 DOI: 10.3201/eid1707.102031] [Cited by in Crossref: 29] [Cited by in F6Publishing: 38] [Article Influence: 2.6] [Reference Citation Analysis]
633 Brigo F, Balter R, Marradi P, Ferlisi M, Zaccaron A, Fiaschi A, Frasson E, Bertolasi L. Vincristine-Related Neuropathy Versus Acute Inflammatory Demyelinating Polyradiculoneuropathy in Children With Acute Lymphoblastic Leukemia. J Child Neurol 2012;27:867-74. [DOI: 10.1177/0883073811428379] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
634 Chang KH, Chuang TJ, Lyu RK, Ro LS, Wu YR, Chang HS, Huang CC, Kuo HC, Hsu WC, Chu CC, Chen CM. Identification of gene networks and pathways associated with Guillain-Barré syndrome. PLoS One 2012;7:e29506. [PMID: 22253732 DOI: 10.1371/journal.pone.0029506] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
635 Dourado ME, Félix RH, da Silva WK, Queiroz JW, Jeronimo SM. Clinical characteristics of Guillain-Barré syndrome in a tropical country: a Brazilian experience. Acta Neurol Scand 2012;125:47-53. [PMID: 21428966 DOI: 10.1111/j.1600-0404.2011.01503.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
636 Sladky JT, Ashwal S. Inflammatory Neuropathies. Swaiman's Pediatric Neurology 2012. [DOI: 10.1016/b978-1-4377-0435-8.00095-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
637 Grobbelaar AO, Woollard ACS. Facial Nerve Innervation and Facial Palsies. Craniofacial Muscles 2012. [DOI: 10.1007/978-1-4614-4466-4_15] [Reference Citation Analysis]
638 Vanhoutte EK, Faber CG, van Nes SI, Jacobs BC, van Doorn PA, van Koningsveld R, Cornblath DR, van der Kooi AJ, Cats EA, van den Berg LH, Notermans NC, van der Pol WL, Hermans MC, van der Beek NA, Gorson KC, Eurelings M, Engelsman J, Boot H, Meijer RJ, Lauria G, Tennant A, Merkies IS; PeriNomS Study Group. Modifying the Medical Research Council grading system through Rasch analyses. Brain 2012;135:1639-49. [PMID: 22189568 DOI: 10.1093/brain/awr318] [Cited by in Crossref: 118] [Cited by in F6Publishing: 124] [Article Influence: 9.8] [Reference Citation Analysis]
639 Ruts L, van Doorn PA, Lombardi R, Haasdijk ED, Penza P, Tulen JHM, Hempel RJ, van den Meiracker AH, Lauria G. Unmyelinated and myelinated skin nerve damage in Guillain-Barré syndrome: correlation with pain and recovery. Pain 2012;153:399-409. [PMID: 22154920 DOI: 10.1016/j.pain.2011.10.037] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 3.4] [Reference Citation Analysis]
640 Lin JJ, Hsia SH, Wu CT, Wang HS, Lin KL, Lyu RK. Risk factors and outcomes of Guillain-Barré syndrome with acute myelitis. Pediatr Neurol 2011;44:110-6. [PMID: 21215910 DOI: 10.1016/j.pediatrneurol.2010.08.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
641 Yuki N, Kokubun N, Kuwabara S, Sekiguchi Y, Ito M, Odaka M, Hirata K, Notturno F, Uncini A. Guillain-Barré syndrome associated with normal or exaggerated tendon reflexes. J Neurol 2012;259:1181-90. [PMID: 22143612 DOI: 10.1007/s00415-011-6330-4] [Cited by in Crossref: 72] [Cited by in F6Publishing: 76] [Article Influence: 6.0] [Reference Citation Analysis]
642 Son DW, Song GS, Sung SK, Kim SH. Guillain-barre syndrome following spinal fusion for thoracic vertebral fracture. J Korean Neurosurg Soc 2011;50:464-7. [PMID: 22259696 DOI: 10.3340/jkns.2011.50.5.464] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
643 McMillan HJ, Darras BT, Kang PB. Autoimmune neuromuscular disorders in childhood. Curr Treat Options Neurol 2011;13:590-607. [PMID: 21912840 DOI: 10.1007/s11940-011-0146-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
644 van Doorn PA, Kuitwaard K, Jacobs BC. Serum IgG levels as biomarkers for optimizing IVIg therapy in CIDP. J Peripher Nerv Syst 2011;16 Suppl 1:38-40. [PMID: 21696496 DOI: 10.1111/j.1529-8027.2011.00304.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
645 Durrieu G, Caillet C, Lacroix I, Jacquet A, Faucher A, Ouaret S, Sommet A, Perault-pochat M, Kreft-jaïs C, Castot A, Damase-michel C, Montastruc J. Campagne nationale de vaccination contre la grippe A (H1N1)v : suivi national de pharmacovigilance. Therapies 2011;66:527-40. [DOI: 10.2515/therapie/2011075] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
646 Hsu CY, Chuang YC, Chiu NC, Chen KW. Childhood subacute inflammatory demyelinating polyneuropathy. Kaohsiung J Med Sci 2011;27:520-3. [PMID: 22005162 DOI: 10.1016/j.kjms.2011.06.016] [Reference Citation Analysis]
647 Song W, Wu Y, Ji Z, Zhu J, Pan S. Guillain–Barré Syndrome following sepsis after stereotactic aspiration for spontaneous pontine hemorrhage. Neurol Sci 2012;33:657-60. [DOI: 10.1007/s10072-011-0823-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
648 van der Maas NAT, Kramer MA, Jacobs BC, van Soest EM, Dieleman JP, Kemmeren JM, de Melker HE, Sturkenboom MCJM. Guillain-Barré syndrome: background incidence rates in The Netherlands. Journal of the Peripheral Nervous System 2011;16:243-9. [DOI: 10.1111/j.1529-8027.2011.00356.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
649 Ng L, Khan F. Use of the international classification of functioning, disability and health to describe patient-reported disability: A comparison of motor neurone disease, Guillain-Barré syndrome and multiple sclerosis in an Australian cohort. Disability and Rehabilitation 2011;34:295-303. [DOI: 10.3109/09638288.2011.606345] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
650 Mateen FJ, Cornblath DR, Jafari H, Shinohara RT, Khandit D, Ahuja B, Bahl S, Sutter RW. Guillain-Barré Syndrome in India: population-based validation of the Brighton criteria. Vaccine 2011;29:9697-701. [PMID: 22001121 DOI: 10.1016/j.vaccine.2011.09.123] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
651 Mac Sweeney R, McAuley DF, Matthay MA. Acute lung failure. Semin Respir Crit Care Med 2011;32:607-25. [PMID: 21989697 DOI: 10.1055/s-0031-1287870] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
652 Shahrizaila N, Goh KJ, Kokubun N, Abdullah S, Yuki N. Serial nerve conduction studies provide insight into the pathophysiology of Guillain–Barré and Fisher syndromes. Journal of the Neurological Sciences 2011;309:26-30. [DOI: 10.1016/j.jns.2011.07.042] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
653 Dimachkie MM, Barohn RJ. Acute Inflammatory Demyelinating Neuropathies and Variants. Neuromuscular Disorders 2011. [DOI: 10.1002/9781119973331.ch24] [Reference Citation Analysis]
654 Umapathi T, Yuki N. Pain in Guillain-Barré syndrome. Expert Rev Neurother 2011;11:335-9. [PMID: 21375438 DOI: 10.1586/ern.11.8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
655 Kuwahara M, Suzuki S, Takada K, Kusunoki S. Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol 2011;239:87-90. [PMID: 21914557 DOI: 10.1016/j.jneuroim.2011.08.016] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 3.6] [Reference Citation Analysis]
656 Gwathmey K, Balogun RA, Burns T. Neurologic indications for therapeutic plasma exchange: An update. J Clin Apheresis 2011;26:261-8. [DOI: 10.1002/jca.20298] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
657 Grimaldi-Bensouda L, Alpérovitch A, Besson G, Vial C, Cuisset JM, Papeix C, Lyon-Caen O, Benichou J, Rossignol M; Lucien Abenhaim for the GBS-PGRx Study Group. Guillain-Barre syndrome, influenzalike illnesses, and influenza vaccination during seasons with and without circulating A/H1N1 viruses. Am J Epidemiol 2011;174:326-35. [PMID: 21652600 DOI: 10.1093/aje/kwr072] [Cited by in Crossref: 58] [Cited by in F6Publishing: 61] [Article Influence: 4.8] [Reference Citation Analysis]
658 Misra UK, Kalita J, Nair PP. Diagnostic approach to peripheral neuropathy. Ann Indian Acad Neurol 2008;11:89-97. [PMID: 19893645 DOI: 10.4103/0972-2327.41875] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 3.8] [Reference Citation Analysis]
659 Hughes RA, Swan AV, van Doorn PA. Cochrane Review: Intravenous immunoglobulin for Guillain-Barré syndrome. Evid -Based Child Health 2011;6:1176-231. [DOI: 10.1002/ebch.810] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
660 Gruver RA. Progressive weakness and inability to walk in a healthy 28-year-old male. Journal of the American Academy of Physician Assistants 2011;24:E1-E3. [DOI: 10.1097/01720610-201107000-00019] [Reference Citation Analysis]
661 Sevketoglu E, Tatlı B, Tuğcu B, Demirelli Y, Hatipoglu S. Response. Pediatric Neurology 2011;45:63-64. [DOI: 10.1016/j.pediatrneurol.2011.03.010] [Reference Citation Analysis]
662 Wang Q, Xiang Y, Yu K, Li C, Wang J, Xiao L. Multiple cranial neuropathy variant of guillain-barré syndrome: A case series: Cranial Variant of GBS. Muscle Nerve 2011;44:252-7. [DOI: 10.1002/mus.22043] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
663 Albertí MA, Alentorn A, Martínez-yelamos S, Martínez-matos JA, Povedano M, Montero J, Casasnovas C. Very early electrodiagnostic findings in Guillain-Barré syndrome. Journal of the Peripheral Nervous System 2011;16:136-42. [DOI: 10.1111/j.1529-8027.2011.00338.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 2.9] [Reference Citation Analysis]
664 Montastruc J, Autret-leca E, Baldin B B, Bavoux F, Bénard-laribière A, Biour M, Beyens M, Colin F, Cocquerel A, Crepin S, Décréau-gaillon G, Dos Santos S, Eftekhari P, Favrelière S, Gautier S, Gras-champel V, Javot L, Jean-pastor M, Le Beller C, Lebrun-vignes B, Millaret A, Perrazi A, Pinzani V, Riché C, Schir E, Sgro C, Tebacher-alt M, Trenque T, Valnet-rabier M, Veyrac G. Bilan du suivi de PharmacoVigilance des vaccins contre la grippe A(H1N1)v durant la campagne 2009-2010 en France. Bulletin de l'Académie Nationale de Médecine 2011;195:1309-1317. [DOI: 10.1016/s0001-4079(19)31991-0] [Reference Citation Analysis]
665 Kuhle J, Petzold A. What makes a prognostic biomarker in CNS diseases: strategies for targeted biomarker discovery? Part 1: acute and monophasic diseases. Expert Opinion on Medical Diagnostics 2011;5:333-46. [DOI: 10.1517/17530059.2011.578624] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
666 Jiao H, Wang W, Wang H, Wu Y, Wang L. Tumor necrosis factor alpha 308 G/A polymorphism and Guillain-Barré syndrome risk. Mol Biol Rep 2012;39:1537-40. [PMID: 21604171 DOI: 10.1007/s11033-011-0892-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
667 Walgaard C, Lingsma HF, Ruts L, van Doorn PA, Steyerberg EW, Jacobs BC. Early recognition of poor prognosis in Guillain-Barre syndrome. Neurology 2011;76:968-75. [PMID: 21403108 DOI: 10.1212/WNL.0b013e3182104407] [Cited by in Crossref: 174] [Cited by in F6Publishing: 178] [Article Influence: 14.5] [Reference Citation Analysis]
668 Grozdanova A, Apostolski S, Suturkova L. The role of molecular mimicry in the etiology of Guillain Barré Syndrome. Maced Pharm Bull 2011;56:3-12. [DOI: 10.33320/maced.pharm.bull.2010.56.001] [Reference Citation Analysis]
669 Güngör L, Güngör I, Oztürk HE, Onar MK. Visual evoked potentials in guillain-barré syndrome. J Clin Neurol 2011;7:34-9. [PMID: 21519525 DOI: 10.3988/jcn.2011.7.1.34] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
670 Caudie C, Quittard Pinon A, Taravel D, Sivadon-Tardy V, Orlikowski D, Rozenberg F, Sharshar T, Raphaël JC, Gaillard JL. Preceding infections and anti-ganglioside antibody profiles assessed by a dot immunoassay in 306 French Guillain-Barré syndrome patients. J Neurol 2011;258:1958-64. [PMID: 21516465 DOI: 10.1007/s00415-011-6042-9] [Cited by in Crossref: 44] [Cited by in F6Publishing: 48] [Article Influence: 3.7] [Reference Citation Analysis]
671 Hong Y, Sung J, Oh M, Moon H, Park K, Lee K. Axonal conduction block at intermediate nerve segments in pure motor Guillain-Barré syndrome. Journal of the Peripheral Nervous System 2011;16:37-46. [DOI: 10.1111/j.1529-8027.2011.00314.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
672 Orlikowski D, Porcher R, Sivadon-tardy V, Quincampoix J, Raphael J, Durand M, Sharshar T, Roussi J, Caudie C, Annane D, Rozenberg F, Leruez-ville M, Gaillard J, Gault E. Guillain-Barre Syndrome following Primary Cytomegalovirus Infection: A Prospective Cohort Study. Clinical Infectious Diseases 2011;52:837-44. [DOI: 10.1093/cid/cir074] [Cited by in Crossref: 83] [Cited by in F6Publishing: 91] [Article Influence: 6.9] [Reference Citation Analysis]
673 Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis. Neuroepidemiology 2011;36:123-33. [PMID: 21422765 DOI: 10.1159/000324710] [Cited by in Crossref: 490] [Cited by in F6Publishing: 514] [Article Influence: 40.8] [Reference Citation Analysis]
674 Hughes RA, Pritchard J, Hadden RD. Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain Barré syndrome. Cochrane Database Syst Rev 2011;:CD008630. [PMID: 21412923 DOI: 10.1002/14651858.CD008630.pub2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
675 Ma Y, Feng J, Qi Y, Dou XG. An immunocompetent adult patient with hepatitis and guillain-barré syndrome after cytomegalovirus infection. Virol J 2011;8:95. [PMID: 21371337 DOI: 10.1186/1743-422X-8-95] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
676 Fuglsang-frederiksen A, Pugdahl K. Current status on electrodiagnostic standards and guidelines in neuromuscular disorders. Clinical Neurophysiology 2011;122:440-55. [DOI: 10.1016/j.clinph.2010.06.025] [Cited by in Crossref: 54] [Cited by in F6Publishing: 60] [Article Influence: 4.5] [Reference Citation Analysis]
677 Poropatich KO, Walker CL, Black RE. Quantifying the association between Campylobacter infection and Guillain-Barré syndrome: a systematic review. J Health Popul Nutr 2010;28:545-52. [PMID: 21261199 DOI: 10.3329/jhpn.v28i6.6602] [Cited by in Crossref: 97] [Cited by in F6Publishing: 104] [Article Influence: 8.1] [Reference Citation Analysis]
678 Leijten F, Poortvliet D, Weerd A. The neurological examination in the assessment of polyneuropathy in mechanically ventilated patients. European Journal of Neurology 1997;4:124-9. [DOI: 10.1111/j.1468-1331.1997.tb00317.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
679 Palace J, Hughes R. Guillain-Barré syndrome with severe persistent disability: relationship to hyperacute Guillain-Barré syndrome. European Journal of Neurology 1994;1:21-7. [DOI: 10.1111/j.1468-1331.1994.tb00046.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
680 Burwen DR, Ball R, Bryan WW, Izurieta HS, La Voie L, Gibbs NA, Kliman R, Braun MM. Evaluation of Guillain-Barré Syndrome among recipients of influenza vaccine in 2000 and 2001. Am J Prev Med 2010;39:296-304. [PMID: 20837279 DOI: 10.1016/j.amepre.2010.05.022] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
681 Simmons Z. Treatment and Management of Autoimmune Neuropathies. Neuromuscular Disorders: Treatment and Management. Elsevier; 2011. pp. 215-35. [DOI: 10.1016/b978-1-4377-0372-6.00014-1] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
682 Khan F, Louisa NG. Guillain–Barré Syndrome. Encyclopedia of Clinical Neuropsychology 2011. [DOI: 10.1007/978-0-387-79948-3_554] [Reference Citation Analysis]
683 Rezania K. Neuromuscular Diseases in Pregnancy. Neurological Disorders and Pregnancy 2011. [DOI: 10.1016/b978-0-12-384911-3.00009-9] [Reference Citation Analysis]
684 Orlikowski D, Sharshar T. Poliradicolonevrite acuta: la sindrome di Guillain-Barré. EMC - AKOS - Trattato di Medicina 2011;13:1-7. [DOI: 10.1016/s1634-7358(11)70645-3] [Reference Citation Analysis]
685 Weimer MB, Reese JJ, Tilton AH. Acute Neuromuscular Diseases and Disorders. Pediatric Critical Care 2011. [DOI: 10.1016/b978-0-323-07307-3.10064-3] [Reference Citation Analysis]
686 Couch RB. Occurrences of the Guillain–Barré Syndrome (GBS) After Vaccinations with the 1976 Swine A/H1N1 Vaccine, and Evolution of the Concern for an Influenza Vaccine-GBS Association. Influenza Vaccines for the Future 2011. [DOI: 10.1007/978-3-0346-0279-2_16] [Reference Citation Analysis]
687 Campbell W, Filler AG. Peripheral Neuropathies. Youmans Neurological Surgery 2011. [DOI: 10.1016/b978-1-4160-5316-3.00236-7] [Reference Citation Analysis]
688 Orlikowski D, Sharshar T. Polyradiculonévrite aiguë : le syndrome de Guillain-Barré. EMC - Traité de médecine AKOS 2011;6:1-7. [DOI: 10.1016/s1634-6939(11)52311-7] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
689 Halawa EF, Ahmed D, Nada MA. Guillain-Barré syndrome as a prominent cause of childhood acute flaccid paralysis in post polio eradication era in Egypt. Eur J Paediatr Neurol 2011;15:241-6. [PMID: 21169042 DOI: 10.1016/j.ejpn.2010.11.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
690 Yerdelen D, Karataş M. Neurological complications without eclampsia during pregnancy in Turkey: Neurological complications and pregnancy. Journal of Obstetrics and Gynaecology Research 2011;37:202-8. [DOI: 10.1111/j.1447-0756.2010.01337.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
691 Caillet C, Durrieu G, Jacquet A, Faucher A, Ouaret S, Perrault-Pochat MC, Kreft-Jaïs C, Castot A, Montastruc JL; French Network of Pharmacovigilance Centres. Safety surveillance of influenza A(H1N1)v monovalent vaccines during the 2009-2010 mass vaccination campaign in France. Eur J Clin Pharmacol 2011;67:649-51. [PMID: 21153631 DOI: 10.1007/s00228-010-0961-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
692 Abai S, Kim SB, Kim JP, Lim YJ. Guillain-barré syndrome combined with acute cervical myelopathy. J Korean Neurosurg Soc 2010;48:298-300. [PMID: 21082065 DOI: 10.3340/jkns.2010.48.3.298] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
693 van Doorn PA, Kuitwaard K, Walgaard C, van Koningsveld R, Ruts L, Jacobs BC. IVIG treatment and prognosis in Guillain-Barré syndrome. J Clin Immunol. 2010;30 Suppl 1:S74-S78. [PMID: 20396937 DOI: 10.1007/s10875-010-9407-4] [Cited by in Crossref: 69] [Cited by in F6Publishing: 75] [Article Influence: 5.3] [Reference Citation Analysis]
694 Terui K, Takahashi Y, Sasaki S, Kudo K, Kamio T, Ito E. Guillain-Barré Syndrome Mimicking Acute Methotrexate-associated Encephalopathy in an Adolescent Patient With Lymphoblastic Lymphoma. Journal of Pediatric Hematology/Oncology 2010;32:615-6. [DOI: 10.1097/mph.0b013e3181d204b1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
695 D’aguanno S, Franciotta D, Lupisella S, Barassi A, Pieragostino D, Lugaresi A, Centonze D, D’eril GM, Bernardini S, Federici G, Urbani A. Protein profiling of Guillain–Barrè syndrome cerebrospinal fluid by two-dimensional electrophoresis and mass spectrometry. Neuroscience Letters 2010;485:49-54. [DOI: 10.1016/j.neulet.2010.08.060] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
696 Incecik F, Ozlem Hergüner M, Altunbasak S. Guillain–Barré syndrome in children. Neurol Sci 2011;32:381-5. [DOI: 10.1007/s10072-010-0434-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
697 Winer JB. Guillain-Barré syndrome: clinical variants and their pathogenesis. J Neuroimmunol 2011;231:70-2. [PMID: 20947177 DOI: 10.1016/j.jneuroim.2010.09.017] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
698 Nyati KK, Prasad KN, Verma A, Paliwal VK. Correlation of matrix metalloproteinases-2 and -9 with proinflammatory cytokines in Guillain-Barré syndrome. J Neurosci Res 2010;88:3540-6. [PMID: 20936699 DOI: 10.1002/jnr.22514] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
699 Khan F, Ng L, Amatya B, Brand C, Turner-Stokes L. Multidisciplinary care for Guillain-Barré syndrome. Cochrane Database Syst Rev 2010;:CD008505. [PMID: 20927774 DOI: 10.1002/14651858.CD008505.pub2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 20] [Article Influence: 0.9] [Reference Citation Analysis]
700 Martinez V, Fletcher D, Martin F, Orlikowski D, Sharshar T, Chauvin M, Bouhassira D, Attal N. Small fibre impairment predicts neuropathic pain in Guillain–Barré syndrome. Pain 2010;151:53-60. [DOI: 10.1016/j.pain.2010.05.017] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 3.3] [Reference Citation Analysis]
701 Mulkey SB, Glasier CM, El-nabbout B, Walters WD, Ionita C, Mccarthy MH, Sharp GB, Shbarou RM. Nerve Root Enhancement on Spinal MRI in Pediatric Guillain-Barré Syndrome. Pediatric Neurology 2010;43:263-9. [DOI: 10.1016/j.pediatrneurol.2010.05.011] [Cited by in Crossref: 41] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
702 Pritchard J. Guillain-Barré syndrome. Clin Med (Lond) 2010;10:399-401. [PMID: 20849020 DOI: 10.7861/clinmedicine.10-4-399] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
703 Kokubun N, Nishibayashi M, Uncini A, Odaka M, Hirata K, Yuki N. Conduction block in acute motor axonal neuropathy. Brain 2010;133:2897-908. [PMID: 20855419 DOI: 10.1093/brain/awq260] [Cited by in Crossref: 125] [Cited by in F6Publishing: 132] [Article Influence: 9.6] [Reference Citation Analysis]
704 Ye Y, Zhu D, Wang K, Wu J, Feng J, Ma D, Xing Y, Jiang X. Clinical and electrophysiological features of the 2007 Guillain-Barré syndrome epidemic in northeast China. Muscle Nerve 2010;42:311-4. [PMID: 20589890 DOI: 10.1002/mus.21701] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
705 Koike H, Atsuta N, Adachi H, Iijima M, Katsuno M, Yasuda T, Fukada Y, Yasui K, Nakashima K, Horiuchi M, Shiomi K, Fukui K, Takashima S, Morita Y, Kuniyoshi K, Hasegawa Y, Toribe Y, Kajiura M, Takeshita S, Mukai E, Sobue G. Clinicopathological features of acute autonomic and sensory neuropathy. Brain 2010;133:2881-96. [PMID: 20736188 DOI: 10.1093/brain/awq214] [Cited by in Crossref: 71] [Cited by in F6Publishing: 71] [Article Influence: 5.5] [Reference Citation Analysis]
706 Mossberg N, Andersen O, Nordin M, Nilsson S, Svedhem A, Bergström T, Hellstrand K, Movitz C. Leukocyte oxygen radical production determines disease severity in the recurrent Guillain-Barré syndrome. J Inflamm (Lond) 2010;7:40. [PMID: 20691112 DOI: 10.1186/1476-9255-7-40] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
707 Wu SH, Lynn JJ, Chan YL, Chiu TF, Chen JC, Chang YC. Acute urinary retention as the initial manifestation of Guillain-Barré syndrome. Am J Emerg Med 2011;29:696.e3-4. [PMID: 20685060 DOI: 10.1016/j.ajem.2010.06.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
708 Hughes RA, Pritchard J, Hadden RD. Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain Barré syndrome. Cochrane Database of Systematic Reviews 2010. [DOI: 10.1002/14651858.cd008630] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
709 Hegen H, Wanschitz J, Ehling R, Deisenhammer F, Löscher WN, Reindl M, Berger T. Anti-alpha B-crystallin immunoreactivity in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J Peripher Nerv Syst 2010;15:150-2. [PMID: 20626779 DOI: 10.1111/j.1529-8027.2010.00264.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
710 Barisić N, Grković L. Long term clinical and electrophysiological assessment of Croatian children with corticospinal tract involvement in Guillain-Barré syndrome (GBS). Eur J Paediatr Neurol 2010;14:391-9. [PMID: 20678946 DOI: 10.1016/j.ejpn.2010.03.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
711 Khan F, Pallant JF, Ng L, Bhasker A. Factors associated with long-term functional outcomes and psychological sequelae in Guillain-Barre syndrome. J Neurol 2010;257:2024-31. [PMID: 20625757 DOI: 10.1007/s00415-010-5653-x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
712 Ghabaee M, Jabedari B, Al-E-Eshagh N, Ghaffarpour M, Asadi F. Serum and cerebrospinal fluid antioxidant activity and lipid peroxidation in Guillain-Barre syndrome and multiple sclerosis patients. Int J Neurosci 2010;120:301-4. [PMID: 20374079 DOI: 10.3109/00207451003695690] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 3.1] [Reference Citation Analysis]
713 Sinha S, Prasad KN, Jain D, Nyati KK, Pradhan S, Agrawal S. Immunoglobulin IgG Fc-receptor polymorphisms and HLA class II molecules in Guillain-Barré syndrome. Acta Neurol Scand 2010;122:21-6. [PMID: 20105138 DOI: 10.1111/j.1600-0404.2009.01229.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 2.2] [Reference Citation Analysis]
714 Prasad KN, Nyati KK, Verma A, Rizwan A, Paliwal VK. Tumor necrosis factor-alpha polymorphisms and expression in Guillain-Barré syndrome. Hum Immunol 2010;71:905-10. [PMID: 20600447 DOI: 10.1016/j.humimm.2010.06.013] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
715 Sartucci F, Bocci T, Borghetti D, Orlandi G, Manfredonia F, Murri L, Giannini F, Rossi A. Further insight on A-wave in acute and chronic demyelinating neuropathies. Neurol Sci 2010;31:609-16. [DOI: 10.1007/s10072-010-0354-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
716 Sejvar JJ, Kohl KS, Gidudu J, Amato A, Bakshi N, Baxter R, Burwen DR, Cornblath DR, Cleerbout J, Edwards KM, Heininger U, Hughes R, Khuri-Bulos N, Korinthenberg R, Law BJ, Munro U, Maltezou HC, Nell P, Oleske J, Sparks R, Velentgas P, Vermeer P, Wiznitzer M; Brighton Collaboration GBS Working Group. Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 2011;29:599-612. [PMID: 20600491 DOI: 10.1016/j.vaccine.2010.06.003] [Cited by in Crossref: 388] [Cited by in F6Publishing: 406] [Article Influence: 29.8] [Reference Citation Analysis]
717 Hughes RA, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain-Barré syndrome. Cochrane Database Syst Rev 2010;:CD002063. [PMID: 20556755 DOI: 10.1002/14651858.CD002063.pub4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
718 Watson BV, Doherty TJ. Localization of frequency-dependent conduction block in carpal tunnel syndrome. Muscle Nerve 2010;42:120-6. [PMID: 20544914 DOI: 10.1002/mus.21628] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
719 Kuijf ML, Samsom JN, van Rijs W, Bax M, Huizinga R, Heikema AP, van Doorn PA, van Belkum A, van Kooyk Y, Burgers PC, Luider TM, Endtz HP, Nieuwenhuis EE, Jacobs BC. TLR4-mediated sensing of Campylobacter jejuni by dendritic cells is determined by sialylation. J Immunol 2010;185:748-55. [PMID: 20525894 DOI: 10.4049/jimmunol.0903014] [Cited by in Crossref: 60] [Cited by in F6Publishing: 66] [Article Influence: 4.6] [Reference Citation Analysis]
720 Olivier N, Laribi H, Pages M, Camu W, Juntas Morales R. Syndrome de Guillain-Barré postopératoire récurrent. Revue Neurologique 2010;166:644-7. [DOI: 10.1016/j.neurol.2009.12.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
721 Sejvar JJ, Davis LE, Szabados E, Jackson AC. Delayed-onset and recurrent limb weakness associated with West Nile virus infection. J Neurovirol 2010;16:93-100. [PMID: 20166837 DOI: 10.3109/13550280903586378] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
722 Sandbrink F. Acquired Neuropathies. International Neurology 2010. [DOI: 10.1002/9781444317008.ch112] [Reference Citation Analysis]
723 Tremblay ME, Closon A, D'Anjou G, Bussières JF. Guillain-Barré syndrome following H1N1 immunization in a pediatric patient. Ann Pharmacother 2010;44:1330-3. [PMID: 20484170 DOI: 10.1345/aph.1P078] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
724 Khan F, Ng L, Amatya B, Brand C, Turner-stokes L, Khan F. Multidisciplinary care for Guillain-Barré syndrome. Cochrane Database of Systematic Reviews. Chichester: John Wiley & Sons, Ltd; 1996. [DOI: 10.1002/14651858.cd008505] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
725 Shah DN. The Spectrum of Guillain-Barré Syndrome. Disease-a-Month 2010;56:262-5. [DOI: 10.1016/j.disamonth.2010.02.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
726 Sivadon-Tardy V, Orlikowski D, Porcher R, Ronco E, Caudie C, Roussi J, Fauchère JL, Mégraud F, Tabor H, Sharshar T. Detection of Campylobacter jejuni by culture and real-time PCR in a French cohort of patients with Guillain-Barre syndrome. J Clin Microbiol. 2010;48:2278-2281. [PMID: 20410350 DOI: 10.1128/JCM.00381-10] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
727 Tabera Hernández MDC, García MT. Síndrome de Guillain-Barré. FMC - Formación Médica Continuada en Atención Primaria 2010;17:271-272. [DOI: 10.1016/s1134-2072(10)70108-0] [Reference Citation Analysis]
728 Ghabaee M, Ghanbarian D, Brujeni GN, Bokaei S, Siavoshi F, Gharibzadeh S. Could Helicobacter pylori play an important role in axonal type of Guillain-Barré Syndrome pathogenesis? Clinical Neurology and Neurosurgery 2010;112:193-8. [DOI: 10.1016/j.clineuro.2009.11.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
729 de Vries JM, Hagemans ML, Bussmann JB, van der Ploeg AT, van Doorn PA. Fatigue in neuromuscular disorders: focus on Guillain-Barré syndrome and Pompe disease. Cell Mol Life Sci 2010;67:701-13. [PMID: 20196238 DOI: 10.1007/s00018-009-0184-2] [Cited by in Crossref: 46] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
730 Rath B, Magnus M, Heininger U. Evaluating the Brighton Collaboration case definitions, aseptic meningitis, encephalitis, myelitis, and acute disseminated encephalomyelitis, by systematic analysis of 255 clinical cases. Vaccine 2010;28:3488-95. [PMID: 20197145 DOI: 10.1016/j.vaccine.2010.02.053] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
731 Pithadia AB, Kakadia N. Guillain-Barré syndrome (GBS). Pharmacological Reports 2010;62:220-32. [DOI: 10.1016/s1734-1140(10)70261-9] [Cited by in Crossref: 60] [Cited by in F6Publishing: 50] [Article Influence: 4.6] [Reference Citation Analysis]
732 Kuitwaard K, Bos-Eyssen ME, Blomkwist-Markens PH, van Doorn PA. Recurrences, vaccinations and long-term symptoms in GBS and CIDP. J Peripher Nerv Syst 2009;14:310-5. [PMID: 20021573 DOI: 10.1111/j.1529-8027.2009.00243.x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 68] [Article Influence: 5.0] [Reference Citation Analysis]
733 van Nes SI, Vanhoutte EK, Faber CG, Garssen M, van Doorn PA, Merkies IS; PeriNomS Study Group. Improving fatigue assessment in immune-mediated neuropathies: the modified Rasch-built fatigue severity scale. J Peripher Nerv Syst 2009;14:268-78. [PMID: 20021568 DOI: 10.1111/j.1529-8027.2009.00238.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 3.3] [Reference Citation Analysis]
734 Dionne A, Nicolle MW, Hahn AF. Clinical and electrophysiological parameters distinguishing acute-onset chronic inflammatory demyelinating polyneuropathy from acute inflammatory demyelinating polyneuropathy. Muscle Nerve 2010;41:202-7. [PMID: 19882646 DOI: 10.1002/mus.21480] [Cited by in Crossref: 78] [Cited by in F6Publishing: 79] [Article Influence: 6.0] [Reference Citation Analysis]
735 Hughes RA, Swan AV, van Doorn PA. Corticosteroids for Guillain-Barré syndrome. Cochrane Database Syst Rev 2010;:CD001446. [PMID: 20166061 DOI: 10.1002/14651858.CD001446.pub3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
736 Nyati KK, Prasad KN, Rizwan A, Verma A, Paliwal VK, Pradhan S. Lymphocyte transformation test detects a response to Campylobacter jejuni antigens in patients with Guillain-Barré syndrome. Med Microbiol Immunol 2010;199:109-16. [DOI: 10.1007/s00430-010-0144-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
737 Linden VVD, Paz JAD, Casella EB, Marques-dias MJ. Guillain-Barré syndrome in children: clinic, laboratorial and epidemiologic study of 61 patients. Arq Neuro-Psiquiatr 2010;68:12-7. [DOI: 10.1590/s0004-282x2010000100004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
738 Bonanni L, Onofrj V, Scorrano V, Onofrj M, Thomas A. Severe outcome of pharyngeal-cervical-brachial pure motor axonal neuropathy. Open Neurol J 2010;4:1-4. [PMID: 20309392 DOI: 10.2174/1874205X01004010001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
739 Meyer Zu Horste G, Heidenreich H, Lehmann HC, Ferrone S, Hartung HP, Wiendl H, Kieseier BC. Expression of antigen processing and presenting molecules by Schwann cells in inflammatory neuropathies. Glia 2010;58:80-92. [PMID: 19544394 DOI: 10.1002/glia.20903] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 3.4] [Reference Citation Analysis]
740 Liu GT, Volpe NJ, Galetta SL. Eyelid and facial nerve disorders. Neuro-Ophthalmology 2010. [DOI: 10.1016/b978-1-4160-2311-1.00014-7] [Reference Citation Analysis]
741 Yardimci N, Avci AY, Kayhan E, Benli S. Bilateral facial nerve enhancement demonstrated by magnetic resonance imaging in Guillain-Barré syndrome. Neurol Sci 2009;30:431-3. [PMID: 19714293 DOI: 10.1007/s10072-009-0120-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
742 Islam Z, van Belkum A, Cody AJ, Tabor H, Jacobs BC, Talukder KA, Endtz HP. Campylobacter jejuni HS:23 and Guillain-Barre syndrome, Bangladesh. Emerg Infect Dis 2009;15:1315-7. [PMID: 19751603 DOI: 10.3201/eid1508.090120] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
743 Huang S, Li L, Liang S, Wang W. Conversion of peripheral CD4+CD25− T cells to CD4+CD25+ regulatory T cells by IFN-γ in patients with Guillain-Barré syndrome. Journal of Neuroimmunology 2009;217:80-4. [DOI: 10.1016/j.jneuroim.2009.10.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
744 Nyati KK, Prasad KN, Verma A, Singh AK, Rizwan A, Sinha S, Paliwal VK, Pradhan S. Association of TLR4 Asp299Gly and Thr399Ile polymorphisms with Guillain-Barré syndrome in Northern Indian population. J Neuroimmunol 2010;218:116-9. [PMID: 19913922 DOI: 10.1016/j.jneuroim.2009.10.018] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 2.6] [Reference Citation Analysis]
745 Rudolph T, Larsen JP, Farbu E. Is there a need for long-term follow-up in chronic idiopathic polyneuropathy? Acta Neurol Scand 2009;120:347-52. [PMID: 19744135 DOI: 10.1111/j.1600-0404.2009.01245.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
746 Kuitwaard K, de Gelder J, Tio-gillen AP, Hop WCJ, van Gelder T, van Toorenenbergen AW, van Doorn PA, Jacobs BC. Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barré syndrome. Ann Neurol 2009;66:597-603. [DOI: 10.1002/ana.21737] [Cited by in Crossref: 147] [Cited by in F6Publishing: 151] [Article Influence: 10.5] [Reference Citation Analysis]
747 Islam Z, van Belkum A, Wagenaar JA, Cody AJ, de Boer AG, Tabor H, Jacobs BC, Talukder KA, Endtz HP. Comparative genotyping of Campylobacter jejuni strains from patients with Guillain-Barré syndrome in Bangladesh. PLoS One 2009;4:e7257. [PMID: 19789649 DOI: 10.1371/journal.pone.0007257] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
748 Mcdaneld LM, Fields JD, Bourdette DN, Bhardwaj A. Immunomodulatory Therapies in Neurologic Critical Care. Neurocrit Care 2010;12:132-43. [DOI: 10.1007/s12028-009-9274-0] [Cited by in Crossref: 44] [Cited by in F6Publishing: 31] [Article Influence: 3.1] [Reference Citation Analysis]
749 Kiriyama T, Hirano M, Kusunoki S, Morita D, Hirakawa M, Tonomura Y, Kitauchi T, Ueno S. Asymmetrical weakness associated with central nervous system involvement in a patient with guillain-barrè syndrome. Clin Med Case Rep 2009;2:51-4. [PMID: 24179374 DOI: 10.4137/ccrep.s3180] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
750 Kalra V, Chaudhry R, Dua T, Dhawan B, Sahu JK, Mridula B. Association of Campylobacter jejuni infection with childhood Guillain-Barré syndrome: a case-control study. J Child Neurol 2009;24:664-8. [PMID: 19491112 DOI: 10.1177/0883073808325649] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
751 Edvardsson B, Persson S. Polyneuritis cranialis presenting with severe autonomic dysfunction. Muscle Nerve 2009;40:316-317. [DOI: 10.1002/mus.21402] [Reference Citation Analysis]
752 Strauss J, Aboab J, Rottmann M, Porcher R, Polito A, Ikka L, Durand M, Orlikowski D, Devaux C, Lofaso F, Annane D, Gaillard J, Sharshar T. Plasma cortisol levels in Guillain-Barré syndrome: . Critical Care Medicine 2009;37:2436-40. [DOI: 10.1097/ccm.0b013e3181a0fdfc] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
753 Khan F, Ng L. Guillain-Barré syndrome: An update in rehabilitation. International Journal of Therapy and Rehabilitation 2009;16:451-60. [DOI: 10.12968/ijtr.2009.16.8.43483] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
754 Galldiks N, Dohmen C, Neveling M, Fink GR, Haupt WF. Selective Immune Adsorption Treatment of Severe Guillain Barré Syndrome in the Intensive Care Unit. Neurocrit Care 2009;11:317-21. [DOI: 10.1007/s12028-009-9252-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
755 Eckert T, Bartels C, Mawrin C, Feistner H, Welte T. A case of influenza vaccination induced Guillain Barré syndrome with normal cerebrospinal fluid protein and improvement on treatment with corticosteroids. Scandinavian Journal of Infectious Diseases 2009;37:621-3. [DOI: 10.1080/00365540510038974] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
756 Demi˙r SÖ, Köseoğlu F. Factors associated with health-related quality of life in patients with severe Guillain – Barré syndrome. Disability and Rehabilitation 2009;30:593-9. [DOI: 10.1080/09638280701352626] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
757 Créange A, Temam G, Lefaucheur J. Lumbosacral Acute Demyelinating Polyneuropathy following Hepatitis B Vaccination. Autoimmunity 2009;30:143-6. [DOI: 10.3109/08916939908993848] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
758 Petzold A, Brettschneider J, Jin K, Keir G, Murray N, Hirsch N, Itoyama Y, Reilly M, Takeda A, Tumani H. CSF protein biomarkers for proximal axonal damage improve prognostic accuracy in the acute phase of Guillain-Barré syndrome: CSF Protein Biomarkers. Muscle Nerve 2009;40:42-9. [DOI: 10.1002/mus.21239] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 2.8] [Reference Citation Analysis]
759 Comi C, Osio M, Ferretti M, Mesturini R, Cappellano G, Chiocchetti A, Carecchio M, Nascimbene C, Varrasi C, Cantello R, Mariani C, Monaco F, Dianzani U. Defective Fas-mediated T-cell apoptosis predicts acute onset CIDP. Journal of the Peripheral Nervous System 2009;14:101-6. [DOI: 10.1111/j.1529-8027.2009.00219.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
760 Orlikowski D, Terzi N, Blumen M, Sharshar T, Raphael JC, Annane D, Lofaso F. Tongue weakness is associated with respiratory failure in patients with severe Guillain-Barré syndrome. Acta Neurol Scand 2009;119:364-70. [PMID: 18976323 DOI: 10.1111/j.1600-0404.2008.01107.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
761 Dekker MJHJ, van den Akker ELT, Koper JW, Manenschijn L, Geleijns K, Ruts L, van Rijs W, Tio-gillen AP, van Doorn PA, Lamberts SWJ, Jacobs BC. Effect of glucocorticoid receptor gene polymorphisms in Guillain-Barré syndrome. Journal of the Peripheral Nervous System 2009;14:75-83. [DOI: 10.1111/j.1529-8027.2009.00216.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
762 Vucic S, Kiernan MC, Cornblath DR. Guillain-Barré syndrome: An update. Journal of Clinical Neuroscience 2009;16:733-41. [DOI: 10.1016/j.jocn.2008.08.033] [Cited by in Crossref: 166] [Cited by in F6Publishing: 177] [Article Influence: 11.9] [Reference Citation Analysis]
763 Kuitwaard K, van Doorn PA. Newer Therapeutic Options for Chronic Inflammatory Demyelinating Polyradiculoneuropathy: . Drugs 2009;69:987-1001. [DOI: 10.2165/00003495-200969080-00004] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 2.3] [Reference Citation Analysis]
764 Noviello TB, Noviello TC, Purisch S, Lamounier RN, Reis JS, Menezes PA, Calsolari MR. [Diabetes ketoacidosis associated with Guillan-Barré syndrome]. Arq Bras Endocrinol Metabol. 2008;52:562-565. [PMID: 18506283 DOI: 10.1590/s0004-27302008000300018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
765 Chiang HL, Lyu RK, Tseng MY, Chang KH, Chang HS, Hsu WC, Kuo HC, Chu CC, Wu YR, Ro LS, Huang CC, Chen CM. Analyses of transthyretin concentration in the cerebrospinal fluid of patients with Guillain-Barré syndrome and other neurological disorders. Clin Chim Acta 2009;405:143-7. [PMID: 19410571 DOI: 10.1016/j.cca.2009.04.022] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
766 Rabie M, Nevo Y. Childhood acute and chronic immune-mediated polyradiculoneuropathies. European Journal of Paediatric Neurology 2009;13:209-18. [DOI: 10.1016/j.ejpn.2008.04.009] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 2.6] [Reference Citation Analysis]
767 Kalra V, Sankhyan N, Sharma S, Gulati S, Choudhry R, Dhawan B. Outcome in childhood Guillain-Barré syndrome. Indian J Pediatr 2009;76:795-9. [PMID: 19381495 DOI: 10.1007/s12098-009-0125-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 30] [Article Influence: 1.7] [Reference Citation Analysis]
768 Deng Y, Ma XJ, Peng W, Sanvito L. Acupuncture for Guillain-Barré syndrome. Cochrane Database of Systematic Reviews 2009. [DOI: 10.1002/14651858.cd007797] [Reference Citation Analysis]
769 Yardimci N, Gulsen S, Avci AY, Altinors N, Zileli T, Can U. Can subdural hematoma be a trigger for Guillain-Barré syndrome? Int J Neurosci 2009;119:366-72. [PMID: 19116843 DOI: 10.1080/00207450802480135] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
770 Gupta D, Nair M, Baheti NN, Sarma PS, Kuruvilla A; Diplomate-American Board. Electrodiagnostic and clinical aspects of Guillain-Barré syndrome: an analysis of 142 cases. J Clin Neuromuscul Dis 2008;10:42-51. [PMID: 19169089 DOI: 10.1097/CND.0b013e31818e9510] [Cited by in Crossref: 18] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]
771 Sharma KR, Saadia D, Facca AG, Resnick S, Ayyar DR. Clinical and electromyographic deep tendon reflexes in polyneuropathy: diagnostic value and prevalence*. Acta Neurol Scand 2009;119:224-32. [PMID: 18664243 DOI: 10.1111/j.1600-0404.2008.01078.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
772 Edvardsson B, Persson S. Polyneuritis cranialis presenting with anti-GQ1b IgG antibody. J Neurol Sci 2009;281:125-6. [PMID: 19324375 DOI: 10.1016/j.jns.2009.02.340] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
773 Ho D, Thakur K, Gorson KC, Ropper AH. Influence of critical illness on axonal loss in Guillain-Barré syndrome. Muscle Nerve 2009;39:10-5. [PMID: 19086065 DOI: 10.1002/mus.21207] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
774 . Individual patients who experienced both Guillain-Barré syndrome and CIDP. Journal of the Peripheral Nervous System 2009;14:66-8. [DOI: 10.1111/j.1529-8027.2009.00208.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [